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We learn more by looking for the answer to a question and not finding it  
than we do from learning the answer itself.  
Lloyd Alexander (1924 - 2007) 
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An apparently new disease affecting cattle was first described in North America in 
1946 (Childs, 1946; Olafson et al., 1946). In some herds one to two animals displayed severe 
clinical signs such as watery and haemorrhagic diarrhoea, tenesmus, depression, anorexia, 
ulceration of oral mucosa, nasal discharge and hypersalivation. These animals died within a 
week (Childs, 1946). The latter report was considered to be the first description of mucosal 
disease (MD) in cattle (Fig. 1) (Pritchard, 1963). Attempts to reproduce these clinical signs 
failed, but resulted in a transmissible disease with additional, but less severe clinical signs: 
respiratory disease, leukopenia, drop in milk production and increased abortion rates (Olafson 
et al., 1946). Rinderpest virus and winter dysentery virus were excluded as causal agents of 
this disease and as no bacteria could be isolated from the inoculum used for a transmission 
experiment, this reproducible disease with varying severity became known as virus diarrhoea 
or bovine viral diarrhoea (BVD) (Olafson et al., 1946; Pritchard, 1963).  
 
Fig. 1. This 18-month-old bull suffering from mucosal disease was presented at the Faculty of 
Veterinary Medicine of Ghent University (2010). Typical clinical signs were erosions of the 
gastrointestinal tract causing hypersalivation and haemorrhagic diarrhoea with tenesmus. The 
animal succumbed soon after arrival. 
Further research demonstrated by using virus neutralization that BVD en MD were 
different disease manifestations, caused by the same virus, Bovine Viral Diarrhoea Virus 
(BVDV) (Gillespie et al., 1961; Kniazeff et al., 1961; Thomson and Savan, 1963). In 1984 
McClurkin et al. described the experimental infection with BVDV of cattle in early 
pregnancy. This resulted in the production of calves persistently infected (PI) with BVDV 
(i.e. the calves were continuously BVDV viraemic) and immune tolerant (i.e. the calves 
  Preface 
4 
 
remained BVDV seronegative after infection with the same BVDV strain). That same year 
MD was experimentally reproduced in PI cattle (Brownlie et al., 1984).  
It was believed that cases of severe clinical disease associated with BVDV all resulted 
from MD in PI cattle, while BVD was designated as a mild disease. However, outbreaks of 
thrombocytopenia resulting in haemorrhages and death associated with BVDV in non-PI 
cattle were reported in the late 1980s (Perdrizet et al., 1987; Rebhun et al., 1989). 
Furthermore, acute BVD outbreaks with high mortality and without explicit signs of 
haemorrhagic disorder were described in Canada and the United States in the 1990s (Pellerin 
et al., 1994; Carman et al., 1998).  
This short historical overview already briefly touched the complex nature of BVDV, 
whose epidemiology, broad range of clinical manifestations, diagnostic tests and factors 
associated with an increased risk of BVDV infection will be further introduced. By the 
aforementioned, predominantly American references the reader could assume BVD-MD is 
especially a problem in North America, but numerous epidemiological studies have 
demonstrated that the virus is worldwide spread (Houe, 2005), including Belgium. Taking 
into account the economic consequences of BVD-MD, control strategies have been 
established. The present doctoral thesis aimed at gaining insight into the current BVDV 
prevalence and implementation of control measures in Belgian cattle herds. The obtained 
results were used to make recommendations for a future mandatory national control 
programme. 
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The viruses 
 
BVDV are positive sense, single stranded RNA viruses belonging to the Pestivirus 
genus, within the Flaviviridae family. Pestiviruses were considered to be host-specific and 
were therefore divided into groups differentiating between porcine, bovine and ovine viruses 
(Ridpath, 2013a). However, although the natural host of BVDV is bovine, natural infections 
of pigs and sheep with BVDV are reported (Vilcek et al., 1997; Tao et al., 2013). Nowadays, 
genomic sequence and antigenic relatedness are used to distinguish subgroups in the 
Pestivirus genus, which currently comprises four recognized species: Border Disease Virus 
(BDV), Classical Swine Fever Virus (CSFV), BVDV-1, and BVDV-2. Because of the high 
rate of genetic mutations observed with these pestiviruses on the one hand and with the 
improvement of virus detection on the other hand, it is assumed that the Pestivirus genus will 
continue to expand (Ridpath, 2013a). Four additional “atypical” Pestivirus species have been 
proposed: Giraffe, Pronghorn, Bungowannah and HoBi (Bauermann et al., 2013) (Fig. 1). 
Because of a high degree of genomic sequence and antigenic relatedness to BVDV-1 and 
BVDV-2, the HoBi species was proposed as BVDV-3 (Liu et al., 2009). 
Single stranded RNA viruses, such as BVDV, are subject to genomic modifications 
due to high rates of point mutations and recombinations, resulting in heterogeneity within 
recognized species (Bolin and Grooms, 2004; Ridpath, 2013a). Because some BVDV isolates 
were as different from each other as from CSFV (Ridpath et al., 1994), the previously 
recognised Bovine Diarrhoea Virus species was split up into the currently recognised species 
BVDV-1 and BVDV-2 (ICTV 7
th
 Report, 1999). Both species (types) are divided into several 
genetic subspecies (subtypes). The biological significance of these subgroupings is a matter of 
debate (Ridpath, 2005). Even between strains (isolates) of a same subspecies antigenic 
differences were noticed (Vilcek et al., 2001). In conclusion, BVDV is not one virus, but a 
group of many genetic variants. 
Both BVDV species are worldwide spread, although the prevalence of BVDV-2 is 
clearly higher in North America compared to Europe (Ridpath, 2005). In Belgium most field 
isolates are identified as BVDV-1b (Couvreur et al., 2002), while also BVDV-2 has been 
described (Couvreur et al., 2002; Letellier et al., 2010). Isolates belonging to the HoBi-like 
(BVDV-3) species have not yet been reported in Belgium, but natural infections have been 
described in Italy (Decaro et al., 2011).  
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Regardless of the species, BVDV may exist as one of two biotypes. Based on their 
ability to cause cytopathic effects in cell cultures, strains are classified as cytopathic (or 
cytopathogenic, cp) and non-cytopathic (or non-cytopathogenic, ncp) biotypes (Peterhans et 
al., 2010). Although this distinction is made in vitro, the difference between the two biotypes 
plays a role in the pathogenesis of BVD. Through genetic recombination cp viruses arise from 
ncp viruses, with the combination of cp and ncp viruses in PI animals leading to MD (Goens, 
2002; Peterhans et al., 2010).  
 
 
Fig. 1. Phylogenetic tree of Pestivirus genus. The currently recognized species (BVDV-1, 
BVDV-2, CSFV and BDV) and four “atypical” species (Giraffe, Pronghorn, Bungowannah 
and HoBi), marked with ‘●’, are shown. The genetic distances between species and strains is 
proportional to the branch lengths. Analysis was performed on partial sequences, which 
consisted of the amino acids from the first five polypeptides Npro; C; Erns; E1 and E2. 
Source: Bauermann et al., 2013. 
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Transmission 
  
BVDV can be maintained within a susceptible cattle population through horizontal 
and vertical transmission, depending on when the animal became infected. Following an acute 
infection acquired postnatally, infected animals can shed the virus transiently. Following a 
congenital infection between the second and fourth month of gestation, animals can become 
persistently infected (PI) and continuously shed the virus (Fig. 2). BVDV can also be spread 
indirectly. Both active immunity (following a transient BVDV infection) and passive 
immunity (colostral antibodies or vaccination) have a considerable impact on the transmission 
rate of BVDV, which can be expressed by the reproduction ratio.  
 
Fig. 2. BVDV transmission in a susceptible cattle population is principally maintained by 
persistently infected (PI) calves, but also transiently infected (TI) animals can spread the 
virus. PI calves are congenitally infected (vertical transmission) with BVDV and continuously 
shed the virus. TI animals result from acute, postnatal BVDV infections (horizontal 
transmission). TI animals in early gestation can give birth to new PI animals. Source: Liebler-
Tenorio, 2005. 
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Transient infections 
The most frequent route of BVDV infections is by oro-nasal uptake of BVDV. Acute 
natural BVDV infections of BVDV seronegative cattle result in a transient viraemia, starting 
3 days post-infection (Lanyon et al., 2014). The duration of virus shedding by transiently 
infected (TI) animals likely depends on the virulence of BVDV strains and their efficiency to 
replicate (Bolin and Ridpath, 1992; Houe, 1999) and varies from less than 1 day to 2 weeks 
(Thurmond, 2005; Lanyon et al., 2014). 
TI animals shed the virus through all excretions and secretions, such as tears, milk, 
saliva, urine, nasal discharge, semen, foetal fluids and faeces (Meyling et al., 1990), although 
faeces are a poor source of virus (Brownlie et al., 1987). Following the clearance of the virus 
from the blood and a systemic immune response, a prolonged spread of BVDV may still be 
possible, due to sequestration of the virus (Baule et al., 2001; Givens and Marley, 2013). In a 
study performed by Baule et al. (2001), nasal swabs were intermittently positive in virus 
isolation up to 31 days following experimental infection of calves. Similarly, protected by the 
blood testicle barrier the semen of TI bulls may remain BVDV positive for more than 2 years 
(Kirkland et al., 1991; Voges et al., 1998; Niskanen et al., 2002a; Givens et al., 2009).  
Because of the short duration of the infection and the intermittent shedding of 
relatively low amounts of virus, TI animals are believed to be of minor importance in the 
epidemiology of BVDV (Lindberg and Houe, 2005). Some studies demonstrated no spread of 
BVDV by experimentally infected animals (Niskanen et al., 2000; Niskanen et al., 2002b). 
Nevertheless, it has been suggested during severe outbreaks with BVDV-2 TI animals 
significantly contribute to virus spread (Ridpath et al., 2006). A recent outbreak of severe 
disease associated with BVDV-2 in Germany and the Netherlands is believed to have spread 
solely through TI animals, since no PI animals were detected (Doll and Holsteg, 2013; Moen, 
2013). Also other reports suggest that BVDV can be maintained in the population only by 
transient infections (Moerman et al., 1993; Moen et al., 2005). However, sufficient evidence 
to prove that transmission was not due to PI animals that have escaped identification should 
be provided in these cases (Lindberg and Houe, 2005). 
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Persistent infections 
During infection with BVDV the pregnant uterus, placenta and foetus easily become 
infected (Fredriksen et al., 1999a). Depending on the biotype of the BVDV strain and stage of 
gestation, infection of the foetus results in early embryonic death, abortion, congenital 
malformations, the birth of PI calves or the birth of healthy calves (Grooms, 2004). When the 
infection of the foetus occurs with ncp virus between 30 and 125 days of gestation 
(McClurkin et al., 1984; Blanchard et al., 2010), viral proteins are recognized as self-antigens 
by the foetus, since it is not immunocompetent at that stage (Peterhans and Schweizer, 2013). 
These PI calves may be born apparently healthy, but remain lifelong infected and will 
persistently shed the virus (Brownlie, 1990).  
Pregnant PI dams invariably transmit the virus to the foetus, resulting in new 
generations of PI calves (Moennig and Liess, 1995). PI calves thus always result from 
congenital BVDV transmission, either by transmission from a PI dam to her foetus or via 
acute infection of the dam with ncp virus between day 30 and 125 of gestation. Semen from 
PI bulls contains large amounts of virus (Voges et al., 1998) and breeding with such semen 
can result in acute infection of BVDV seronegative dams and possibly a PI calf (Meyling and 
Jensen, 1988).  
During their life PI animals, and only PI animals, can suffer from MD, which is a highly fatal 
form of BVD and develops when cp BVDV appears in PI animals. The cp biotype arises from 
the persisting ncp biotype by mutations or recombinations in the PI animal or by 
superinfection with a cp strain from another PI animal suffering from MD and which is 
antigenically homologous to the persisting ncp strain (Brownlie et al., 1984; Peterhans et al., 
2010). While MD is in general fatal within 2-3 weeks (Brownlie et al., 1984), some PI 
animals develop chronic MD and may survive when superinfection occurs with a more 
heterologous cp strain (Baker, 1995). PI animals usually die young, but they can also reach 
the normal life span of commercial cattle and be used for reproduction since it was 
demonstrated that more than 10% of PI animals were older than 2 years (Presi et al., 2011). 
Taken into account this high mortality among PI animals, the prevalence of PI animals in a 
population infected with BVDV will usually be no more than 2% (Houe, 2005).   
Notwithstanding the low prevalence and their short life expectancy PI cattle play the 
principal role in BVDV transmission. Once colostrum-derived BVDV antibody titres have 
declined they continuously shed BVDV in large quantities through all their secretions and 
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excretions (Lindberg and Houe, 2005). In herds where cattle are housed in close contact a PI 
animal can infect up to 97% of susceptible cattle during a period of 6 months (Houe and 
Meyling, 1991; Houe et al., 1993).  
 
Indirect transmission 
 Like other enveloped viruses, BVDV is easily inactivated by organic solvents. 
However, considering the massive amounts of virus shed by PI animals, several studies have 
demonstrated that susceptible animals can become BVDV infected through indirect 
transmission. BVDV are shed by the foetal fluids at the birth of PI animals and can infect 
animals exposed to the uterine lochia or housed in pens where PI calves were born (Lindberg 
et al., 2004). Pens where PI animals have been housed can be a source of BVDV for a limited 
period of time and infect susceptible cattle (Niskanen and Lindberg, 2003). Material such as 
nose tongs or rectal gloves previously used on PI animals can transmit BVDV (Gunn, 1993; 
Lang-Ree et al., 1994). Flies can serve as mechanical vectors in BVDV transmission (Gunn, 
1993; Tarry et al., 1991). Cattle housed near a PI calf without direct contact can get infected 
through ambient air transmission (up to 10 m) (Niskanen and Lindberg, 2003). Iatrogenic 
transmission can occur by repeated use of the same needle (Gunn, 1993), contaminated 
vaccines (Barkema et al., 2001; Niskanen and Lindberg, 2003) or clothing (Ståhl et al., 2005). 
Embryos originating from BVDV infected animals (Brock et al., 1997) or washed with 
contaminated foetal calf serum (Bolin et al., 1991; Bolin and Ridpath, 1998) can transmit the 
virus to susceptible recipients. Although indirect BVDV transmission is of minor importance 
compared to direct animal contacts, attention should be paid to this transmission route as a 
control programme proceeds and the probability of direct contacts decreases (Hult and 
Lindberg, 2005). 
 
Immunity 
Colostral antibodies have a considerable impact on BVDV transmission. First, they 
decrease the amount of virus spread by infected animals. Secondly, the number of animals 
susceptible to infection are reduced and clinical signs are less pronounced. Low neutralizing 
antibody titres of 1:16-1:32 (i.e. two-fold dilution series that neutralize BVDV) are believed 
to be sufficient to offer protection against clinical signs associated with BVDV infections 
(Howard et al., 1989; Bolin and Ridpath, 1992). Depending on the quality and quantity of 
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colostrum consumed, calves are protected from BVDV infection during the first 2 to 4 months 
of life. In a study of Munoz-Zanzi et al. (2002) neutralizing colostral antibody titres in half of 
the calves declined to < 1:16 after about 110 days and 80 days of age for BVDV-1 and 
BVDV-2, respectively. The half-life of colostral antibodies in PI calves was much shorter 
compared to non-PI calves (5 to 11 days versus 3 weeks), resulting in a clearance of these 
antibodies in PI animals by 8 weeks of age (Palfi et al., 1993). The same study revealed that 
PI calves under protection of colostral antibodies shed only low amounts of BVDV. Colostral 
antibodies also interfere with diagnostic tests (Palfi et al., 1993; Zimmer et al., 2004; Fux and 
Wolf, 2012) and vaccination (Endsley et al., 2003) by blocking the virus or its antigens. For 
example, due to the neutralizing capacity of antibodies, BVDV is no longer able to propagate 
in cell culture and young PI calves can therefore be considered as false negative since they 
could not be detected by virus isolation (Palfi et al., 1993).  
A transient BVDV infection evokes an immunosuppression by an impairment of the 
innate immune response and a lymphopenia (Chase et al., 2004). This immunosuppression is 
followed by the development of both a cell mediated and humoral immune response (Chase, 
2013). The humoral immune response is characterized by the presence of serum antibodies 
from 2-3 weeks post-infection onwards (Howard et al., 1992). Animals remain BVDV 
seropositive during their entire life (normal life span of commercial cattle) (Brownlie, 1990; 
Fredriksen et al., 1999b). The fact that a TI animal remains seropositive for BVDV during its 
entire life may result from repeated stimulations of the immune response when BVDV is 
maintained within a population following the birth of one or more PI animals and subsequent 
infection of susceptible cattle in early gestation (Lindberg and Alenius, 1999). However, this 
could also indicate that the virus is still replicating and being presented to the lymphoid tissue 
in BVDV infected, recovered and immune cattle (Thurmond, 2005). This is supported by a 
study that was capable of isolating wild-type BVDV from peripheral blood mononuclear cells 
in BVDV seropositive cattle (Gogorza et al., 2005). Another study demonstrated that BVDV 
seropositive cattle can continue to carry virus in peripheral blood mononuclear cells for at 
least 98 days and transfer of infection was possible through blood transfer (Collins et al., 
2009). Although this experimental transfer of infection was possible, natural transfer of 
infection is believed to be unlikely (Lanyon et al., 2014). Protection against BVDV infection 
is dependent on the virus strain and the level and isotype of antibodies produced (cross-
protection). Neutralizing antibodies prevent disease development following homologous 
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challenge (Potgieter, 1995), but animals with neutralizing antibodies can develop viraemia 
(Nobiron et al., 2003). 
Immunization following vaccination will be introduced below.  
 
The reproduction ratio 
The transmission rate of an infectious disease, i.e. the potential to spread, in a 
population can be expressed by its reproduction ratio, R. The basic reproduction ratio, R0, is 
defined as the mean number of secondary infections arising from one typical infectious case 
introduced in a fully susceptible population (Kroese and de Jong, 2001; Lindberg and Houe, 
2005; Velthuis et al., 2007). The use of R0 is restricted to the situation without intervention 
(fully susceptible population) while the transmission rate is usually described by R in 
situations with control measures (e.g. vaccination) (Velthuis et al., 2007).  
A value for R0 of 4 means that one infectious animal can infect on average four new 
susceptible animals. R0 has thus a threshold value equal to 1. This means that an infection 
may spread when R0 > 1, possibly resulting in a major outbreak, and will fade out when R0 < 
1, always resulting in a minor outbreak (Lindberg and Houe, 2005; Velthuis et al., 2007). R0 
is determined by the following parameters (Lindberg and Houe, 2005; Thurmond, 2005): the 
probability of transmission during a contact between an infectious and susceptible animal (β), 
the number of contacts per time period (k) and the duration of the infectious period (d).  
As stated above, PI animals continuously shed massive amounts of virus, resulting in 
high values for the parameters β en d. The amount of virus spread by TI animals is much 
lower because of a much shorter duration of the infectious period and the relatively low 
amounts of virus shed, resulting in low values for the parameters β en d. PI animals are 
therefore considered as very successful virus transmitters (R0 assumed > 1), whereas TI 
animals are believed to be less important in spreading BVDV (R0 assumed < 1).  
Few studies were performed to determine R0 for horizontal BVDV transmission by TI 
animals. In pigs a limited horizontal transmission of BVDV-1b by experimentally infected 
pigs was demonstrated (Wieringa-Jelsma et al., 2006). Moerman et al. (1993) estimated that 
the horizontal BVDV transmission rate by TI cattle had an R0 of 3.3 (95% CI 2.6; 4.1). 
However, although separated from the study group, PI animals were present in the herd 
during this study. As these animals shed massive doses of virus, they may have attributed to 
General Introduction  Chapter 1 
17 
 
virus spread through indirect transmission (Niskanen and Lindberg, 2003; Lindberg et al., 
2004), resulting in an overestimation of R0.  
 
 
Clinical features 
 
Virulence of BVDV 
The clinical outcome of infection depends on host factors (e.g. immune status and 
pregnancy status), environmental factors (e.g. concurrent infections) and viral factors. It is 
generally assumed that variation in virulence exists between different BVDV isolates. 
However, the basis for clinical variation at the virus level is not understood (Bolin and 
Grooms, 2004). Disease severity is likely to be linked to the degree of viraemia (Walz et al., 
2001) and thus the propensity to replicate of the infecting strain (Bolin and Ridpath, 1992).  
Initially BVDV-2 was only associated with severe BVD outbreaks while BVDV-1 was 
linked to mild and subclinical infections. However, also BVDV-1 infections can result in 
severe clinical disease (Vilcek et al., 2001) and BVDV-2 isolates of low virulence are likely 
to predominate over virulent BVDV-2 isolates (Ridpath et al., 2000). Severe clinical signs 
linked with BVDV-1 and BVDV-2 infections have been described in Belgium (Letellier et al., 
2010; Laureyns et al., 2011a; Laureyns et al., 2011b; Laureyns et al., 2013b).  
 Ncp BVDV predominate in nature while cp viruses are rare and usually found in 
association with MD, which achieve a high mortality rate (Ridpath, 2010). Cp BVDV 
amplifies viral RNA at a much higher level (Kummerer et al., 2000). However, 
cytopathogenicity of a pestivirus does not correlate with its virulence, since most virulent 
strains are of the ncp biotype (Peterhans and Schweizer, 2010). 
 
Effects of BVDV infections on disease and production 
In a study of Loneragan et al. (2005) PI animals were on average treated twice as 
much compared to other calves that received treatment. Eventually, the PI animals were 
removed from the herd before the age of slaughter because of chronic illness (147 days after 
arrival) or death (58 days after arrival). In the same study PI animals were more likely to die 
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before the age of slaughter as their prevalence among dead cattle was 2.5% while at arrival 
this was only 0.3% (Loneragan et al., 2005). When evaluating the national BVDV eradication 
campaign in Switzerland, Presi et al. (2011) noticed that only 10% of PI animals were older 
than 2 years. 
Occasionally severe outbreaks with high mortality rates and whether or not associated 
with haemorrhagic disorders are reported (Corapi et al., 1990; David et al., 1994; Pellerin et 
al., 1994; Carman et al., 1998; Doll and Holsteg, 2013; Moen, 2013). During an outbreak in a 
feedlot 76% of the calves became clinically ill and 31% eventually died (Hessman et al., 
2012). During the recent BVDV-2c outbreak in Germany mortality rates up to 20% and 80% 
were reported in a dairy herd and veal calf herd, respectively (Doll and Holsteg, 2013). 
It has been estimated that 70% to 90% of acute BVDV infections occur with only mild 
fever and leukopenia (Ames, 1986; Baker, 1995). Other mild clinical signs in TI cattle are for 
instance depression, anorexia, diarrhoea and nasal discharge. However, also subclinical 
infections impair animal production. Moerman et al. (1994) reported a 10% drop in milk 
production for several days in subclinically infected cows. After recovery milk production 
increased again, but remained 5% lower than before the drop in half of the cows. Another 
study estimated that milk production was 5.8% lower in herds with a high BVDV antibody 
titre in bulk tank milk compared to herds with a lower titre (Heuer et al., 2007). Calf mortality 
within one year of birth was found to be 1.35% and 3.05% higher in BVDV seropositive 
herds compared to negative control herds for beef and dairy herds, respectively (Gates et al., 
2013a). 
BVDV infects cells of the immune system, which evokes an immunosuppression 
leading to a decreased response to other infectious agents (Chase et al., 2004) and can 
aggravate the clinical signs of other infectious diseases (Ridpath, 2010). A 7% increase was 
noted in the incidence rate of clinical mastitis in herds exposed to BVDV as compared with 
non-exposed herds (Waage, 2000). A significant lower bulk milk somatic cell count (211,390 
cells/ml versus 242,790 cells/ml) was observed in BVDV naïve herds compared to BVDV 
seropositive herds (Laureyns et al., 2013c). The number of cases of mastitis, retained placenta 
and miscellaneous diseases increased in herds with an increased BVDV antibody milk titre 
(Niskanen et al., 1995).  
In a study on morbidity and mortality in white veal calves in Belgium 26% of the 
necropsied and virologically tested calves was BVDV RT-PCR-positive and a positive test 
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was associated with chronic pneumonia (OR= 21.6; 95% CI 5.7; 81.9) and pleuritis (OR= 4.9; 
95% CI 1.5; 16.3) (Pardon et al., 2012). Among calves entering a feedlot, 45% of calves 
treated for respiratory disease had seroconverted for BVDV while this was only 22% of 
untreated calves (Martin and Bohac, 1986). Eradication of BVDV in a dairy herd resulted in a 
decrease of diarrhoea within one month of birth from 71% to 19% (Klingenberg et al., 1999).  
Reproductive consequences of BVDV infections such as reduced fertility, congenital 
defects, abortion and of course persistent infections are well described (Baker, 1995; Grooms, 
2004). In an experimental study reduced conception rates were demonstrated in heifers 
intranasally infected with BVDV before insemination: 44% compared to 79% for the control 
group (McGowan et al., 1993). Calves congenitally infected with BVDV were 2.3 times more 
likely to have a severe illness (requiring at least three days of treatment or resulting in death) 
during the first 10 months after birth compared to calves without congenital infection 
(Munoz-Zanzi et al., 2003). 
 
 
Zootechnical impact of BVDV infections 
 
Economic consequences of BVDV infections 
 
One cannot expect to find all of the different clinical signs in one herd or during one 
outbreak (Laureyns, 2014). The costs following BVDV infection will therefore vary 
according to the type of clinical signs, the severity of the outbreak (virulence of the infecting 
strain) and the initial herd immunity (Houe, 1999).  
For an affected dairy herd Heuer et al. (2007) estimated the losses per cow per year to 
be €53 (NZ$83), especially due to the reduced milk production, increased abortion rates, 
increased time to conception, loss among PI animals and calf losses as a consequence of 
abortion or induction. For a similar outbreak another study estimated the costs to vary 
between €48 and €67 (Fourichon et al., 2005). These estimated costs lie within the range of 
the costs usually reported for an average outbreak in dairy herds: between €21 ($25) and €135 
($160) per cow per year (Houe, 2003; Lindberg et al., 2006). The mean financial loss per cow 
per year in beef herds where the disease is not diagnosed quickly and without intervention or 
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re-infection was estimated to be €46 (£37) (Gunn et al., 2004). Depending on the initial 
BVDV status of the herd and the management practices undertaken to prevent virus 
transmission, the costs of re-infection with BVDV were estimated to vary between almost €0 
and €51 (£40) per cow per year (Stott et al., 2010). Losses from more severe BVD outbreaks 
are estimated to be more than €340 per cow (Houe, 2003; Lindberg et al., 2006). 
 When deciding to eradicate or control at the herd level or at regional/national level, it is clear 
that the expenses of the control measures should not exceed the costs associated with BVDV 
infections. Several cost-benefit analyses, usually at the national level, have been published. A 
cost-benefit study on the control and eradication programme in Norway showed that the 
programme was already cost-effective from the second year onwards (Valle et al., 2005). A 
study in New Zealand showed that all considered control options – vaccination, test and cull, 
increased biosecurity or combinations – would be economically favourable (Reichel et al., 
2008). Stott et al. (2012) estimated that the payback periods of a potential eradication 
programme in Ireland for the beef and dairy sector were respectively 1.2 and 0.5 years, which 
corresponded to a cost-benefit ratio of 1:5 and 1:14, respectively. An eradication programme 
in France was estimated to be cost-effective only after 15 years (Dufour et al., 1999). For this 
estimation extensive blood sampling on individual animals was taken into account, which 
raised the costs of the programme considerably. Currently more efficient diagnostic tests such 
as analysis of ear notch samples (see below) are available, which can reduce the costs of a 
control programme, as shown by Stott et al. (2012). These studies show that the control of 
BVDV is beneficial, but that the period for a programme to become cost-effective varies and 
depends on the design (Saatkamp et al., 2006). 
 
Other beneficial effects of BVDV control 
As described above, BVDV infections involve a higher need for disease treatment and 
BVDV control could therefore result in a reduction in antimicrobial usage (Pardon, 2012). 
Furthermore, the impact of BVDV infections on animal welfare is often overlooked, e.g. PI 
animals suffering from MD (Lindberg et al., 2006). As the performance of a herd is related to 
the job satisfaction of a farmer (Hanna et al., 2009), a successful BVDV control programme 
could enhance the job satisfaction. Finally, if neighbouring countries also would implement 
national BVDV control and Belgium remains endemic, this could possibly hamper 
international trade.      
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Risk factors for occurrence of BVDV infections 
 
 Risk factors for BVDV infection usually are identified at the herd level. A herd can be 
considered as BVDV infected by the presence of BVDV seropositive animals following 
serologic examination (e.g. Valle et al., 1999) or by the presence of virus-positive animals 
(e.g. Graham et al., 2013). Some risk factors such as the purchase of cattle are obvious risk 
factors, while others may be confounded by other factors. Whenever the association between 
the risk factor and the occurrence of BVDV infections was not so obvious, a possible 
explanation is given by the authors of the corresponding study. 
 Valle et al. (1999) identified the following statistically significant risk factors for 
Norwegian herds being BVDV seropositive: over-the-fence pasture contact, purchasing 
animals, not asking information about BVDV status when purchasing animals, exchange of 
calves and sharing of cattle housing with other farmers during summer, not consulting dairy-
association advisors, being a younger farmer and use of common pasture. Younger farmers 
purchased more cattle and tended not to ask for health certificates when purchasing animals 
more often than older farmers. The use of common pasture was also identified as a risk factor 
in Croatia by Bedekovic et al. (2013). 
In New Zealand, Cuttance and Cuttance (2014) identified the purchase of animals 
(introduction of replacement heifers) as a risk factor for being BVDV seropositive at the herd 
level, together with the farmer considering BVD was an issue on the farm and an increasing 
number of heifers on the farm. A larger number of heifers could suggest a higher probability 
of infecting at least one susceptible dam in early gestation, resulting in the birth of a PI 
animal. Vaccination of introduced breeding bulls resulted in a decreased odds of being BVDV 
seropositive.  
 Similar to the previous study, a larger herd size was found to be a risk factor for 
Brazilian dairy herds being BVDV seropositive when considering dairy herds BVDV 
seropositive based on bulk tank milk analysis (Almeida et al., 2013). Furthermore, the use of 
artificial insemination (AI) was significantly associated with herds being BVDV seropositive. 
Interestingly, the semen used for AI was used from selected bulls from well-known AI centres 
and should therefore be BVDV negative. This result suggested that other factors, such as the 
visits of AI technicians, were likely to be associated with BVDV infection and illustrates that 
General Introduction  Chapter 1 
22 
 
risk factors only demonstrate an association and not necessarily a causal relation between risk 
factor and disease. 
 Other studies using bulk tank milk samples demonstrated that vaccination for BVD, 
suspicion of BVD, housing of cows in gestation with calves, the number of cows, the 
proportion of cows that were dry, the purchase of cattle and the number of breeding farms 
within a 10 km radius were associated with an increased level of BVDV antibodies in bulk 
tank milk in Scottish cattle herds (Humphry et al., 2012; Gates et al., 2013b). Regarding the 
risk factor ‘the proportion of the herd that were dry’, a possible explanation could be that 
BVDV infected herds had lower conception rates and animals were therefore dry for a longer 
period of time. 
    A study using data of more than 8,000 Danish dairy herds demonstrated the following 
significant associations with the presence of PI animals: herd size, distance to neighbouring 
farms and the presence of BVDV infected neighbours (Ersbøll and Stryhn, 2000).  
 In Ireland, Graham and co-workers (Graham et al., 2013) used the presence of at least 
one virus-positive animal based on analysis of ear notches as outcome of interest and 
identified the following risk factors: province, herd size (log number of cows), introduction of 
cattle during 2009-2011, the number of tested calves whose dams had been purchased within 
9 months of their calving date and calf mortality. When the vaccination status of the herds 
was included, a significant interaction between the vaccination status and log number of cows 
was observed. Vaccination reduced the probability of positive test results and the impact of 
vaccination was bigger in larger compared to smaller herds. 
 
 
Diagnosis 
 
Laboratory diagnosis 
As most BVDV infections occur subclinically and because of the broad range of 
clinical disease manifestations, the diagnosis of BVDV based upon clinical signs is not 
obvious and should therefore be supported by laboratory tests (Laureyns, 2014). Fortunately, 
these tests are generally considered to be very reliable, given their high sensitivity and 
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specificity (Saliki and Dubovi, 2004; Sandvik, 2005; Dubovi, 2013). Two diagnostic 
approaches to detect BVDV infections are used: direct tests (detection of the virus or viral 
components) and indirect tests (detection of the immune response to BVDV). 
  
Detection of the virus or viral components 
 Virus isolation (VI) of BVDV out of samples in cell cultures, is the gold standard to 
which other virus detection tests are compared (Dubovi, 2013). The following cell lines are 
most widely used for VI: bovine turbinate (BT), bovine testicle (Btest) and Madin-Darby 
Bovine Kidney (MDBK) (Saliki and Dubovi, 2004). Studies have shown that MDBK cells are 
less sensitive to BVDV compared to BT and Btest cells (Onyekaba et al., 1987; Dubovi, 
2013). Regarding the sample, the highest sensitivity is obtained with a blood sample from 
which viable mononuclear cells can be harvested. In this way virus can even be isolated from 
samples containing antibodies. Viable cells come in close contact with the indicator cells 
permitting infection without the virus coming in contact with neutralizing antibodies. 
Freezing and thawing of the mononuclear cells to release the virus is unnecessary and permits 
the neutralization of the virus by antibodies, leading to false negative results (Dubovi, 2013). 
Since most BVDV field isolates in samples are ncp virus, they cause no visual cytopathic 
effects and the inoculated cells are therefore examined for the presence of BVDV either by 
immunofluorescence or immunoperoxidase staining with a specific BVDV antiserum. A 
reference method for VI can be found in the OIE Manual of Diagnostic Tests and Vaccines 
for Terrestrial Animals (OIE, 2014). The main advantage of VI is the detection of viable 
virus, but it is time-consuming and expensive (Lanyon et al., 2014). VI should therefore be 
used as back-up and reference test for other diagnostic tools (Sandvik, 2005).   
 
Antigen Enzyme Linked ImmunoSorbent Assays (Ag-ELISA) are used to detect the 
presence of BVDV antigen in various sample matrices, such as non-coagulated blood, serum, 
skin biopsies (ear notches), tissue samples (spleen, lung, liver, kidney) and milk (Sandvik, 
2005; Lanyon et al., 2014). The samples should contain sufficient material, as there is no 
amplification of the target (Sandvik, 2005). Suitable viral proteins for detection are the 
envelope glycoprotein Erns and the nonstructural protein NS3 (Dubovi, 2013). Several 
commercial Ag-ELISA kits are available. The kits used by the regional centres for animal 
disease control “Dierengezondheidszorg Vlaanderen (DGZ)” in Flanders (northern part of 
Belgium) and “Association Régionale de Santé et d’Identification Animales (ARSIA)” in 
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Wallonia (southern part of Belgium) detect the Erns Ag. The Ag-ELISA is robust, simple and 
cost-efficient (Lanyon et al., 2014), but false negative test results may occur due to the 
presence of colostral antibodies that capture the antigens and make them unavailable for the 
test (Zimmer et al., 2004; Fux and Wolf, 2012). However, even in the presence of colostral 
antibodies Erns Ag remains detectable in ear notch samples and Ag-ELISA that target Erns in 
combination with ear notch sampling is therefore preferred to test young animals (Fux and 
Wolf, 2012).  
Reverse-Transcription Polymerase Chain Reaction (RT-PCR) detects the presence 
of viral RNA and is widely accepted as the standard for BVDV diagnosis as it is faster and 
less expensive compared to VI, but also highly sensitive and suitable for a large variety of 
samples, including blood, milk, saliva, follicular fluid and tissue samples (Lanyon et al., 
2014). RT-PCR consists of four steps: extraction of RNA from the sample, reverse 
transcription to cDNA, amplification of cDNA and finally detection of the amplified products 
(Sandvik, 2005). Combining the last three steps in a single tube reduces the risk of false 
positive results due to cross-contamination (Sandvik, 2005; Dubovi, 2013). The main 
advantages of RT-PCR are a high sensitivity, no interference of antibodies with the detection 
of the virus genome and the possibility to pool the samples as a consequence of the high 
sensitivity. By using specific primers (and probes) it is possible to distinguish between 
BVDV-1 and BVDV-2 (Letellier et al., 1999). Quantitative or real-time RT-PCR (RT-qPCR) 
can give semi-quantitative results in terms of a threshold cycle (Ct), with lower values 
indicating a higher amount of viral RNA, or quantitative results, expressed in the number of 
BVDV copies present in the sample (Letellier and Kerkhofs, 2003). 
 
Detection of BVDV infection based on the immune response  
Virus neutralisation (VN) is the gold standard and quantifies the inhibitory effect of 
specific neutralizing antibodies on virus replication in cell cultures. The result is expressed as 
the highest serum dilution able to inhibit replication of a quantified amount of the challenge 
virus (Sandvik, 2005). The sensitivity of the test depends on the cells used (e.g. MDBK versus 
BT) and the antigenic relatedness between the antibodies in the sample and the virus strains 
used in the test (Lanyon et al., 2014). For example, when an animal was infected with BVDV-
2, a higher sensitivity is obtained with a BVDV-2 strain than with a BVDV-1 strain as 
challenge virus, since BVDV-1 and BVDV-2 are antigenically distinct (Ridpath et al., 2000). 
General Introduction  Chapter 1 
25 
 
If cp reference strains are used for VN tests, then viral inhibition is directly visible, otherwise 
immunoperoxidase staining is needed. A reference method for VN can be found in the OIE 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (OIE, 2014). VN is very 
specific and sensitive, but time-consuming and expensive. 
Antibody ELISA (Ab-ELISA) to detect the presence of BVDV-antibodies are less 
expensive and less time-consuming compared to VN and can be used for a large amount of 
samples (Sandvik, 2005). Several commercial Ab-ELISA kits are available. Serum and milk 
samples are suitable matrices for Ab-ELISA. Ab-ELISA also return quantitative results in 
terms of optical densities (Lanyon et al., 2014) and a positive association between Ab-ELISA 
results and VN titres was demonstrated (Lanyon et al., 2013). A reference method for Ab-
ELISA can be found in the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial 
Animals (OIE, 2014). Interference of vaccination with Ab-ELISA tests is an issue as no 
marker vaccine to differentiate between infected and vaccinated animals (DIVA) is available 
up to date and no Ab-ELISA tests are able to differentiate vaccine-induced antibodies from 
antibodies following natural infections (Makoschey et al., 2007; Raue et al., 2011). 
 
Diagnostic approaches in the field 
Diagnostic tests are indispensable to BVDV control and several test strategies have 
been described (Brock, 2004; Larson, 2005; Houe et al., 2006). The strategy recommended by 
the regional centres for animal disease control and faculties of veterinary medicine in Belgium 
has been described (Laureyns et al., 2010; Laureyns, 2014). Whatever strategy is used, the 
following diagnostic objectives should be achieved (Lindberg et al., 2006): 
1) to detect new cases of BVDV infection, 
2) to identify free herds and confirm their status and 
3) to evaluate the progress by estimating the prevalence. 
Each of these objectives can be performed both at the herd level and animal level. 
 
Determination of the BVDV status at the herd level  
The BVDV status of a herd is verified without testing every animal separately, but by 
testing samples from multiple representative individuals in a herd (Houe et al., 2006). The 
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spot test or testing bulk tank milk for the presence of BVDV antibodies are convenient test 
strategies for this purpose. The spot test is an indirect screening for the presence of PI animals 
in the herd by testing a limited number of young stock (3 to 10 animals) for BVDV specific 
antibodies (Houe, 1992; Houe, 1994). The advantage of testing young stock is that it detects a 
recent or on-going infection given the young age of the animals (Brülisauer et al., 2010). Bulk 
tank milk samples can be used to detect antibodies amongst lactating cows by Ab-ELISA. 
Antibody concentrations are associated with the prevalence of immune cows and thus the 
likelihood of a herd being infected (Beaudeau et al., 2001). However, vaccine-induced 
antibodies might hamper the interpretation of bulk milk testing (Houe et al., 2006). 
 
Identification of individual infected animals 
When the presence of PI animals is suspected, every individual animal has to be tested 
for the presence of BVDV. Bulk tank milk can be tested for animals contributing to the bulk 
tank milk at the moment of sampling. One should be aware that only information is obtained 
about the animals contributing to the bulk tank milk and additional animals should be tested 
separately (Laureyns et al., 2010; Lanyon et al., 2014). The BVDV status of a group of 
animals can be verified with one single RT-PCR test by pooling samples such as blood, serum 
and ear notches (Munoz-Zanzi et al., 2000; Kennedy et al., 2006). An optimal pool size of 20 
is advised (Munoz-Zanzi et al., 2000). A positive test result involves testing of the individual 
samples for which the cheaper Ag-ELISA can be used (Mars and van Maanen, 2005; Hanon 
et al., 2014).  
The detection of PI calves has to be continued for one year after the removal of the last 
identified PI animal (Laureyns et al., 2010). Ear notch samples from new-born calves, which 
are obtained when placing the official ear tag, are very suitable for this purpose. Furthermore, 
all newly acquired cattle or animals at suspicion of a BVDV infection based on clinical signs 
should be tested for the presence of BVDV (Smith and Grotelueschen, 2004; Houe et al., 
2006), with special attention for the Trojan cow, i.e. a TI dam carrying a PI foetus (Laureyns 
et al., 2010; Lanyon et al., 2014).  
A single positive test result in VI, Ag-ELISA or RT-PCR can originate from a PI or a 
TI animal. To distinguish between PI and TI animals a second sampling is needed. The 
requested time between sample collection is usually set to 3 weeks as BVDV can be cleared 
from the blood of TI animals within 14 to 21 days post-infection (Howard, 1990). A TI 
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animal positive by Ag-ELISA or VI during the first sampling should have a negative test 
result 3 weeks later using the same tests. However, viral RNA has been shown to be longer 
detectable than viable virus (Givens et al., 2002) and RT-PCR should therefore not be used 
for resampling (Laureyns, 2014). Studies also suggest that differentiation between PI and TI is 
possible with one single RT-qPCR test (Bhudevi and Weinstock, 2001; Hanon et al., 2014). 
The interpretation of a single quantitative result may be complicated by the variation in levels 
of viraemia such as intermittent viraemia in PI cattle (Laureyns et al., 2010). 
 
 
Elements for BVDV control 
 
When considering BVDV control, two main strategies used to be proposed: 
vaccination versus application of biosecurity measures (Lindberg and Houe, 2005; Houe et 
al., 2006). Now it is generally accepted that every BVDV control programme should involve a 
combination of different measures (Ridpath, 2013b). A general model for successful BVDV 
control was proposed by Lindberg and Houe (2005) and consists of three essential elements: 
biosecurity, virus elimination and monitoring. An optional element is immunization (Fig. 3). 
 
Fig. 3. The general model for BVDV control as proposed by Lindberg and Houe (2005) 
consists of three essential measures: preventive measures (biosecurity), removal of PI animals 
(virus elimination) and follow-up of the BVDV status (monitoring). Immunization through 
vaccination is as an optional fourth element. 
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Biosecurity 
Farm biosecurity embraces all aspects of the prevention of pathogens entering and 
spreading within a group of animals (Laanen et al., 2013). It can be divided into external 
biosecurity, which includes all measures preventing pathogens from entering a herd, and 
internal biosecurity (or biocontainment), which embraces measures reducing the spread of 
pathogens within a herd (Villarroel et al., 2007; Laanen et al., 2013). 
Biosecurity is not a new concept in animal agriculture, but rather a scientifically 
underpinned redefinition of earlier ideas and practices historically considered to be good 
animal husbandry (Barrington et al., 2002). Biosecurity became somewhat of a ‘buzzword’ in 
the United Kingdom livestock industry following the foot and mouth disease outbreak of 
February 2001 (Gunn et al., 2008). Indeed, biosecurity is usually associated with collective 
action for disease control in case of large epidemic outbreaks (Heffernan et al., 2008). 
However, it is also a crucial element in the control of endemic diseases.  
Expected consequences of the reduced disease spread and thus indirectly from 
applying biosecurity measures are improved production characteristics and thus greater 
profits, better animal welfare, improved immune responses to vaccines and enhanced job 
satisfaction for farmers (Brennan and Christley, 2012). Recently it was shown in pig 
production that a higher biosecurity status is associated with a reduction in antimicrobial 
usage and an improved production (Laanen et al., 2013). 
Although biosecurity not necessarily focuses on one particular infectious disease and 
aims at upgrading herd health in general, measures are based on the knowledge of the 
epidemiology of specific pathogens (Barrington et al., 2002). Despite the fact that between 
pathogens there are considerable epidemiologic differences such as the reservoir, modes of 
transmission and incubation period (Barrington et al., 2002; Villarroel et al., 2007), the basic 
principle is to reduce contact between disease agents and susceptible animals (Callan and 
Garry, 2002). As a result, most biosecurity measures are not specific to a single infectious 
agent (Barrington et al., 2002).  
The most important route of disease transmission is generally considered to be direct 
contact between live animals, but also indirect transmission should not be ignored (Barrington 
et al., 2002; Callan and Garry, 2002; Brennan et al., 2008; Nöremark et al., 2013) (Fig. 4). 
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Considering external biosecurity, all cattle (both purchased and returning) must be put 
in quarantine and preferably tested for endemic diseases such as BVD, neosporosis and 
paratuberculosis (Villarroel et al., 2007). Furthermore, contact on pastures with cattle from 
neighbouring farms should be avoided (Wells et al., 2002). The access for vehicles and 
professional visitors entering the farm should be restricted and farm-specific protective 
clothing and boots should be provided. 
Considering internal biosecurity, new-born calves and cows in the periparturition 
period are very susceptible to disease (Villarroel et al., 2007) and a clean and disinfected 
calving box where no diseased animals are housed should be available (Wells et al., 2002). 
Since older animals are more resistant to disease and as they often are reservoirs of disease 
agents, compartmentalization into age groups and working from younger towards older 
animals may reduce this type of disease spread (Barrington et al., 2002).   
Animate vectors such as pets, insects, rodents and wild birds can spread disease both 
between and within farms and specific measures can be implemented. For example, the access 
of pets into sheds should be restricted (Wells et al., 2002) and manure should be handled in 
such a way to reduce the breeding sites of flies (McCluskey, 2002).   
Specific preventive measures concerning BVDV spread have been described (Smith 
and Grotelueschen, 2004; Villarroel et al., 2007). Moreover, the implementation of 
biosecurity is even considered as the most essential pillar for BVDV control (Lindberg and 
Houe, 2005) (Fig. 3).  
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Fig. 4. The basic principle in biosecurity is to reduce contact between disease agents and 
susceptible animals. For both external and internal biosecurity this can be divided into 
avoiding direct and indirect transmission, further translated into biosecurity measures 
applicable for upgrading herd health in general. 
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Virus elimination 
When herds are BVDV infected it is essential to eliminate the virus from the herd. 
Since PI animals are generally considered to be the source of infection as they continuously 
shed massive amounts of virus (Lindberg and Houe, 2005), this measure can actually be 
reduced to the removal of PI animals. So far it was assumed that TI animals did not 
significantly contribute to BVDV spread. However, the recent BVDV-2c outbreak in 
Germany and the Netherlands has challenged this assumption. Since no PI animals were 
detected during this outbreak (Doll and Holsteg, 2013), it is believed that BVDV has spread 
solely through TI animals and therefore the importance of these TI animals in the 
epidemiology of BVDV is questioned. However, as mentioned above, sufficient evidence to 
prove that transmission was not due to PI animals that have escaped identification should be 
provided (Lindberg and Houe, 2005). Furthermore, other transmission routes such as 
iatrogenic transmission due to contaminated vaccines should be taken into account (Barkema 
et al., 2001). 
 
Monitoring and surveillance 
Monitoring, or follow-up of the BVDV status, is a third essential measure for 
successful BVDV control and evaluates the effectiveness of elimination of BVDV in infected 
herds. Monitoring also serves for detection of new infections and therefore also herds with no 
history of BVDV infections should be strongly encouraged to monitor the BVDV status, as 
(re-)infections with BVDV often occur. In the Netherlands, where BVDV control is voluntary 
at the herd level, every year antibodies are detected in the monitoring system in 5 to 10% of 
these herds, indicating virus circulation in the herd. New-born PI animals were found in half 
of these herds (Mars and Van Maanen, 2005). Denmark started a national BVDV eradication 
programme in 1994. In 1998, 333 herds were found to be re-infected with BVDV after 
previously having been found free (Bitsch et al., 2000).  
Whenever monitoring involves specific actions in case of a possible (re-)infection, this 
is defined as surveillance (Lindberg et al., 2006). Specific actions include for instance testing 
of new-born calves to early detect new PI animals or testing diseased animals for BVDV 
viraemia. 
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Immunization 
Immunization is a fourth control measure and does not cancel out the need for the 
other measures proposed in the general model for BVDV control (Lindberg and Houe, 2005). 
The need for immunization, which is usually obtained by vaccination, as an additional control 
measure depends on the risk of re-infection of herds that cleared BVDV (Lindberg et al., 
2006). Vaccination as a single measure is often assumed, by farmers and veterinarians, to be 
sufficient in the control of BVDV, thereby neglecting the three essential measures (Laureyns 
et al., 2013a). However, incorrect use of vaccination can lead to incomplete protection 
(Meadows, 2010) and should therefore be implemented in combination with the previously 
mentioned essential control measures. The birth of PI animals in vaccinated herds has been 
reported (Van Campen et al., 2000). 
Undoubtedly, some drawbacks are associated with vaccination. First, as mentioned above, it 
can interfere with diagnostic tests. Secondly, BVDV vaccines currently registered in Belgium 
only contain BVDV-1 strains. This may be of concern as studies have demonstrated 
incomplete foetal protection against BVDV-2 strains in animals vaccinated with BVDV-1 
vaccines (Ridpath et al., 1994; Brock and Cortese, 2001). Furthermore, concerns related to 
BVDV vaccination with modified live vaccines (MLV) are discussed by Ridpath (2013b): 
BVDV contamination of MLV, immunosuppression and post vaccinal mucosal disease, i.e. 
MD following vaccination of PI animals with MLV containing cp virus. A commercial 
BVDV-1 MLV was used as emergency vaccination during a recent BVDV-2c outbreak in 
Germany (Doll and Holsteg, 2013). Currently no MLV vaccines are registered in Belgium. 
Recently, the European Medicines Agency (EMA) has approved the marketing authorisation 
of a new MLV BVDV vaccine (EMA, 2014). The vaccine contains both a BVDV-1 and a 
BVDV-2 strain and its launch is planned for spring 2015 (Boehringer-Ingelheim, 2014). 
  Immunization following ‘controlled natural exposure to a PI animal’ was also 
suggested by Lindberg and Houe (2005). However, several disadvantages are involved with 
this immunization procedure: welfare implications concerning the PI animal, possible clinical 
manifestations in TI cattle, immunosuppression associated with BVDV infections and no 
guarantee that every animal is immunized. Moreover, biosecurity measures may fail to avoid 
infection of pregnant cattle.   
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BVDV control at the regional/national level 
Given the variability in animal density, movement of animals, production structures, 
BVDV prevalence and the diagnostic tests available, there is no “one-size-fits-all” approach 
to the design of BVDV control and eradication programmes (Ridpath and Fulton, 2009; 
Brülisauer et al., 2010; Presi and Heim, 2010). Several European countries have initiated 
diverse national and regional campaigns with Denmark, Finland, Norway and Sweden already 
in 1993-1994 (Sandvik, 2004; Lindberg et al., 2006). Also the Shetland Islands started in the 
early 1990s and it became mandatory in entire Scotland in 2011 (Voas, 2012). A regional 
voluntary programme was launched in Austria in 1997 and was made compulsory for the 
entire country in 2004 (Rossmanith et al., 2010). Eradication and control programmes using 
ear notch testing were launched in Switzerland (2008) and Germany (2011) (Presi and Heim, 
2010; Ståhl and Alenius, 2012). A programme was made compulsory in Ireland in 2013 
(Graham, 2013). Regional programmes are operative in France and Italy. 
Until now BVDV control in Belgium was on a voluntary basis at the herd level. The 
only legislation was the annulment of sale when purchasing a PI animal. Recently, the outline 
of the first phase of a Belgian mandatory BVDV control programme has been published 
(Royal Decree on the control of BVD, 18 June 2014) and the programme has been launched 
in January 2015.  
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To evaluate the effectiveness of interventions in the framework of BVDV control, it is 
important to start with a good insight in the BVDV prevalence. Furthermore, when 
considering a control plan at the national level this information is of crucial importance for the 
design of a such a plan. At the start of this research, only limited and outdated data on the 
BVDV prevalence in Belgium were available. Therefore the first aim of this doctoral thesis 
was to determine the BVDV prevalence in Belgium (Chapter 3). 
It has been stated before that a successful BVDV control scheme should be based on 
three central elements. First, the elimination of virus sources from infected herds is crucial. 
Since PI animals are considered to be the main source of infection, this measure generally 
focuses on the elimination of PI animals. However, recent outbreaks suggest that TI animals 
may have an impact on BVDV spread as well. Since the role of these TI animals in the 
epidemiology of BVDV remains highly controversial, the second aim of this research was to 
determine the role of cattle transiently infected with virulent BVDV strains in the 
transmission of BVDV (Chapter 4). 
Furthermore, the implementation of biosecurity measures is crucial to prevent re-
infection in free herds. Yet, information on the implementation of biosecurity in Belgian cattle 
herds, a very densely populated livestock area, is currently lacking. Therefore the third aim of 
this thesis was to gain insight into the current implementation of biosecurity measures in the 
daily management of Belgian cattle herds (Chapter 5). 
Finally, continuous monitoring and surveillance is needed to rapidly detect new 
infections. To optimize the prevention and early detection of new BVDV infections, 
knowledge of the risk of BVDV (re-)infection and associated risk factors may be very useful. 
Therefore the final aims of this thesis were to assess the risk of BVDV re-infection in non-
vaccinating herds, given the current implementation of BVDV control measures (Chapter 6) 
and to identify risk factors for infection and re-infection with BVDV (Chapters 3 and 6). 
Recently a mandatory Belgian BVDV control programme was launched. In the general 
discussion of this thesis (Chapter 7) the obtained results are used to assess the current outline 
of this control programme and to make some recommendations for further improvements of 
the programme. 
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Abstract 
 
Bovine viral diarrhoea virus (BVDV) is a worldwide spread virus that most commonly 
infects cattle and can cause considerable economic losses. To determine the prevalence of 
BVDV in Belgium, a cross-sectional study was performed between November 2009 and 
March 2010. Young stock aged between 6 and 12 months from 773 randomly selected 
Belgian cattle herds were tested for BVDV specific antibodies and antigen. With a target and 
maximum of 10 animals per sampled herd, a total of 5246 animals were selected. Additionally 
a questionnaire including different herd management topics and questions about participation 
in animal health programmes, including BVDV, was sent to 1100 Belgian cattle herds, 
including the 773 herds for BVDV testing. This paper focuses on results regarding these 773 
herds. 
The true prevalence of BVDV-specific antibodies and antigen at the herd level was 
respectively 47.4% and 4.4%, while at the animal level this was 32.9% and 0.3%, 
respectively. In 44.4% of the herds where BVDV-specific antibodies were detected at least 
60% of the sampled young stock was BVDV seropositive. Interestingly, 83.4% of these 
farmers stated not to have suffered from problems related to BVDV. Moreover, only 8.4% of 
all farmers who completed the questionnaire (n = 895) reported problems possibly related to 
BVDV the past 3 years. This result demonstrates that farmers are often unaware of the 
presence of BVDV in their herd. 
Risk factors for a herd to be BVDV seropositive were identified by a multivariable 
logistic regression model. Large herds were significantly more likely to be BVDV 
seropositive (OR = 1.004, p < 0.01). The interaction between “Antigen positive animal 
detected in this study” and “BVDV vaccination in 2009” was significant (p < 0.01). In non-
vaccinating herds, the detection of antigen positive animals was significantly associated with 
BVDV seropositive herds (OR = 13.8, p < 0.01). In herds with no antigen positive animals 
detected, vaccination resulted in a significant risk factor to be BVDV seropositive compared 
to non-vaccinating herds (OR = 3.4, p < 0.01). Herds reporting BVDV-related problems the 
past 3 years were more likely to be BVDV seropositive (OR = 1.9, p < 0.05). This relation 
became non-significant (OR = 1.8, p = 0.08) when only a subset of herds with no vaccination 
of animals < 12 months was taken into account. The results of the current study suggest an 
active circulation of BVDV in a considerable number of Belgian cattle herds. 
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Introduction 
 
In 1946 bovine viral diarrhoea virus (BVDV) was described in the United States as the 
cause of a new transmissible cattle disease (Olafson et al., 1946). Up to date many studies 
have been published and are still being performed in order to understand the complex 
pathogenesis and epidemiology of this pestivirus. 
The complex epidemiology of BVDV partially lies in its ability to infect the foetus. If 
the infection occurs between the second and fourth month of gestation, the virus is able to 
cause a persistent infection of the foetus which may result in the birth of a persistently 
infected (PI) calf (Peterhans et al., 2010). These PI animals are important sources of infection 
because they continuously shed BVDV in large quantities (Lindberg and Houe, 2005). 
Clinical symptoms caused by BVDV are highly variable due to the ability of the virus to 
infect multiple organ systems. Symptoms can range from subclinical to acute infections with 
high mortality. BVDV infections also affect animal productivity and make animals more 
susceptible to other diseases (Houe, 1999). For these reasons, the economic impact of BVDV 
infections is likely to be underestimated. Several studies have demonstrated a negative 
financial impact of BVDV infections (Houe, 2003; Gunn et al., 2004;  Fourichon et al., 2005). 
Convinced by the economic importance of BVDV, several European countries 
launched an eradication campaign. By selective culling of PI animals Scandinavian countries 
have successfully eradicated BVDV without the use of vaccination. At this moment BVDV is 
being eradicated in Austria and Switzerland (Houe et al., 2006; Presi et al., 2011) and an 
eradication programme has been launched in Germany in 2011 (Meier et al., 2010). Given the 
variability in important influencing factors such as density of animal populations, movement 
of animals and the incidence of BVDV infections in different countries, there is no “one-size-
fits-all” approach to the design of BVDV eradication programmes (Ridpath and Fulton, 2009; 
Brülisauer et al., 2010). Therefore, it is of crucial importance, before even considering the 
design of an eradication plan, to have a good insight into the current BVDV prevalence for a 
specific country (Brülisauer et al., 2010). 
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In Belgium, an important beef cattle and milk producing country in Europe, only 
limited and outdated data on the prevalence and the current situation of BVDV were 
available. Therefore the aim of this study was to estimate both the virological and the 
serological BVDV prevalence in Belgium using a large representative sample. Additionally, 
potential risk factors for herds to be BVDV seropositive were studied. 
 
Material and methods 
 
Selection of the herds and animals 
In Belgium 32,000 active cattle herds and 2,637,519 domestic bovine animals were 
registered in the animal identification and registration system (SANITEL) in October 2009. 
This resulted in an average population density at municipality level of respectively 1.1 
herds/km² and 86.4 animals/km². 
The BVDV data were collected as part of a larger cross-sectional survey, the cattle 
winter screening campaign 2009-2010 commissioned by the Federal Agency for the Safety of 
the Food Chain. The main objective of this survey was to prove the absence of bluetongue 
virus serotype 8 (BTV-8) circulation in Belgium. Statistical sample size calculations were 
performed in relation to this main objective. Out of the 32,000 registered Belgian cattle herds 
(SANITEL, October 9th 2009) 1100 herds were randomly selected with the 
SURVEYSELECT procedure in SAS® version 9.2 (SAS Institute Inc., Cary, NC, USA). Veal 
holdings and farms with no cattle present at the time of selection were not included in the 
study. 
Samples for examination of BVDV antigen and antibodies were collected from 
animals aged between 6 and 12 months. This age category was selected to avoid as much as 
possible the detection of maternal antibodies and antibodies induced by vaccination. In some 
herds, no animals between 6 and 12 months of age were present at the time of sampling. 
Therefore, out of the 1100 selected herds, 773 herds were examined for BVDV antigen and/or 
antibodies. Per herd a maximum number of 10 randomly selected animals was sampled. If in 
the age category the required number of animals was not present, all animals in this age 
category were sampled. A total of 5246 animals were sampled. 
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Sample collection 
All blood samples were collected by the herd veterinarians between November 2009 
and March 2010 during the winter screening campaign 2009-2010. Samples for antibody 
detection were collected in tubes allowing coagulation. Samples for antigen detection were 
collected in tubes inhibiting coagulation in order to maintain whole blood (EDTA). 
 
Laboratory analysis 
For the detection of BVDV-specific antibodies a commercial enzyme-linked 
immunosorbent assay (ELISA) was used (Herd Chek BVDV Antibody test kit, IDEXX, 
changed to BVDV Total Ab Test). This ELISA provides a specificity and sensitivity of 
respectively 99.5% and 96.3% (BVDV Total Ab Test Brochure, IDEXX). Analyses were 
done on serum samples according to the instructions provided by the manufacturer. 
For the detection of BVDV antigen a commercial ELISA was used (Herd Chek 
Antigen/Serum Plus test kit, IDEXX, changed to BVDV Ag/Serum Plus Test). This test 
provides a specificity of more than 99.7% and a sensitivity of nearly 100% (BVDV Ag/Serum 
Plus TestBrochure, IDEXX). Analyses were done on whole blood according to the 
instructions provided by the manufacturer. 
Analyses were performed by the regional centres for animal disease control 
“Dierengezondheidszorg Vlaanderen (DGZ)” in Flanders (the northern part of Belgium) and 
“Association Régionale de Santé et d’Identification Animales (ARSIA)” in Wallonia (the 
southern part of Belgium). 
 
Questionnaire 
A questionnaire (in Dutch or French) was distributed during the winter screening 
2009-2010 to all 1100 selected herds. The questionnaire contained two questions with regard 
to farm infrastructure, two questions concerning purchasing policy and general animal health 
programmes, 18 questions about more specific animal health programmes (BVDV, BHV-1 
and BTV) and 9 questions about herd management. With regard to BVDV, closed questions 
were asked about the occurrence of BVDV problems in the past (detection of PI animals), 
current BVDV problems and BVDV vaccination. To fill in the questionnaire the farmer could 
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collaborate with the herd veterinarian. A copy of the questionnaire (in Dutch or French) can 
be obtained upon request. 
 
Analysis of the test results 
A map showing the sample distribution and the cattle density at municipality level was 
produced using Arc Map® version 3.2.1 (ESRI, Redlands, CA, USA). The animal density 
data were extracted from SANITEL at the time of selection of the herds. 
The estimation of the animal prevalence with 95% confidence interval (95% CI) of 
BVDV antibodis and antigen was based on a Generalized Estimating Equation (GEE) using 
the GENMOD procedure in SAS® version 9.2 taking into account the possible correlation 
among the animals within the same herd. A logit link function and binomial distribution were 
assumed. An exchangeable working correlation structure was used assuming a constant 
correlation between any two animals within the same herd. Sampling weights were taken into 
account by weighting the observation of each animal by the inverse of the probability of this 
animal being sampled within the age group of 6- to 12-month-old animals present in the herd 
at the time of herd selection. This probability was calculated based on the sampling fraction of 
Belgian herds and the number of 6- to 12-month-old animals present in the herd at time of 
herd selection. Estimations of the animal prevalence of BVDV antibodies and antigen were 
also obtained by production type. For the latter, herds were classified as dairy, beef or mixed 
(herds containing beef and dairy cattle) based on the answers to this question in the 
questionnaire. All obtained apparent animal prevalence estimates and their 95% CI were 
converted into true prevalence estimates by means of the Rogan and Gladen estimator (1978) 
taking into account the sensitivity and specificity estimates of the used tests. For the antigen 
ELISA, a sensitivity of 100% and a specificity of 99.7% were assumed. 
The estimation of the herd prevalence (and 95% CI) of BVDV antibodies and antigen 
was obtained using a logistic regression (GENMOD procedure, SAS® version 9.2). A herd 
was considered seropositive/antigen positive if at least one of the sampled animals had a 
positive test result. Estimations were obtained by production type according to the 
classification described above. 
Descriptive statistical analysis was performed to define questionnaire results based on 
the questionnaire dataset. 
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Potential risk factors for a herd to be BVDV seropositive and/or Ag-positive were 
identified by means of a multivariable logistic regression model using SPSS 19.0 for 
Windows (SPSS Inc., Chicago, IL, USA). This was performed both on the full dataset (all 
BVDV tested herds) and on a subset of the dataset where herds with BVDV vaccination of 
animals younger than 12 months were excluded to eliminate the possible influence of vaccine-
induced antibodies. First, univariable analysis was performed of each potential risk factor. 
Subsequently, all variables with a p-value < 0.2 were combined in a multivariable model. 
Pearson and Spearman correlation coefficients were estimated to explore the relationship 
between all selected independent variables. If the correlation between two variables was > 
0.6, only the variable with the smallest p-value was included in the multivariable model. This 
model was built in a stepwise backward manner resulting in a model in which only significant 
risk factors (p < 0.05) were retained. Odds ratios, including 95% CI, are reported for all 
significant variables. Confounding was checked for by monitoring the change in regression 
parameters and was considered to be present if parameters changed by > 0.25. In the final 
model all two-way interactions were tested and significant interactions (p < 0.05) were taken 
up in the model. The goodness-of-fit of the final multivariable model was tested using the 
Hosmer-Lemeshow test (Hosmer and Lemeshow, 2000) with a significance level set at 5%. 
The added value of including herd as random effect in the model and thus analyzing 
the data at the animal level rather than at herd level was verified by fitting a two-level 
binomial model in MLwiN 2.02 (Centre for Multilevel Modelling, Bristol, UK) with ‘herd’ as 
random effect. A dispersion parameter was calculated to quantify the amount of clustering of 
animals within a herd by dividing the Pearson chi-square by its degrees of freedom. A value 
lower than one was considered to indicate underdispersion and thus no need for taking into 
account clustering of animals within a herd (Dohoo et al., 2009). 
 
Spot test 
As the sampling was performed in young stock, the testing can be considered as a spot 
test for each individual herd. This is an indirect screening for the presence of PI animals in the 
herd by testing a limited number of young stock (3-10 animals) for BVDV-specific antibodies 
(Houe, 1992; 1994). To evaluate the sensitivity of the spot test to detect the presence of Ag-
positive animals, serological results of herds with a minimum of five animals tested and in 
which at least one Ag-positive animal was detected were studied in more detail. 
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Results 
 
Characterization of selected cattle herds 
Selected and sampled herds were scattered over the entire country and cattle-dense 
regions were well represented (Fig. 1). The BVDV sampled herds had an average herd size of 
97 animals. 
A total of 5212 animals, originating from 770 cattle herds, and 5205 animals, 
originating from 769 cattle herds, were tested for the presence of respectively BVDV-specific 
antibodies and antigen and had a valid test result. Serum samples from 34 animals and whole 
blood samples from 41 animals could not be analysed for the presence of respectively BVDV 
antibodies and antigen due to loss of samples, empty tubes or an insufficient sample quantity. 
 
Fig. 1. Production types and municipality level animal densities of the BVDV sampled cattle 
herds. A total of 773 cattle herds were sampled for BVDV, of which 357 beef herds, 139 
dairy herds and 177 mixed herds (herds containing beef and dairy cattle). For 100 herds the 
production type characteristics were missing in the questionnaire and those herds could 
therefore not be classified. Cattle densities at municipality level are displayed in the 
background. 
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BVDV prevalence in Belgium 
Serological and virological BVDV true prevalence estimates at the herd and animal 
level were stratified by production type based on herds for which the production type was 
known as a result of completed questionnaires (Table 1). 
The seroprevalence at the herd level was significantly lower for beef herds than for 
mixed herds (p < 0.05). This difference was not noticed at the animal level. No other 
significant differences between production types were present for antibody prevalence. No 
significant differences were detected between the production types with regard to the 
virological prevalence at the herd and animal level. 
 
Table 1. Serological en virological BVDV true prevalence in Belgium in 2009-2010. 
Apparent prevalence estimates were based on a Generalized Estimating Equation and 
converted into true prevalence estimates by means of the Rogan and Gladen estimator. 
 
Total  Dairy  Beef  Mixed  
Seropositive herds*  351/770 63/139 149/356 93/176 
Herd seroprevalence 47.4% (46.0-48.8)  47.1% (45.7-48.5) 43.4% (42.0-44.8) 55.3% (53.9-56.7) 
Seropositive animals 1527/5212 298/989 589/2104 425/1422 
Animal seroprevalence 32.9% (31.6-34.2) 29.5% (28.2-30.8) 30.6% (29.3-31.9) 36.4% (35.0-37.7) 
Antigen positive herds* 36/769 10/139 13/355 6/176 
Herd virological prevalence 4.4% (3.8-5.0) 6.9% (6.2-7.6) 3.4% (2.9-3.9) 3.1% (2.6-3.6) 
Antigen positive animals 44/5205 13/989 15/2099 9/1413 
Animal virological prevalence 0.3% (0.1-0.6) 0.8% (0.5-1.1) 0.3% (0.1-0.5) 0.1% (0.0-0.3) 
*= Herd with at least one positive sample; prevalence estimates are reported with 95% CI 
 
A frequency distribution of the within-herd BVDV seroprevalence demonstrated that 
in 44.4% of the seropositive herds at least 60% of the tested animals was BVDV seropositive 
(Fig. 2). 
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Fig. 2. Frequency distribution of the apparent within-herd BVDV seroprevalence. Percentages 
above the bars indicate the frequency of the percentage of seropositive animals in the BVDV 
antibody sampled herds (left vertical axis). The graph line demonstrates the cumulative 
frequency of seropositive herds (with cumulative percentage for each category) starting with 
herds with the highest percentage of seropositive animals (right vertical axis). This graph 
clearly shows that in 44.4% of the seropositive herds at least 60% of the tested animals were 
BVDV seropositive. 
 
Spot test 
Out of the sampled herds, 31 herds in which at least one Ag-positive animal was 
detected and a minimum of five animals was tested for antigen and antibodies were studied in 
more detail (Fig. 3). When more than 60% of sampled animals in a herd is BVDV 
seropositive, this is a strong indication for the presence of a PI animal (Houe et al., 1995a). As 
such, the sensitivity of the spot test to detect the presence of a PI animal was estimated to be 
64.5% (20/31). 
In one herd (herd 31) all tested animals were seropositive, including the antigen 
positive animal.  
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Fig. 3. Percentage of seropositive young stock in herds with a minimum of five animals tested 
and at least one BVDV antigen positive animal detected in this study. In six herds no BVDV-
specific antibodies were detected despite the presence of a BVDV antigen-positive animal. In 
another five herds less than 60% of the tested animals were BVDV seropositive. 
 
Questionnaire 
As 895 of the 1100 herds selected for the winter screening 2009–2010 answered the 
questionnaire, the response rate was 81.4%. Results of the answers to the BVDV-related 
questions are listed for all herds and per production type (Table 2). 
 
Table 2. Questionnaire results for BVDV-related questions 
     Question Yes 
Production type 
All herds Dairy Beef Mixed 
Did the herd suffer from problems possibly 
related to BVDV the past 3 years? 
n  
%* 
75/890  
8.4 
19/165  
11.5 
25/514  
4.9 
31/202  
15.3 
Have PI animals ever been detected  
during a full screening? 
n  
%* 
92/868 
 10.6 
28/160  
17.5 
36/504  
7.1 
28/196  
14.3 
Were animals BVDV                   
vaccinated in 2009? 
n  
%* 
158/874  
18.1 
33/159  
20.8 
72/506  
14.2 
53/198  
26.8 
*valid percentage (not-applicable and missing values excluded from denominator)   
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It has to be noted that for the question “Have PI animals ever been detected during a 
full screening?” the 10.6% herds that did detect a PI animal had done a full screening and 
detected a PI animal during this screening. No information was available about the proportion 
of herds that performed a full screening but did not detect a PI animal. 
As production types are concerned, differences between beef herds and mixed herds 
were significant (p < 0.05) for all three questions. The difference between dairy and beef 
herds was only significant for the question “Have PI animals ever been detected during a full 
screening?” (p < 0.05). No significant differences were detected between dairy and mixed 
herds for any of the three questions. 
 
Risk factor analysis 
Herd BVDV seropositivity was significantly associated with seven factors following 
univariable analysis: “Number of animals” (herd size) (p < 0.01), “Antigen positive animal 
detected in this study” (p < 0.01), “BVDV vaccination in 2009” (p < 0.01), “Reporting 
BVDV-related problems the past 3 years” (p < 0.01), “Detection of PI animals in the past 
during a full screening” (p < 0.01), “Herd production type” (p = 0.06) and “The age of starting 
BVDV vaccination” (p < 0.01). Checking the correlations showed that a relevant correlation 
was present between “BVDV vaccination in 2009” and “The age of starting BVDV 
vaccination” (r = 0.785). Consequently “The age of starting BVDV vaccination” was not 
included in the multivariable model. 
In the multivariable model four factors remained significantly associated with herd 
BVDV seropositivity: “Number of animals”, “Antigen positive animal detected in this study”, 
“BVDV vaccination in 2009” and “Reporting BVDV-related problems the past 3 years” 
(Table 3 and Table 4). No confounding was detected. The two-way interaction between 
“Antigen positive animal detected in this study” and “BVDV vaccination in 2009” was 
statistically significant (p < 0.01) in all herds and in the subset of herds with no BVDV 
vaccination of animals < 12 months. The model fitted the data sufficiently well, as no 
significant results were obtained with the Hosmer and Lemeshow test for all herds and herds 
with no vaccination of animals < 12 months. Similar results were obtained with herd as 
random effect in a two-level binomial model. The dispersion parameter was 0.451 and 0.421 
respectively for all herds and herds with no vaccination of animals < 12 months, indicating 
overclustering when a two-level binomial model was used. 
BVDV prevalence and risk factors  Chapter 3 
 
71 
 
Due to a lack of power (because of the limited number of antigen positive herds), 
potential risk factors for BVDV antigen presence could not be identified. 
Finally, the relation between BVDV vaccination and the reporting of BVDV-related 
problems was analysed. The odds for BVDV vaccination was 4.6-fold higher in herds 
reporting BVDV-related problems compared to herds which did not report such problems 
(95% CI  2.8; 7.6). 
  
 
Table 3. Multivariable odds ratios (OR) and 95% confidence intervals (CI) for risk factors associated with a herd to be tested BVDV seropositive 
in all sampled herds (n = 664). 
Factor Category n Prevalence (%) OR 95% CI p-value 
       
Number of animals (herd size) 
(average: 96; range: 1 - 642) - - - 1.004 1.002; 1.006 < 0.01 
BVDV vaccination in 2009: No 
Antigen positive animal detected  
 
No 
Yes 
 
488 
25 
 
35.7 
88.0 
 
1.0 
13.8 
 
Reference 
4.0; 46.9 
 
 
< 0.01 
BVDV vaccination in 2009: Yes 
Antigen positive animal detected  
 
No 
Yes 
 
147 
4 
 
72.1 
25.0 
 
1.0 
0.1 
 
Reference 
0.0; 1.5 
 
 
0.10 
Antigen positive animal detected: No 
BVDV vaccination in 2009 
 
No 
Yes 
 
488 
147 
 
35.7 
72.1 
 
1.0 
3.4 
 
Reference 
2.2; 5.2 
 
 
< 0.01 
Antigen positive animal detected: Yes 
BVDV vaccination in 2009 
 
No 
Yes 
 
25 
4 
 
88.0 
25.0 
 
1.0 
0.04 
 
Reference 
0.00; 0.47 
 
 
< 0.05 
BVDV-related problems  
the past 3 years 
No 
Yes 
591 
73 
42.8 
68.5 
1.0 
1.9 
Reference 
1.1; 3.3 
 
< 0.05 
 
  
 
Table 4. Multivariable odds ratios (OR) and 95% confidence intervals (CI) for risk factors associated with a herd to be tested BVDV seropositive 
in herds where animals younger than 12 months were not vaccinated (n = 579). 
Factor Category n Prevalence (%) OR 95% CI p-value 
Number of animals (herd size) 
(average: 88; range: 1 - 642) 
- - - 1.004 1.002; 1.006 < 0.01 
BVDV vaccination in 2009: No 
Antigen positive animal detected  
 
No 
Yes 
 
484 
25 
 
35.5 
88.0 
 
1.0 
13.8 
 
Reference 
4.1; 47.1 
 
 
< 0.01 
BVDV vaccination in 2009: Yes 
Antigen positive animal detected  
 
No 
Yes 
 
66 
4 
 
63.6 
25.0 
 
1.0 
0.2 
 
Reference 
0.0; 2.4 
 
 
< 0.20 
Antigen positive animal detected: No 
BVDV vaccination in 2009 
 
No 
Yes 
 
484 
66 
 
35.5 
63.6 
 
1.0 
2.2 
 
Reference 
1.3; 4.0 
 
 
< 0.01 
Antigen positive animal detected: Yes 
BVDV vaccination in 2009 
 
No 
Yes 
 
25 
4 
 
88.0 
25.0 
 
1.00 
0.03 
 
Reference 
0.00; 0.46 
 
 
< 0.05 
BVDV-related problems 
the past 3 years 
No 
Yes 
530 
49 
39.2 
59.2 
1.0 
1.8 
Reference 
0.9; 3.3 
 
0.08 
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Discussion 
 
This paper describes the results of a BVDV virological and serological prevalence 
study in Belgium. This is the first complete study for Belgium as in the past studies either 
described the BVDV prevalence for only certain regions of Belgium (Onclin et al., 1995; 
Schreiber et al., 1999) or focused on the detection of PI animals (Letellier et al., 2005). The 
random selection of cattle herds and the large sample of young stock results in an accurate 
estimation of the virological and serological BVDV prevalence in 6- to 12-month-old animals 
at both the herd and animal level (Table 1). The within-herd virological and serological 
prevalence in the entire herd may be biased as only animals aged between 6 and 12 months 
were sampled. A high between-herd (Table 1) and within-herd seroprevalence (Fig. 2) of 
young stock suggests an active circulation of BVDV in a considerable number of Belgian 
cattle herds. Recently, similar results were obtained in beef suckler herds in Scotland 
(Brülisauer et al., 2010). 
When comparing with former BVDV prevalence studies, caution has to be applied to 
the target population and the methodology used (Brülisauer et al., 2010). None of the previous 
Belgian studies were performed with a random selection of herds. The selection of the tested 
herds was based on a history of BVDV in the herd or suspicion of BVDV infection of 
animals. This can explain why these studies report a higher prevalence of BVDV Ag-positive 
animals, namely 1.8% (Letellier et al., 2005); or PI animals, namely 2.3% (Wellemans and 
Vanopdenbosch, 1990), 1.4% (Onclin et al., 1995) and 0.8% (Schreiber et al., 1999). A 
Danish study selecting dairy herds with an unknown BVDV status obtained a PI animal 
prevalence of 0.1% (Houe et al., 1995b) which is lower than the 0.3% found in our study. 
This can be explained by a possible overestimation of PI animal prevalence in our study due 
to the inclusion of transient infections since the Ag-positive animals have not been retested to 
differentiate between a transient and persistent infection. Though, a positive test result for 
BVDV antigen is likely to originate from PI animals (Sandvik, 2005). We also possibly 
overestimated the PI animal prevalence by testing only young stock compared to testing all 
animals in a herd since detection of PI animals at adult age occurs less frequently. PI animals 
usually die from mucosal disease before the age of 2 years (Peterhans et al., 2010) or leave the 
herd because their production is insufficient (Houe, 2003). Yet, PI animals can sometimes live 
beyond the age of 2 years (Houe, 1992). 
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As previous BVDV prevalence studies performed in Belgium focused on PI animals, 
little information about BVDV seroprevalence is available. Schreiber et al. (1999) estimated a 
seroprevalence of 65.5% at the animal level after testing all animals in 61 herds. When 
sampling all animals in a herd, also older animals are included. Obviously, older animals are 
more likely to have been exposed to the virus and as animals stay seropositive life-long, the 
herd seroprevalence is likely to be higher when older animals are also included in the sample. 
Moreover, vaccination is more frequently applied in adult animals than in young stock. The 
non-random selection of the herds and the different age of the sampled animals make it 
difficult to compare the seroprevalence results. 
The serological results of the young stock can be considered as a spot test for each 
individual herd and as such can provide useful information about the BVDV infection status 
of each herd (Houe, 1992). The advantage of testing young stock for the presence of BVDV-
specific antibodies is that it detects a recent or on-going infection given the young age of the 
animals (Brülisauer et al., 2010). When only the herds with a minimum of five animals tested 
are taken into account, 54.1% (286/529) of the herds were BVDV seropositive (data not 
shown). Almost half (48.3%) of these seropositive herds had a within-herd seroprevalence ≥ 
60%, suggesting the presence of a PI animal in these herds when considering these results as a 
spot test (Brülisauer et al., 2010). 
Pillars and Grooms (2002) obtained a sensitivity of 66.7% to detect the presence of PI 
animals when at least 3 out of 5 unvaccinated heifers aged 6-12 months were BVDV 
seropositive. A similar sensitivity of 64.5% was calculated in the present study. This might be 
an underestimation of the true sensitivity of the spot test due to possible false positive antigen 
detection results. Given the specificity of 99.7% of the used antigen test and the number of 
animals tested (n = 5205), about 15 false positive results are expected. It is impossible to 
determine which of the 44 Ag-positive animals were false positive, but it is likely that at least 
some of these herds with an apparent antigen positive animal and no seropositive animals had 
false positive antigen test results. Moreover, also a number of biological factors may impair 
the spot test sensitivity. A first factor is a limited contact of the PI animal with the sampled 
animals, for instance when animals are housed separately. If animals are housed in different 
groups, spot testing should be performed on each cohort (Pillars and Grooms, 2002; Laureyns 
et al., 2010). When a PI animal was recently added to the group, it is possible that cohort 
animals have not seroconverted yet (Houe et al., 2006). Therefore the value of the spot test 
increases by repeating it at regular intervals (Houe, 1999). In herds with spot tests results 
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ranging between 0% and 60% of the sampled animals testing seropositive, it is favourable to 
repeat the spot test 3 months later to evaluate the previously obtained results (Pillars and 
Grooms, 2002 and Laureyns et al., 2010). The same holds for the antigen results since BVDV 
Ag-positive animals in this study have not been retested to confirm PI status and therefore it is 
possible that some animals were transiently infected (TI) or even false positive. TI animals are 
a much smaller source of infection compared to PI animals (Lindberg and Houe, 2005), which 
may explain why some sampled animals did not seroconvert. In one herd (herd 31, Fig. 3) all 
tested animals were seropositive including the Ag-positive animal. This may be an indication 
of a transient infection in this animal. 
The influence of the herd production type on BVDV infections is not well known. Few 
differences between production types were detected in this study. Only between beef herds 
and mixed herds statistically significant differences could be detected: beef herds had a 
significantly lower seroprevalence, reported less BVDV-related problems and vaccinated less 
compared to mixed herds. Fewer beef herds detected PI animals in the past compared to dairy 
and mixed herds. All these differences were not significant between dairy herds and mixed 
herds. It is suggested that beef herds purchase less BVDV susceptible animals in early 
pregnancy, which could possibly explain these findings. Though, one can argue if these 
statistically significant differences are of any biological importance. 
The number of animals present in the herd was identified as a risk factor for a herd to 
be BVDV seropositive. Large herds were significantly more often seropositive than small 
herds (p < 0.01). This was also found in other studies (Houe, 1999; Talafha et al., 2009). 
Small herds are more likely to eliminate BVDV infections spontaneously. The probability of 
this self-clearance depends on the prevalence of susceptible animals in early pregnancy, 
which is lower in small herds (Lindberg and Houe, 2005). 
Despite a high BVDV prevalence in Belgian cattle herds, only 8.4% of the farmers 
stated to have had problems possibly related to BVDV. Moreover, 83.4% of the farmers with 
a spot test ≥ 60% seropositive stated not to have had any BVDV-related problems (data not 
shown). This can be explained by the ability of BVDV to cause a broad range of symptoms 
and by the fact that 70-90% of BVDV infections occur subclinically. Nevertheless, these 
subclinical infections also affect animal productivity, for instance by decreasing milk yield 
(Fourichon et al., 2005). 
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The fact that farmers mostly are not aware of the presence of BVDV in their herds 
could explain why “Reporting BVDV-related problems the past 3 years” could not be 
identified as a significant risk factor for a herd to be BVDV seropositive (Table 4). Such herds 
had an odds of 1.8 of being seropositive, but this was not statistically significant (p = 0.08). 
One would have expected this effect to be more explicit but the fact that BVDV infections 
mostly remain undetected has probably attenuated the association between herd seropositivity 
and this factor. 
The influence of BVDV vaccination on BVDV herd seropositivity depended on the 
detection of Ag-positive animals in the present study. Non-vaccinating herds with Ag-positive 
animals detected, were significantly more often BVDV seropositive compared to herds with 
no Ag-positive animals detected (p < 0.01). This was to be expected as viraemic animals (TI 
and especially PI animals) are the most important source of infection (Lindberg and Houe, 
2005). In vaccinating herds no significant relation between the detection of Ag-positive 
animals and seropositive herds could be demonstrated (p = 0.10). With only four vaccinating 
herds where Ag-positive animals were detected and this limited number relative to the 
vaccinating herds with no Ag-positive animal detected (n = 147), no firm conclusions should 
be drawn from this result. In the subset of herds with no vaccination of animals < 12 months 
the discrepancy between the number of vaccinating herds with Ag-positive animals (n = 4) 
and without Ag-positive animals detected (n = 66) was smaller (Table 4). Nevertheless, the 
relation between the detection of Ag-positive animals and seropositive herds remained non-
significant (p = 0.20). When no Ag-positive animals were detected, vaccination was a 
significant risk factor for a herd to be seropositive (p < 0.01). This can partially be explained 
by the detection of vaccine-induced antibodies (Raue et al., 2011). However, in herds with no 
vaccination of the sampled animals (but with possible vaccination of older animals), 
vaccination also appeared to be a risk factor (Table 4). As the sampled animals were not 
BVDV vaccinated, this means they have BVDV antibodies which must be originating from a 
BVDV infection. It can be assumed that herds with BVDV-related problems apply 
vaccination as a measure to control the infection: herds reporting BVDV-related problems 
applied significantly more often BVDV vaccination (p < 0.01) compared to herds non-
reporting such problems. In herds where Ag-positive animals were detected, vaccination 
protected herds of becoming seropositive (p < 0.05). Vaccination reduces the number of 
susceptible animals and is therefore able to decrease the virus spread (Lindberg and Houe, 
2005). 
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Besides the significant relation between reporting BVDV-related problems and 
applying BVDV vaccination, we noticed that some farmers which did not report BVDV-
related problems also applied vaccination. Some hypotheses can be proposed why they 
vaccinated anyway. Farmers who experienced BVDV-related problems in the past often 
continue vaccination without considering the necessity of it. Moreover, some herd 
veterinarians advise all their clients to apply BVDV vaccination, irrespective of the risk of 
infection. Some farmers will vaccinate as a preventive measure because they fear to get 
BVDV infected. 
 
Conclusions 
 
This paper describes the first Belgian virological and serological BVDV prevalence 
study based on a random selection of a young cattle. The high between-herd and within-herd 
seroprevalence of young stock suggests an active circulation of BVDV in a considerable 
number of Belgian cattle herds. Despite a high BVDV prevalence, few farmers are aware of 
the presence of BVDV in their herds. Nevertheless, useful information about the BVDV 
infection status of a herd can easily be obtained by performing a spot test at regularly 
intervals. The identified risk factors illustrate that the detection and removal of PI animals is 
of crucial importance to eradicate BVDV at the herd level, which may be more difficult in 
larger herds. 
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Abstract 
 
Bovine viral diarrhoea virus (BVDV) causes persistent infections by infecting the 
foetus of susceptible animals during gestation. These persistently infected (PI) animals are 
important sources of infection. On the contrary, transiently infected (TI) animals are believed 
to be less important, but transient infections with a severe BVDV-2 strain can spread 
explosively. 
To assess the importance of TI cattle in the epidemiology of BVDV, two experimental 
infections were performed to determine basic reproduction ratios (R0). In each experiment 
three calves were infected via intranasal inoculation and housed together with seven 
susceptible animals. Two strains isolated in Belgium were used, a virulent BVDV-1b and a 
virulent BVDV-2a field isolate, resulting in an R0 of 0.25 (95% CI 0.01; 1.95) and 0.24 (95% 
CI 0.01; 2.11), respectively. A PI animal was then introduced to the remaining uninfected 
animals and produced an R of +∞ (95% CI 1.88; +∞). These results support the suggestion 
that TI animals, compared to PI animals, contribute only a limited amount to BVDV spread. 
Additionally, the severe clinical symptoms observed in the field with these isolates could not 
be reproduced during these experiments suggesting that other factors besides strain virulence 
influence the clinical manifestations evoked by BVDV. 
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Introduction 
 
Bovine viral diarrhoea virus (BVDV) is characterized by a strong genetic diversity and 
can be divided into two genotypes, BVDV-1 and BVDV-2, each subdivided into 
subgenotypes (Neill, 2013). Disease severity is likely to be linked to the degree of viraemia 
(Walz et al., 2001). 
Acute BVDV infections of BVDV seronegative cattle result in a transient viraemia of 
10-14 days, starting 3 days post-infection (Lanyon et al., 2014). The duration of virus shed by 
these transiently infected (TI) animals varies considerably and is likely to depend on the 
virulence of the strain (Bolin and Ridpath, 1992). After 5-7 days of incubation about 70% to 
90% of acute infections are subclinical, associated with only a mild raise in body temperature 
and leukopenia (Baker, 1995). By infecting cells of the immune system, BVDV evokes an 
immunosuppression leading to a decreased response to other infectious agents (Chase et al., 
2004). BVDV also causes persistent infections by infecting the foetus in early gestation 
(Peterhans et al., 2010). Once colostrum-derived BVDV antibody titres have declined, these 
persistently infected (PI) animals continuously shed BVDV in large quantities (Lindberg and 
Houe, 2005). 
The transmission rate of an infectious disease in a population can be expressed by its 
reproduction ratio, R. A special case is the basic reproduction ratio, R0, defined as the mean 
number of secondary infections arising from one typical infectious case introduced in a fully 
susceptible population. R has a threshold value equal to 1. This means that an infection may 
spread when R > 1 and will fade out when R < 1 (Velthuis et al., 2007). PI animals are very 
successful virus transmitters (R0 assumed > 1), whereas TI animals are believed to be less 
important in spreading BVDV (R0 assumed < 1), due to the shorter duration of infection and 
the intermittent shedding of relatively low amounts of virus (Lindberg and Houe, 2005). 
However, it has been suggested that during severe BVDV-2 outbreaks transient infections 
significantly contribute to BVDV transmission (Ridpath et al., 2006). 
Belgium is characterized by a high cattle density and a high BVDV prevalence; about 
one-third of the young stock is BVDV seropositive (Sarrazin et al., 2013). In addition, severe 
clinical symptoms linked to BVDV-1 and BVDV-2 have been described (Letellier et al., 
2010; Laureyns et al., 2011a; Laureyns et al., 2011b; Laureyns et al., 2013). We hypothesized 
Belgian BVDV strains  Chapter 4.1   
 
90 
 
that TI animals may contribute substantially more to BVDV spread than is generally assumed. 
The objective of the present study was to estimate R0 for BVDV transmission by TI cattle 
following experimental infections using Belgian BVDV field isolates. 
 
Material and methods 
 
All experiments were approved by the Ethics Committee of the Belgian Veterinary 
and Agrochemical Research Centre (reference number 120102-01 BOVIDI1, 2 January 
2012). 
 
Animals 
For each trial 10 Holstein-Friesian calves were selected from BVDV free herds (no 
BVDV history despite regular monitoring). The calves were checked twice for the absence of 
BVDV-RNA and antibodies using real-time RT-PCR (RT-qPCR) and virus neutralization 
(VN), respectively, as described below. At the time of infection, animals in trials 1 and 2 were 
aged between 65 and 90 days and between 100 and 128 days, respectively. 
 
Virus isolates 
For trial 1, a non-cytopathic (ncp) BVDV-1b strain isolated from a 2-day-old PI 
animal with spontaneous skin bleeding (Laureyns et al., 2013) was cultivated on Madin-
Darby Bovine Kidney (MDBK) cells (one passage). The titre obtained was 2.6 x 10
6
 tissue 
culture infective dose/mL (TCID50/mL). For trial 2, the ncp BVDV-2a isolate 07/3913 was 
used (Letellier et al., 2010) after cultivation (two passages). The titre obtained was 3.7 x 10
5
 
TCID50/mL. 
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Experimental design (Table 1) 
During trial 1 calves were housed together in a box 3.2 ×10.0 m on a slatted floor (Fig. 
1), which was cleaned daily with water. After an acclimatization period of 14 days, three 
randomly chosen calves were isolated from the other calves and inoculated with BVDV-1b 
through intranasal inoculation of 5.0 x 10
6
 TCID50. After 2 days of separation the inoculated 
animals were housed with the seven contact animals. When no infectious animals were left, 
i.e. all blood samples and nasal swabs were negative by RT-qPCR (69 days after study start), 
all BVDV seropositive animals were removed, and the trial process was repeated with three of 
the remaining calves being inoculated with the virus. All 10 calves were slaughtered 38 days 
after the start of this second phase of the trial (trial 1.2). 
For trial 2, housing conditions, acclimatization period and inoculation procedures were 
identical to trial 1, except that the BVDV-2a strain was used. When no infectious animals 
were left (56 days after study start), all BVDV seropositive animals were removed, and the 
trial process was repeated (trial 2.2) with three of the remaining calves inoculated with the 
virus. Forty-four days later, a 6-month-old calf persistently infected with a BVDV-1b strain 
was commingled with all 10 calves from trial 2 (seven of which had seroconverted to BVDV-
2a and three of which had remained susceptible) (trial 2.3). The serum viral titre of the PI calf 
was approximately 2.4 × 10
4
 TCID50/mL. All 11 animals were slaughtered 34 days after the 
introduction of the PI animal. 
 
Clinical examination and sample collection 
Clinical characteristics and rectal temperatures were recorded during daily 
examination using a scoring system adapted from Cortese et al. (1998) and Pardon (2012) (see 
Appendix A, Supplementary material). 
Whole blood was collected in EDTA-coated tubes and stored at 4 °C. Serum was 
collected in tubes with a cloth activator, centrifuged for 10 min at 1800 g and stored at -20 °C. 
Nasal swabs were dipped in 0.5 mL Minimum Essential Medium (MEM, Invitrogen) 
containing penicillin, gentamicin and amphotericin B and stored at -80 °C. 
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Fig. 1. The calves were housed together in a box 3.2 ×10.0 m on a slatted floor which was 
cleaned daily with water. Freely moving and nose-to-nose contact was always possible, 
except during feeding and sampling (one hour daily). 
  
 
Table 1. Overview and results of the experimental design. The status of a calf at the start and the end of each trial is presented.  
The days of sample collection are shown on the right. 
Trial 1: BVDV-1b transmission through TI animals  
Days after first inoculation Calf 
Sampling 
(days after each inoculation) 
 1 2 3 4 5 6 7 8 9 10   
First inoculation             
Start 0 I I I S S S S S S S  0; 2-10: daily; 12-24, 27- 31, 
34-38: every 2 days; 45 End 69 R R R S S S S S S S  
Second inoculation              
Start 69    I I I S S S S  0; 2-11: daily; 14-18, 21-25: 
every 2 days; 30 End (slaughter) 107    R R R C S S S  
Trial 2: BVDV-2a transmission through TI animals  
Days after first inoculation Calf 
Sampling 
(days after each inoculation) 
  1 2 3 4 5 6 7 8 9 10 PI  
First inoculation              
Start 0 I I I S S S S S S S - 0; 2-12: daily; 14-18, 21-31: 
every 2 days; 37; 45; 51 End 56 R R R C S S S S S S - 
Second inoculation              
Start 56     I I I S S S - 0; 2-4, 7-11, 14-18: every 2 
days; 22; 25 End 100     R R R S S S - 
Introduction of PI animal: BVDV-1b transmission through PI animal  
Start 100 R R R R R R R S S S PI 0; 2; 5; 8; 12; 14; 19; 26; 28; 
33 End (slaughter) 134 R R R R R R R C C C PI 
TI, transiently infected; PI, persistently infected; I, infectious; S, susceptible; C, contact infected; R, recovered. 
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Virus isolation and determination of viral titre 
An in-house haemolysis buffer (0.31 M NH4Cl, 0.02 M NaHCO3 and 0.63 mM 
Na2EDTA) was added to 1.5 mL blood. A pellet of leucocytes was obtained after 
centrifugation for 10 min at 200 g, suspended in 1 mL MEM and used to make 10-fold 
dilutions. Serial dilutions were inoculated in 96-well microtitre plates containing monolayers 
of MDBK-cells in MEM, 10% fetal calf serum, L-glutamine and antibiotics. 
After incubation for 6 days at 37 °C in humidified air containing 5% CO2, the 
supernatant was removed and the monolayers were rinsed with phosphate-buffered saline 
(PBS) solution, dried overnight at 37 °C and stored at -20 °C for a minimum of 12 h to lyse 
the cells. MDBK-cells were stained for BVDV antigen using an immunoperoxidase 
monolayer assay (IPMA) adapted from Jensen (1981). The monolayers were fixed with 4% 
formalin, rinsed, overlaid with 100 µL of BVDV polyclonal serum diluted 1/200 and 
incubated for 1.5 h at 37 °C. Washing and staining procedures were performed (Jensen, 
1981), using a rabbit anti-bovine peroxidase conjugate (Sigma-Aldrich) diluted 1/500. 
Reading was done using a light microscope and viral titre was calculated (Reed and Muench, 
1938). 
 
RT-qPCR 
Total RNA was extracted from haemolysed blood (obtained as described above) and 
nasal swabs using RNeasy Mini kit (QIAGEN) and MagMAX Pathogen RNA/DNA kit (Life 
Technologies), respectively. Reverse transcription, using 10 µL RNA and hexanucleotides 
(Roche), and qPCR assay were performed as described by Letellier et al. (1999) and Letellier 
and Kerkhofs (2003), respectively. RT-qPCR was used in a qualitative way to follow the 
infection in the inoculated animals and to verify if the susceptible calves were contact 
infected. 
 
Virus neutralization 
Sera from all calves were tested for virus neutralizing antibodies against the 
homologous strain using a VN protocol adapted from Edwards (1990). Duplicates of two-fold 
dilutions, starting at 1:5, were incubated with each virus strain for 2 h. MDBK cells were then 
added and incubated for a further 3 days. Virus-infected cells were detected by IPMA staining 
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as described above. Neutralizing antibody titre was defined as the inverse of the highest 
dilution with complete inhibition of virus growth (Walz et al., 2001). 
 
Haematology 
Packed cell volume, haemoglobin concentration and the total number of leucocytes 
and thrombocytes were determined in EDTA-treated blood samples using an ADVIA 2120i 
haematology system (Siemens). 
 
Data analysis 
R0 was estimated by maximum likelihood (MLE) according to the final size method 
(Velthuis et al., 2007). Two-sided 95% confidence intervals (CI) and p-values for testing the 
null hypotheses R0 ≥ 1 and R0 ≤ 1 were obtained. The design of three infectious and seven 
susceptible animals at the start was based on power calculations of Kroese and de Jong 
(2001); these numbers were sufficient to test H0: R0 ≤ 1 (5% significance level). An animal 
was considered as infected if positive test results were obtained for RT-qPCR and/or virus 
isolation (VI) and VN. 
Fever was defined when the rectal temperature was > 39.0 °C, the one-sided upper 
limit of the 95% CI obtained for the average rectal temperature of all calves during the last 3 
days before inoculation. 
To evaluate whether blood composition was associated with BVDV infection, a linear 
mixed model approach was used in SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Normal 
probability tests and plots of scaled residuals were examined to check whether the 
assumptions of normality and homoscedasticity were fulfilled. A Bonferroni correction was 
applied for post-hoc comparisons.  
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Results 
 
Virus transmission 
Following the first inoculation with BVDV-1b (trial 1) no virus transmission by the 
inoculated calves to the contact animals was detected (Table 1). The experimental infection 
was repeated by inoculating 3/7 remaining susceptible animals. One of four contact animals 
was infected (blood samples became RT-qPCR-positive 10 days post infection [dpi]; Fig. 2). 
For trial 1 the MLE of R0 was 0.25 (95% CI 0.01; 1.95). During trial 1, the original, undiluted 
samples of the inoculated and contact infected animals were positive in VI (Fig. 2). However, 
because the dilution series were negative in VI, the viral titre could not be determined. 
 
Fig. 2. The period during which inoculated animals were RT-qPCR-positive for the first phase 
of trials 1 and 2 are represented by a solid line and for the second phase of trials 1 and 2 by a 
dashed line. A dotted line is used for the animals infected by contact (after the second 
inoculation in trial 1, and first inoculation and introduction of persistently infected (PI) in trial 
2). Days on which whole blood samples were positive for virus isolation (VI) and/or nasal 
swabs were RT-qPCR-positive are presented. During trial 2, after the introduction of the PI 
animal, one animal infected by contact was RT-qPCR-positive for one sampling day only 
(marked with ▴). 
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During the first part of trial 2, 1/7 contact animals was infected (blood samples 
became RT-qPCR-positive at 10 dpi; Fig. 2). For the second phase 3/6 remaining susceptible 
animals were inoculated, but none of the three remaining contact animals became infected. 
For trial 2, the MLE of R0 was 0.24 (95% CI 0.01; 2.11). Compared to trial 1 a higher degree 
of viraemia was obtained and viral titre was able to be determined (Table 2). 
After the introduction of the PI animal, all three remaining susceptible calves were 
infected, with two becoming RT-qPCR-positive 5 days after its introduction (Fig. 2). For this 
phase of trial 2 the MLE of R was +∞ (95% CI 1.88; +∞). None of the seven animals which 
seroconverted to BVDV-2a became RT-qPCR-positive after introduction of the PI (which was 
excreting BVDV-1b). 
 
Table 2. Mean (range) of viral titres (log10 TCID50/mL) of the inoculated animals (both 
inoculation phases) and the animal infected by contact (trial 2.1).  
dpi  Trial 2 - first inoculation  Trial 2 - second inoculation 
 Inoculated animals Animal infected  
by contact 
 Inoculated animals 
2 < 2.30 Not done  Negative 
3 < 2.30 Not done  Not done 
4 2.66 (< 2.30-2.80) Not done  < 2.30 
5 2.27 (< 2.30-2.63) Not done  Not done 
6 2.30 (< 2.30-2.53) Not done  Not done 
7 2.55 (< 2.30-2.97) Not done  2.38 (< 2.30-2.63) 
8 2.61 (< 2.30-2.97) Not done  Not done 
9 < 2.30 Not done  < 2.30 
10 < 2.30 Negative  Not done 
11 Not done Not done  < 2.30 
12 Negative < 2.30  Not done 
14 Not done 2.97  Negative 
16 Not done 2.30  Not done 
18 Not done < 2.30  Not done 
21 Not done Negative  Not done 
dpi,
  
days post inoculation.   
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Clinical results 
A leukopenia and thrombocytopenia was noticed in all RT-qPCR-positive animals 
during both trials (Table 3). Except for some occasional coughing for two inoculated animals 
(coughing score = 2) no clinical symptoms were noticed during the first part of trial 1. No 
clinical symptoms were noticed after the second inoculation. In trial 2 loss of appetite 
(appetite score = 2) was noticed 2-3 dpi in 2/3 calves inoculated at the beginning of the trial 
while the third of those calves did not eat at 9 dpi (appetite score = 4). This animal also 
displayed nasal discharge (score = 2; 8-10 dpi) and apathy (lying down score = 2). Except for 
some occasional coughing (score = 2; 17 dpi), the calf which became infected showed only 
subclinical infection. None of the second group of inoculated animals showed any clinical 
signs, nor did the calves exposed to the PI. All inoculated and contact infected animals 
showed fever (> 39.0 °C) during infection, with higher and longer periods of pyrexia during 
trial 2 (see Appendix B, Supplementary Material). 
Table 3. Comparison of haematology between RT-qPCR-negative and RT-qPCR-positive 
animals during both inoculations of trial 1 and after first inoculation of trial 2. 
 RT-qPCR-negative RT-qPCR-positive p-value
 
 Estimate 95% CI Estimate 95% CI  
Trial 1 - first inoculation      
Leucocytes (1000/µL) 10.2 8.6;11.9 9.9 8.1;11.7 0.46 
Thrombocytes (1000/µL) 590 524;656 614 527;701 0.43 
Packed cell volume (%) 31.8 30.0;33.6 32.3 30.2;34.3 0.39 
Haemoglobin (g/dL) 11.0 10.4;11.7 11.0 10.3;11.8 0.95 
Trial 1 - second inoculation      
Leucocytes (1000/µL) 9.7 8.6;10.9 7.0 5.8;8.3 < 0.001 
Thrombocytes (1000/µL) 449 420;478 401 359;442 0.02 
Packed cell volume (%) 31.4 29.8;32.9 30.6 28.8;32.3 0.23 
Haemoglobin (g/dL) 10.9 10.5;11.4 10.6 10.1;11.1 0.03 
Trial 2 - first inoculation      
Leucocytes (1000/µL) 8.5 7.8;9.2 5.9 5.0;6.7 < 0.001 
Thrombocytes (1000/µL) 633 556;710 423 333;513 < 0.001 
Packed cell volume (%) 28.3 26.3;30.2 28.8 26.7;30.9 0.28 
Haemoglobin (g/dL) 10.1 9.4;11.0 10.5 9.7;11.3 0.07 
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Neutralizing antibody titres 
The mean time between infection and rise of neutralizing antibody titres in VN for 
trial 1 and 2 was 13.0 days (SD 1.7 days) and 11.8 days (SD 2.0 days), respectively (Fig. 3). 
The contact infected animal in trial 1 seroconverted 18 dpi, while in trial 2 this was 21 dpi. 
Neutralizing antibody titres peaked at 3840 starting at 36 dpi (trial 1) and 9-12 weeks dpi 
(trial 2, data not shown). Following the introduction of the PI animal, the contact infected 
calves seroconverted after 17.3 days (SD 2.9 days). 
 
 Fig. 3. Neutralizing antibody titres resulting from virus neutralization (VN) using the 
homologous strain are presented on a logarithmic scale per replication of each trial for the 
inoculated and animals infected by contact. Mean values with their standard deviation are 
presented for the inoculated animals and the animals infected by the persistently infected (PI) 
animal. Animals were considered BVDV-seropositive when the neutralizing antibody titre 
rose above a threshold of 5 (reference line). The remaining susceptible animals and the PI 
animal were BVDV seronegative, so their results are not shown. 
Belgian BVDV strains  Chapter 4.1   
 
100 
 
 
Fig. 3. Neutralizing antibody titres resulting from virus neutralization (VN) using the 
homologous strain. (continued) 
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Discussion 
 
During this study, limited BVDV transmission by TI animals was observed, in contrast 
to very rapid transmission after the introduction of a PI animal. These results are consistent 
with the assumption that TI cattle do not substantially contribute to BVDV spread, but 
nevertheless the estimation of R0 provides additional information on BVDV transmission by 
TI animals. 
Moerman et al. (1993) estimated that horizontal BVDV transmission rate by TI cattle 
had an R0 of 3.3 (95% CI 2.6; 4.1). However, although separated from the study group, PI 
animals were present in the herd during this study. As these animals shed massive doses of 
virus, they may have attributed to virus spread through indirect transmission (Niskanen and 
Lindberg, 2003; Lindberg et al., 2004), resulting in an overestimation of R0. 
Although the experimental setup in our study was designed to approach field 
conditions, there were limitations that have to be taken into account. First, under experimental 
conditions, animals are likely to be less challenged by other pathogens and environmental 
conditions that may contribute to a depressed immune response, disease development and 
pathogen spread. Calves were housed on a slatted floor which was cleaned daily with water to 
remove all faeces. Although direct nose-to-nose contact is considered to be the most effective 
route for transmission, these housing conditions may have hampered viral spread as 
contaminated pens may be a source of infection (Niskanen and Lindberg, 2003). Nonetheless, 
virus transmission was observed during both trials 1 and 2. 
Secondly, during both trials non-infected in-contact animals were re-used to increase 
the power of the experimental design. These non-infected animals had already had been 
exposed to BVDV, making them possibly more resistant to infection. However, inoculation 
resulted in active infection in all three calves in both trials and susceptible animals were 
infected during the second phase of trial 1 and after introduction of the PI animal in trail 2. 
This suggests that the remaining susceptible calves were not refractory to infection. To our 
knowledge, natural resistance to BVDV infection in apparently susceptible cattle has not been 
described. 
The dose of virus used for intranasal inoculation dose was similar to those used in 
other studies to ‘create’ TI animals (Hamers et al., 2000; Walz et al., 2001; Kelling et al., 
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2002). In our opinion, it is unlikely that the inoculation dose influenced the transmission rate 
as the amount and duration of virus shed is believed to depend on the intensity of replication 
within the host (Bolin and Ridpath, 1992). 
During this study a PI animal rapidly infected three susceptible animals in a group 
with seven BVDV seropositive calves. This resulted in R significantly > 1, which confirms 
that PI animals can maintain BVDV infection, as already described (Lindberg and Houe, 
2005; Fulton et al., 2006; Nickell et al., 2011). The use of R0 is restricted to fully susceptible 
populations (Velthuis et al., 2007) and therefore we reported R for trial 2.3, as the BVDV 
seropositive animals from trial 2.1 and 2.2 were not removed at the start of trial 2.3. 
Nonetheless, it is unlikely that these animals contributed to the infection of the remaining 
susceptible animals. This would have been detected by RT-qPCR as it distinguishes between 
BVDV genotypes: the PI animal transmitted BVDV-1b while BVDV-2a was used in trial 2. 
None of the contact infected animals during trial 2.3 tested positive for BVDV-2. 
As described by Ridpath et al. (2006), acute BVDV infections can spread explosively. 
By using virulent strains we had expected to observe sufficient virus transmission to reject H0: 
R0 ≤ 1. However, very limited transmission was observed; each trial was therefore repeated 
with the remaining susceptible animals in an attempt to reject H0: R0 ≥ 1. However, there was 
insufficient power to reject H0. Small point estimates (R0 < 1) were obtained, which means 
that the infection would theoretically fade out. Although statistically not significant, these 
results support the assumption that TI cattle, unless in early gestation, are of little importance 
for BVDV spread (Lindberg and Houe, 2005), as already demonstrated (Niskanen et al., 2000; 
Niskanen et al, 2002). 
BVDV infection was associated with leukopenia (trials 1 and 2) and thrombocytopenia 
(trial 2 only), but, except for fever, few additional clinical symptoms were noticed, even 
though the strains were isolated from animals suffering from clinical BVDV infections 
(Letellier et al., 2010; Laureyns et al., 2013). This is probably not surprising as most BVDV 
infections are subclinical (Baker, 1995), and the experimental conditions meant that the 
decreased immunity resulting from BVDV infection was not challenged by concurrent 
pathogens. In addition, other studies using virulent BVDV strains have also failed to 
reproduce the severe symptoms observed under field conditions (Hamers et al., 1999, Hamers 
et al., 2000 and Kelling et al., 2002). Age appears to be a key influence on the clinical 
manifestations associated with BVDV infection (Hamers et al., 2003), as studies producing 
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severe clinical symptoms under experimental conditions have used calves that were at most 2 
months old (Corapi et al., 1989; Bolin and Ridpath, 1992; Bezek et al., 1994; Cortese et al., 
1998; Ellis et al., 1998; Walz et al., 2001). 
BVDV is genetically highly variable (Vilcek et al., 2001) and changes in the genome 
with shifts in strain virulence following virus cultivation may also explain the mild clinical 
manifestations. To avoid genetic change as much as possible, the first and second passage of 
the cultivated virus were used for trial 1 and 2, respectively. Changes in the viral genome 
could be verified by sequence analysis after each passage, but virulence markers on a genetic 
level have not, so far, been described (Bolin and Grooms, 2004). 
 
Conclusions 
 
The limited viral spread from TI animals in this study indicates that they only make a 
limited contribution to BVDV transmission, whereas, under the same conditions, a PI animal 
was demonstrated to be a successful virus transmitter. This supports the conclusion that the 
removal of PI animals is essential for BVDV control, whereas a focus on TI animals should 
not be necessary. The severe clinical symptoms observed in the field could not be reproduced, 
which suggests that other factors besides strain virulence influence the clinical manifestations 
of BVDV infection. 
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Supplementary Material 
 
Appendix A: Clinical scoring system  
Adapted from Cortese et al. (1998) and Pardon (2012). 
Characteristic Score 
Posture (apathy) 
 
0 =  The calf is standing or lying down with the head held high. 
1 =  The calf is standing with the head kept down. 
2 =  The calf is lying down with the head on the ground. 
3 =  The calf is in lateral decubitus.  
 
When lying down, 
0 =  the calf stands up itself. 
1 =  the calf stands up when approaching. 
2 =  the calf stands up when touching. 
3 =  the calf needs a clear stimulus to stand up itself. 
4 =  the calf does not stand up itself, but does when pulled up. 
5 =  the calf does not stand up itself and does not keep standing when  
pulled up. 
 
Nasal discharge 
 
0 =  No nasal discharge 
1 =  Clear nasal discharge 
2 =  Mucopurulent nasal discharge 
3 =  Blood 
 
Coughing 
 
0 =  No coughing 
1 =  The calf coughs once 
2 =  The calf coughs occasionally (< 10 times during stable visit) 
3 =  The calf coughs regularly (> 10 times during stable visit)  
 
Respiration rate 
 
0 =  20-24 per minute 
1 =  > 40 per minute 
2 =  > 80 per minute 
3 =  > 80 per minute + difficulty to breath 
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Clinical scoring system (continued) 
Characteristic Score 
Behaviour  
 
0 =  The calf comes towards the fence or looking at the person   
performing the clinical examination. 
1 =  The calf is standing with other calves. 
2 =  The calf is walking alone in the stable. 
3 =  The calf is standing alone and is not interested in the 
environment. 
 
Appetite 
 
0 =  The calf starts eating immediately. 
1 =  The calf hesitates to eat, but finally eats everything. 
2 =  The calf hesitates to eat and does not eat much. 
3 =  The calf hesitates to come to the fence and does not eat much. 
4 =  The calf hesitates to come to the fence and does not eat. 
5 =  The calf does not come to the fence. 
 
Faeces 
consistency 
 
0 =  Normal faeces consistency 
1 =  Fluid faeces consistency 
2 =  Watery faeces 
3 =  Blood in the faeces 
 
Rectal temperature =   …  °C 
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Appendix B: Evolution of rectal temperature per trial 
Mean values are associated with their standard deviation. A reference line at 39.0 °C is 
shown. Fever was defined as a rectal temperature > 39.0 °C, the one-sided upper limit of the 
95% CI obtained on the average rectal temperature of all calves during the last 3 days before 
inoculation. 
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Summary 
 
 To assess the importance of transiently infected (TI) cattle in the epidemiology of 
BVDV-2 infections and to describe the clinical signs caused by such an infection, a 
transmission experiment was performed. Three calves were intranasally infected with a 
hypervirulent BVDV-2c field strain isolated during a severe BVDV outbreak in Germany and 
housed together with seven susceptible animals. The clinical signs of the BVDV infected 
animals varied from very mild disease (fever, loss of appetite) to severe watery and 
haemorrhagic diarrhoea and death. The clinical signs and the level of BVDV excretion 
depended on the degree of viraemia. The basic reproduction ratio (R0) was estimated to be 
0.49 (95% CI 0.06; 2.99), suggesting a limited viral spread using the BVDV-2c strain. This 
suggests that this BVDV-2 infection in TI animals resulted in limited transmission towards 
other animals. 
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Introduction 
 
Cattle get infected with bovine viral diarrhoea virus (BVDV) either through a 
congenital infection (vertical transmission) or through a postnatal, acute infection (horizontal 
transmission). Vertical BVDV transmission from the second up to the fourth month of 
gestation can result in the birth of persistently infected (PI) calves (McClurkin et al., 1984; 
Peterhans et al., 2010). Acute BVDV infections of BVDV seronegative cattle result in 
transiently infected (TI) animals, which are viraemic for 10-14 days, starting 3 days post-
infection (Lanyon et al., 2014). 
The transmission rate of an infectious disease can be expressed by its reproduction 
ratio, R. A special case is the basic reproduction ratio, R0, defined as the mean number of 
secondary infections arising from one typical infectious case introduced in a fully susceptible 
population (Kroese and de Jong, 2001; Lindberg and Houe, 2005; Velthuis et al., 2007). R0 is 
determined by the following parameters (Lindberg and Houe, 2005): the probability of 
transmission during a contact between an infectious and susceptible animal (β), the number of 
contacts per time period (k) and the duration of the infectious period (d).  
Once colostrum-derived BVDV antibody titres have declined, PI animals continuously 
shed massive amounts of virus, resulting in high values for the parameters β en d (Lindberg 
and Houe, 2005). The amount of virus spread by TI animals is much lower because of a much 
shorter duration of the infectious period and the relatively low amounts of virus shed, 
resulting in low values for the parameters β en d. Therefore, PI animals are considered the 
main source of infection and can maintain the presence of  BVDV in a susceptible population, 
while TI animals are generally considered to be of minor importance in spreading BVDV 
(Lindberg and Houe, 2005; Fulton et al., 2006; Nickell et al., 2011; Sarrazin et al., 2014).  
However, the virulence of BVDV strains is suggested to influence the amount and 
duration of virus shed by TI animals (Bolin and Ridpath, 1992). Whereas the spread of low 
virulent strains is most likely to originate only from PI animals, it is suggested that highly 
virulent strains can be maintained within a susceptible population with only TI animals as 
source of infection (Ridpath et al., 2006). Therefore transmission experiments with TI animals 
were conducted to test this hypothesis, hereby using BVDV strains isolated from individual 
cattle suffering from severe clinical BVDV-associated signs (Sarrazin et al., 2014). The 
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results of this study demonstrated a very limited viral spread from TI animals and confirmed 
the previous believe that TI animals only make a limited contribution to BVDV transmission.   
In autumn 2012 and spring 2013 an outbreak of BVDV-2c in Germany and the 
Netherlands resulted in a high mortality rate, up to 80% in some veal calf herds (Doll and 
Holsteg, 2013; Moen, 2013). Since no PI animals were detected during this outbreak, it is 
suggested that BVDV has spread solely through TI animals (Doll, 2013), which could indicate 
that TI animals may contribute substantially more to BVDV-2c spread than is generally 
assumed.  
The objective of the present study was to perform a transmission experiment according 
to the experiment performed by Sarrazin et al. (2014) with this BVDV-2c field strain isolated 
during the severe outbreak in Germany to quantify BVDV transmission by TI cattle. 
 
 
Material and methods 
 
The experimental design was identical to the protocol of the previously described 
transmission experiments (Sarrazin et al., 2014). Ten calves were checked for the absence of 
BVDV-RNA and antibodies using real-time RT-PCR (RT-qPCR) and virus neutralization 
(VN), respectively. At the time of infection, the animals were aged between 109 and 141 
days, respectively. A BVDV-2c field strain (NRW 14-13) isolated during the BVDV outbreak 
in Germany (Jenckel et al., 2014) was cultivated on Madin-Darby Bovine Kidney cells (two 
passages) and a titre of 1.3 x 10
6
 tissue culture infective dose/mL (TCID50/mL) was obtained. 
After an acclimatization period of 14 days, three randomly chosen calves were isolated from 
the other calves and inoculated with BVDV-2c through intranasal inoculation of 5.0 x 10
6
 
TCID50. After 2 days of separation the inoculated animals were housed together in one box 
with the seven contact animals and BVDV spread and clinical signs were daily recorded. 
When no infectious animals were left (i.e. all blood samples and nasal swabs were negative by 
RT-qPCR), all BVDV seropositive animals were removed and the non-infected contact 
animals were used in a second infection experiment that started 63 days after the first 
inoculation. All calves were slaughtered 50 days after the start of this second experiment.  
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The clinical examination (see Appendix A of Chapter 4.1), sample collection, virus 
isolation (VI), RT-qPCR, virus neutralization (VN), haematology and estimation of R0 were 
performed as previously described (Sarrazin et al., 2014). An animal was considered infected 
if positive test results were obtained for RT-qPCR, VI and VN. R0 was estimated by 
maximum likelihood (MLE) according to the final size method (Velthuis et al., 2007). Fever 
was defined when the rectal temperature was > 39.0 °C, the one-sided upper limit of the 95% 
CI obtained for the average rectal temperature of all calves during the last 3 days before 
inoculation. 
 
 
Results 
 
Following the first inoculation, blood samples of all three inoculated animals were 
positive in RT-qPCR (from 2 up to 17 days post inoculation [dpi]) and VI (from 3 up to 11 
dpi), but differences in the degree of viraemia were noticed (Fig. 1a-b). One inoculated animal 
(“Inoculated 1”, Fig. 1) died 17 dpi and was still RT-qPCR-positive at that moment. After the 
first inoculation 2 out of 7 contact animals were infected.. The first contact infected animal 
became positive in RT-qPCR and VI at 11 dpi and 16 dpi, respectively (Fig. 1a-b), while the 
second contact infected animal was RT-qPCR-positive between 24 and 38 dpi (Fig. 1b).  
The experimental infection was repeated by inoculating 2 out of 5 remaining BVDV 
negative susceptible animals, but none of the three remaining contact animals became 
infected. Compared to the first inoculation a lower degree of viraemia was obtained and the 
viral titre could not be determined. Nevertheless, both inoculated calves were positive in VI 
(Fig. 2a) and the nasal swabs were RT-qPCR-positive between 2 and 10 dpi (Fig. 2c).  
BVDV-infection was confirmed by the development of neutralizing antibodies in all 
five inoculated animals (from 9 dpi on) and both contact infected animals (from 18 dpi and 30 
dpi on). The remaining susceptible animals were BVDV seronegative until the end of the 
experiment.  
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Fig. 1. Virological results from the first inoculation (three inoculated animals and seven 
susceptible animals). a) Viral titres (log10 TCID50/mL) of positive blood samples of the 
inoculated animals and both animals infected by contact. The dotted line represents the 
detection limit (2.30). Samples represented on the detection limit are positive in virus 
isolation, but the viral titre was insufficiently high to determine a viral titre. b) Ct-values of 
RT-qPCR-positive blood samples. A lower Ct-value indicates a higher amount of viral RNA 
present in the sample. c) Ct-values of RT-qPCR-positive nasal swabs.  
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Fig. 2. Virological results from the second inoculation (two inoculated animals and three 
susceptible animals. a) Viral titres (log10 TCID50/mL) of positive blood samples of the 
inoculated animals. The dotted line represents the detection limit (2.30). Samples represented 
on the detection limit are positive in virus isolation, but the viral titre was insufficiently high 
to determine a viral titre. b) Ct-values of RT-qPCR-positive blood samples. A lower Ct-value 
indicates a higher amount of viral RNA present in the sample. c) Ct-values of RT-qPCR-
positive nasal swabs.  
German hypervirulent BVDV strain  Chapter 4.2 
122 
 
The combined MLE of R0 for the first and second inoculation was 0.49 (95% CI 0.06; 
2.99). Although statistically not significantly different from 1, this point estimate indicated 
that one typical infectious case introduced in a fully susceptible population would cause on 
average only 0.49 secondary infections and suggests that infection with TI animals infected 
with this BVDV-2c strain would theoretically fade out. 
 Following the first inoculation, the inoculated calves had a loss of appetite for 6 days 
starting 7 dpi (appetite score = 3). Together with fever between 4 and 11 dpi, loss of appetite 
was the only clinical sign that was noticed for one inoculated animal (“Inoculated 2”, Fig. 1). 
The two other inoculated animals developed severe watery diarrhoea 8 dpi for 6 days (faeces 
consistency score = 2). While one of these animals (“Inoculated 3”, Fig. 1) completely 
recovered 14 dpi, the other (“Inoculated 1”, Fig. 1) became recumbent 14 dpi (posture score = 
2, lying down score = 4) and died 17 dpi. The first and second contact infected animal both 
developed a haemorrhagic diarrhoea (faeces consistency score = 3) between 21 and 26 dpi 
and between 30 and 36 dpi, respectively. Both animals also lost appetite (appetite score = 3) 
during 3 consecutive days, but completely recovered 28 and 38 dpi, respectively. 
 Following the second inoculation few clinical signs were noticed. Both animals lost 
appetite for 2 days beginning at 7 dpi, were depressed (posture score = 2) and showed nasal 
discharge (nasal discharge score = 1) 8 dpi.  
  All inoculated and contact infected animals showed fever (> 39.0 °C) during infection, 
with duration of pyrexia varying between 5 and 8 days. Compared to the RT-qPCR-negative 
calves leucocyte and thrombocyte counts were significantly lower in RT-qPCR-positive 
animals during both inoculations (Table 1). 
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Table 1. Comparison of haematology between RT-qPCR-negative and RT-qPCR-positive 
animals during both inoculations. During the first inoculation 3 inoculated animals infected 2 
out of 7 susceptible animals in contact. A second inoculation was performed 63 days later, 
during which none of the 3 susceptible animals were contact infected by the 2 inoculated 
animals. 
 RT-qPCR-negative RT-qPCR-positive p-value
a
 
 Estimate 95% CI Estimate 95% CI  
      
First inoculation      
Leucocytes (1000/µL) 9.0 8.0; 10.1 6.4 5.2; 7.6 < 0.001 
Thrombocytes (1000/µL) 486 394; 578 338 240; 436 < 0.001 
Packed cell volume (%) 29.7 27.1; 32.3 30.2 27.6; 32.9 0.29 
Haemoglobin (g/dL) 11.1 10.1; 12.1 11.3 10.3; 12.3 0.14 
      
Second inoculation      
Leucocytes (1000/µL) 8.8 7.2; 10.3 6.6 4.9; 8.3 < 0.001 
Thrombocytes (1000/µL) 487 295; 679 346 115; 547 0.002 
Packed cell volume (%) 27.4 25.8; 29.1 26.7 24.8; 28.7 0.33 
Haemoglobin (g/dL) 10.5 9.7; 11.3 10.4 9.5; 11.3 0.84 
a
 Linear mixed model with “RT-qPCR-positive” (no/yes) and “Animal” as fixed and random 
effect, respectively (SAS 9.4, SAS Institute). 
 
 
Discussion 
 
 Although pronounced clinical signs such as diarrhoea and death were observed during 
this study, these clinical observations were not as severe as encountered during the outbreak 
in Germany (Doll and Holsteg, 2013). Several different BVDV field strains were isolated 
during this outbreak (Jenckel et al., 2014), which indicates that the BVDV-2c strains were 
genetically highly variable. Two of these field strains were used in experimental infections. 
Results from the infection with the NRW 14-13 strain are described in the current study, 
while Jenckel et al. (2014) experimentally infected 8-week-old calves with NRW 19-13-8. 
Both strains were considered to have a high level of virulence (Jenckel et al., 2014). During 
the latter study all animals (n = 8) died acutely or had to be euthanized within 11 days. Given 
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the high genetic variability in these BVDV-2c strains, changes in the genome with shifts in 
strain virulence following virus cultivation can possibly explain the difference in morbidity 
and mortality observed during our study on the one hand and encountered in the field and 
during the experimental infection of Jenckel et al. (2014) on the other hand. To avoid genetic 
changes as much as possible, the second passage on cell culture of the isolated virus was used. 
Another explanation for the observation of more mild clinical signs could be the age of 
calves, since age appears to have a key influence on the clinical manifestations associated 
with BVDV infection: more pronounced clinical signs are observed in younger animals 
(Hamers et al., 2003). While in our study the calves were aged between 16 and 20 weeks and 
between 25 and 29 weeks at the moment of the first and second inoculation, respectively, the 
calves in the study of Jenckel et al. (2014) were only 8 weeks old. However, also adult cattle 
suffered from severe clinical disease during the outbreak in Germany (Doll and Holsteg, 
2013). 
The clinical signs of the BVDV infected animals in the present study were varying 
from very mild disease to severe watery and haemorrhagic diarrhoea and death. The severity 
of the clinical signs was associated with the degree of viraemia. Animals with a higher viral 
titre (VI) and lower Ct-values (RT-qPCR) showed more severe clinical signs. This result is in 
agreement with comparable observations made by Walz et al. (2001).  
The amount of virus shed is likely to depend on the propensity of a strain to replicate 
(Bolin and Ridpath, 1992) and could thus also be related to the degree of viraemia. The 
patterns of the RT-qPCR results of the nasal swabs and blood samples were indeed similar 
(Fig. 1b-c, Fig. 2b-c).  
 During the outbreak in Germany TI animals with a high viral titre (genomic load 
almost equivalent to that in PI animals) and long-lasting virus shedding (up to 8 weeks) were 
reported (Doll, 2013). Moreover, during the experimental infection executed by Jenckel et al. 
(2014) very high viral loads in blood and organs (Ct-values < 20 in RT-qPCR) were shown in 
all animals. In a study comparing Ct-values of PI and TI animals, it has been shown that only 
1 out of 57 TI animals obtained a Ct-value below 25, while only 1 out of 17 PI animals had a 
Ct-value above 25 (Hanon et al., 2014). These results indicate that in the present study, very 
similar to the observations encountered in the field (Doll, 2013), the animal “Inoculation 1” 
(Fig. 1) obtained a genomic load 8-9 dpi almost equivalent to that in PI animals, which 
indicates that this animal, at least for 1-2 days, has substantially contributed to BVDV spread. 
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At the moment of its death (17 dpi) the animal was still RT-qPCR-positive, but negative in 
VI, which suggests that viral shed had stopped. The duration of viral shed was thus much 
shorter than 8 weeks as observed in the field (Doll, 2013). To study the role of these TI 
animals with a high viral load, the transmission experiment could be repeated using a ‘one to 
one’ approach (one infective and one susceptible, repeated five times), since this method is 
preferred to study the most relevant characteristics of R0 (Kroese and de Jong, 2001). 
Despite the presence of this animal with a high viral titre and four additional 
inoculated calves during two inoculations, a limited BVDV transmission was demonstrated. 
Nevertheless, since the nasal swabs of all BVDV infected animals (both inoculated and 
contact infected) were RT-qPCR-positive, it can be assumed they all had the potential to 
spread BVDV (Fig. 1c; 2c). This result supports the general assumption that TI cattle, unless 
infected in early gestation, have little contribution to the overall BVDV spread, as already 
demonstrated before (Niskanen et al., 2000; Niskanen et al., 2002; Sarrazin et al., 2014). 
 This result is in contrast with the observations in the field, where it is suggested that 
BVDV has spread solely through TI animals (Doll, 2013). Nevertheless, thorough evidence is 
needed to prove that it is not due to PI animals that have escaped identification (Lindberg and 
Alenius, 1999; Lindberg and Houe, 2005; Laureyns et al., 2010), as this is also suggested for 
the German outbreak (Jenckel et al., 2014). It might for instance have been the case that PI 
animals died before they were identified as PI. Furthermore, BVDV can also spread when PI 
animals are aborted or stillborn (Lindberg et al., 2004). Other factors that may have hampered 
viral spread, such as the experimental conditions, under which animals are likely to be less 
challenged by other pathogens and environmental conditions have already been discussed 
(Sarrazin et al., 2014).  
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Abstract 
 
The shift from cure towards prevention in veterinary medicine involves the 
implementation of biosecurity, which includes all measures preventing pathogens from 
entering a herd and reducing the spread of pathogens within a herd. In Belgium no studies 
have considered the implementation of biosecurity measures in the daily management of 
cattle farms. Therefore the aim of the study was to map the current application of biosecurity 
measures in Belgian cattle farms in the prevention of disease transmission within and between 
farms. 
Between March 2011 and April 2013 the data were collected as part of a larger cross-
sectional study, conducted to identify risk factors for re-infection with BVDV in cattle herds 
assumed free from BVDV. Questionnaire data from 33 dairy farms, 16 beef farms and 25 
mixed (dairy and beef cattle) farms were analyzed using a combination of a linear scoring 
system, a categorical principal component analysis and a two-step cluster analysis to 
differentiate these farms based on their biosecurity level and visit frequencies. 
Further enhancement of preventive measures considering external and internal 
biosecurity was still possible for each farm, as none of the farms obtained an overall high 
biosecurity level. Three groups of cattle farms were differentiated with a biosecurity level 
varying from low to high-medium, of which the group with the lowest biosecurity level 
mainly consisted of mixed farms. Animal-to-animal contacts with cattle from other herds 
were frequently possible as only 12% of the farmers purchasing cattle quarantined purchased 
animals at least 3 weeks and contacts over fences on pasture were possible in 70% of the 
herds. Basic biosecurity measures such as farm-specific protective clothing and boots were 
present in the majority of the farms, but they were insufficiently or incorrectly used. Cattle 
farms were very often visited by professional visitors of which the herd veterinarian, the AI 
technician and the cattle salesman most frequently entered the farm. 
It can be concluded that since few biosecurity measures were undertaken by Belgian 
cattle farmers, they expose their herd to the risk of disease transmission within and between 
farms. Especially in regions with a high cattle density, small distances to neighbouring farms 
and high frequencies of professional visits, a farm-specific preventive strategy should be 
developed, thereby using the facilities often already present on the farm. 
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Introduction 
 
In modern veterinary medicine, disease prevention at the herd level has become 
increasingly important in replacing individual animal medicine (Lin et al., 2003; Derks et al., 
2013). This shift from treating individuals towards prevention involves the implementation of 
biosecurity, which includes all measures preventing pathogens from entering a herd (i.e. 
external biosecurity) and reducing the spread of pathogens within a herd (i.e. internal 
biosecurity or biocontainment) (Villarroel et al., 2007; Laanen et al., 2013). The 
implementation of biosecurity measures reduces disease spread and is therefore part of the 
measures frequently proposed in the control of several infectious diseases. Although 
biosecurity is usually associated with collective action for disease control in case of large 
epidemic outbreaks such as foot-and-mouth disease and bovine spongiform encephalopathy 
(Heffernan et al., 2008), it is also a crucial element in the control of endemic diseases. For the 
control of bovine viral diarrhoea virus (BVDV) at the herd level, the implementation of 
biosecurity is even considered the most essential pillar (Lindberg and Houe, 2005). Also for 
the control of neonatal diarrhoea (Barrington et al., 2002) and respiratory disorders (Callan 
and Garry, 2002), biosecurity measures are seen as indispensable preventive measures. 
Expected consequences of the reduced disease spread and thus indirectly from 
applying biosecurity measures are improved production characteristics and thus greater 
profits, better animal welfare, improved immune responses to vaccines and enhanced job 
satisfaction for farmers (Brennan and Christley, 2012). Recently it was shown in pig 
production that a higher biosecurity status is linked with a reduction in antimicrobial usage 
(Laanen et al., 2013). 
Although the importance and usefulness of biosecurity is elaborately described, 
studies demonstrated that most cattle farmers do not implement adequate biosecurity 
measures (Nöremark et al., 2010; Negron et al.; 2011, Brennan and Christley, 2012; Sayers et 
al., 2013). In Belgium, an important beef cattle and milk producing country in Europe and a 
very densely populated livestock area, the application of biosecurity measures in pig and 
poultry herds has already been studied (Ribbens et al., 2008; Van Steenwinkel et al., 2011). 
However, for Belgian cattle farms no similar studies have been conducted yet (literature 
search with keywords ‘biosecurity’ - ‘cattle’ - ‘Belgium’). In order to optimize the use of 
biosecurity as preventive tool, it is important to understand first if and how such preventive 
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measures are being used (Brennan and Christley, 2012). Therefore the aim of this study was 
to map the current application of biosecurity measures in cattle farms in the prevention of 
disease transmission within and between farms. 
 
Material and methods 
 
Selection of the farms 
In Belgium 2,441,319 domestic bovine animals were registered in the animal 
identification and registration system (SANITEL) in November 2013 (NIS, 2013). This 
resulted in an average population density at municipality level of 85 animals/km². 
The target population for this study comprised all farms with cattle in Belgium. The 
data were collected as part of a larger cross-sectional study, conducted to identify risk factors 
for re-infection with BVDV in cattle herds assumed free from BVDV. A non-random sample 
was obtained based on the following inclusion criteria: having a history of BVDV circulation 
in the herd and the assumption of being BVDV free at the moment of participation, according 
to the herd veterinarian's judgement and previous test results. For farm selection, herd 
veterinarians were contacted to propose cattle farms satisfying the inclusion criteria. 
Therefore, an e-mail was sent to herd veterinarians in the database of the Institute for 
Continuing Education at the Faculty of Veterinary Medicine, Ghent University (February 
2011). A second call for participation was sent by means of a newsletter of the regional 
centres for animal disease control “Dierengezondheidszorg Vlaanderen (DGZ)” in Flanders 
(northern part of Belgium) (November 2011) and “Association Régionale de Santé et 
d’Identification Animales (ARSIA)” in Wallonia (southern part of Belgium) (January 2012). 
Proposed farms fulfilling the inclusion criteria were contacted by phone to explain the study 
objectives and to verify their willingness to participate. 
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Questionnaire 
The questionnaire was designed to collect data regarding BVDV management and 
control at herd level. According to the control strategy plan of Lindberg and Houe (2005), the 
questionnaire consisted of four main topics: biosecurity, virus detection, monitoring and 
vaccination. Most questions were semi-closed. Except for the language (Flanders = Dutch and 
Wallonia = French), the questionnaires for both parts of the country were identical and 
checked for consistency by a bilingual researcher. Regarding the biosecurity part, the 
questionnaire was adapted from an online biosecurity testing tool for pig and poultry herds 
(www.BioCheck.UGent.be; Laanen et al., 2010). The questionnaire covered several aspects 
regarding the degree of biosecurity and the different types of contacts between farms. The full 
questionnaire is available upon request to the first author. The questionnaire was pre-tested 
regarding content, interpretation of questions and responses. It was emphasised to the farmers 
that questionnaires would be processed anonymously. The selected farmers were subjected to 
a face-to-face questionnaire interview. All interviews were conducted by the first author 
between March 2011 and April 2013. 
 
Data processing 
All information was coded numerically to assist analysis, entered into a database 
worksheet program (Microsoft Excel, 2010) and recoded into categorical data (nominal or 
ordinal level) for further analysis. Data were exported for analysis into SPSS 22.0 (SPSS Inc., 
Chicago, IL). 
 
Data analysis 
Cattle density map 
A map showing the sample distribution and the cattle density at municipality level was 
produced using Arc Map® version 3.2.1 (ESRI, Redlands, CA, USA). The animal density 
data were extracted from SANITEL in December 2012. 
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Creating a biosecurity scoring system 
A biosecurity scoring system was created as described by Van Steenwinkel et al. 
(2011). All variables were coded using values of 1 (biosecurity measure present) or 0 
(absent). The variables were divided into groups, each expressing a different aspect of farm 
biosecurity. Then, for each biosecurity variable group (made up of several measures) the 
values for each individual variable were added up to generate a biosecurity score. Finally, 
each group score was equally weighed by scaling from 0 to 10, with a higher score implying a 
‘better’ biosecurity level for the variable group concerned. The following biosecurity groups 
were considered: 
a) Other animals: on-farm and between-farm animal-to-animal contacts. 
b) Onto herd movements of animals: purchase of cattle. A farmer was listed as “not 
purchasing cattle” when the last purchase was at least five years ago. 
c) Onto herd movements of persons: frequency of professional visitors entering the herd. 
Professional visitor frequency was categorized as ‘no visit’, ‘low’ (between null and one 
visit per month), ‘medium’ (between one visit per month and one visit per week) or ‘high’ 
(more than one visit per week). The latter three categories were formed based upon the 
33.33 and 66.67 percentile of the number of professional visits in the selected herds, 
excluding the ‘no’ visits. A score was defined on a scale from 1 to 4, with a higher score 
implying lower visit frequencies. 
d) Off herd movements: animals and material leaving the herd. 
e) Hygiene infrastructure: structures or activities in the daily management to reduce disease 
spread by the farmer himself, focusing on internal biosecurity. 
f) Hygiene visitors: measures taken to prevent disease spread by professional visitors. 
 
Categorical principal component analysis 
To analyse the categorical data, a categorical principal component analysis (CATPCA) 
was performed according to the methodology described by Van Steenwinkel et al. (2011). All 
variable groups were given an ordinal measurement scale in the analysis. Two supplementary 
variables were included and attributed a multiple nominal measurement scale: herd type and 
herd size. Herd size was categorized as ‘small’ (< 100 animals), ‘medium’ (between 100 and 
150 animals) or ‘large’ (> 150 animals), based upon the 33.33 and 66.67 percentile of the 
number of cattle present in the selected farms. The quantification of a supplementary variable 
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allows the interpretation of its relationship with the result obtained for the other variables, but 
has no influence on the actual analysis. 
The number of dimensions was set to two to allow for a two-dimensional graphical 
representation. These dimensions represent the principal components to which the variables 
are reduced and are linear transformations of the original data such that as much original 
information as possible is retained. Whether a reduction to two dimensions was acceptable, 
was verified by checking the sum of the percentage of variance accounted for (PVAF), a 
measure of the amount of retained information and model fit (Linting et al., 2007). 
 
Two-step cluster analysis 
The object scores obtained from the CATPCA solutions were then included in a two-
step cluster analysis (TSCA, SPSS 22.0) to identify clusters of cattle farms with a similar 
biosecurity level and farm visit frequencies (Ribbens et al., 2008). 
 
Results 
 
Response 
A total of 38 veterinary practices responded. Three of them were from the Netherlands 
and therefore not included in the study. Six veterinary practices had no farms fulfilling the 
inclusion criteria after further explanation of the study goals. After receiving further 
information, another four veterinarians preferred not to participate because of lack of time or 
compensation. For one veterinarian, willing to participate and having several farms fulfilling 
the inclusion criteria, it was not appropriate to be included in the study because of a 
brucellosis outbreak in that region. Eventually, a total of 74 cattle farms from 23 different 
veterinary practices were visited of which 33 dairy farms, 16 beef farms and 25 mixed (dairy 
and beef) farms. Also two Dutch dairy farms belonging to the clientele of a Belgian veterinary 
practice were included in the study. Up to 58% of the participating herds were located in 
cattle-dense regions (> 100 animals/km²) (Fig. 1). 
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Fig. 1. Production types and municipality level animal densities of the studied cattle farms. A 
total of 74 cattle farms were studied, of which 16 beef farms, 33 dairy farms and 25 mixed 
farms (farms containing beef and dairy cattle). Cattle densities at municipality level are 
displayed in the background. 
 
General characteristics of the studied farms 
The high density of cattle farms in Belgium is reflected in a mean distance of only 
0.57 km to the nearest cattle farm. For mixed farms this distance is only 0.28 km (Table 1). 
Also pig herds and sheep premises (from professionals and hobby keepers) were located 
nearby, with minimum distances of only 0.05 km (data not shown). The average number of 
cattle present at the studied farms was 138, with mixed farms tending to have slightly more 
animals. 
 
  
Biosecurity  Chapter 5 
141 
 
Table 1. General characteristics of the studied farms (n = 74). 
 Dairy 
(n = 33) 
Beef 
(n = 16) 
Mixed
a
 
(n = 25) 
Number of animals 
Mean (SE) 135 (10) 129 (21) 147 (14) 
95% CI [115; 155] [84; 173] [117; 177] 
Size
b
 : n (% within herd type)    
Small (< 100 animals) 7 (21%) 8 (50%) 9 (36%) 
Medium  17 (52%) 3 (19%) 5 (20%) 
Large (> 150 animals) 9 (27%) 5 (31%) 11 (44%) 
Distance to nearest cattle farm (km) 
Mean (SE) 0.82 (0.18) 0.49 (0.10) 0.28 (0.05) 
95% CI  [0.45; 1.20] [0.29; 0.70] [0.18; 0.38] 
Distance to nearest pig farm (km) 
Mean (SE) 2.54 (0.55) 2.55 (0.84) 1.35 (0.42) 
95% CI  [1.41; 3.66] [0.75; 4.34] [0.48; 2.22] 
Distance to nearest sheep premise
c
 (km) 
Mean (SE) 2.12 (0.55) 0.70 (0.19) 0.54 (0.17) 
95% CI  [1.00; 3.24] [0.29; 1.11] [0.19; 0.90] 
SE, standard error; CI, confidence interval 
a 
Dairy and beef cattle 
b
 33.33 and 66.67 percentile of the number of cattle present in the selected farms 
c
 Professional farms and hobby keepers 
 
 
Professional visitors entering the farms 
In dairy and mixed farms, milk is collected on a regular basis, with milk collection 
trucks entering the farms every 3 days (Table 2). For one farm, milk was collected daily. 
Other professional visitors frequently entering the farm, were the artificial insemination (AI) 
technician, the veterinarian and the cattle salesman. Of the 37 farmers that were making use of 
the services of an AI technician, beef farms were visited on average less by the AI technician 
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compared to farms with dairy cattle. On the contrary, the former were visited on average more 
by the herd veterinarian. A large range in visiting frequencies by the veterinarian was noticed 
for all herd types. The visiting frequency of rendering company lorries was highly influenced 
by the possible presence of pigs at the farm. 
 
Table 2. Mean number of monthly professional visits on a cattle farm per herd type. 
 Dairy Beef Mixed
a
 
 Mean (SE) freq./month    [95% CI] 
Veterinarian 3.4 (0.4) 
[2.5; 4.3] 
6.6 (1.0) 
[4.4; 8.7] 
5.9 (0.9) 
[4.0; 7.9] 
A.I. technician 9.6 (1.2) 
[7.2; 12.1] 
2.0 (0.9) 
[0.0; 4.0] 
7.5 (1.1) 
[5.0; 10.0] 
Cattle salesman 4.1 (0.6) 
[2.9; 5.3] 
1.7 (0.3) 
[1.1; 2.4] 
4.7 (0.8) 
[3.0; 6.4] 
Feed supplier 1.3 (0.1) 
[1.0; 1.6] 
1.0 (0.1) 
[0.7; 1.3] 
1.6 (0.2) 
[1.1; 2.1] 
Milk collection 10.6 (0.6) 
[9.4; 11.8] 
- 9.6 (0.4) 
[8.8; 10.4] 
Cadaver removal 0.9 (0.1)  
[0.7; 1.2] 
0.6 (0.2) 
[0.2; 0.9] 
0.9 (0.2) 
[0.5; 1.4] 
Other farmers 1.0 (0.5) 
[0.0; 2.1] 
0.3 (0.1) 
[0.0; 0.6] 
0.6 (0.2) 
[0.2; 1.0] 
SE, standard error; CI, confidence interval. 
a
 Dairy and beef cattle 
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Biosecurity measures 
Table 3 shows the percentage of farms implementing different types of biosecurity 
measures for each herd type, listed per biosecurity category. From the category ‘Other 
animals’ it was noticed that grazing cattle can be exposed to disease agents, as pasture 
contacts over fences were frequently possible and manure from other farms very often was 
dispersed close to the proper farm. Measures related to internal biosecurity (‘Hygiene 
infrastructure’), compartmentalization of young stock and working from young to old 
(working lines) were in general poorly implicated in cattle farms. The impact of sick animals 
on herd health was considered limited by the farmers as it appeared that animals which had 
aborted rarely were isolated and the calving box was used to house sick animals without 
cleaning and disinfection of this box. Although rendering companies request to collect 
cadavers at farm entrance, less than half of the farmers provided such a facility at the 
entrance. A remarkable contradiction was noticed when asking about the lorry of the cattle 
salesman when animals were transported: most of the farmers considered the lorry was clean 
while the lorry very often was already loaded with animals from another farm when entering 
the farm. Highest category scores were obtained for the ‘Onto herd movements of animals’. 
This can be explained by the fact that farmers never purchasing cattle (34%) received the 
highest score for this category. Farmers purchasing cattle scored very low on the application 
of good quarantine measures, i.e. using a quarantine stable (no contact with own animals) and 
a quarantine period of at least 3 weeks. Only 12% of the herds purchasing cattle jointly 
implemented both quarantine measures. Low category scores were obtained for the hygiene 
measures for professional visitors. It is remarkable that 88% of the farmers wanted visitors to 
check in when entering the farm, while an equal percentage of farmers provided direct access 
to the stables for those visitors. Farm-specific boots, farm-specific clothing for visitors and 
disinfection footbaths were present in 70%, 66% and 61% of the farms, respectively. Despite 
their presence in the majority of the farms, only in 20%, 13% and 9% of the studied herds, 
respectively, these measures were actually used. 
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Table 3. Percentage of farms implementing different types of biosecurity measures per 
category and per herd type. Per category a mean score (out of ten) and standard deviation 
(SD) is given. 
Category  Biosecurity components Dairy 
(n=33) 
Beef 
(n=16) 
Mixed
a
 
(n=25) 
Other 
animals 
No other farm animals present 64 75 48 
No dogs present 39 38 20 
Permanent rodent control 79 94 92 
No pasture contact 48 13 16 
No participation to auctions/competitions 85 94 96 
No dispersion of manure from other herds within 500m of the herd  9 25 12 
Score (mean; SD) (5.4; 2.0) (5.6; 1.6) (4.7; 1.4) 
Hygiene 
infrastructure 
Calves and young stock separated from older animals 58 38 32 
Working from young to old animals 15 19 8 
Separated material for young and old animals 21 13 16 
Sick animals treated as last 30 44 28 
Always testing of abortions 42 88 48 
Always isolating animals which aborted 6 13 4 
Cleaning and disinfection of stable after abortion 18 19 8 
Calving takes place in a separated calving box 85 69 56 
No use of calving box to house sick animals  36 69 16 
Cleaning of box after each calving 27 63 28 
Cleaning and disinfection of material used for calving after each 
calving / use of disposable calving material 
58 75 52 
Between age groups clothes are changed  6 6 4 
Between age groups hands are cleaned and disinfected  9 6 0 
Score (mean; SD) (3.2; 1.6) (4.0; 2.0) (2.3; 1.4) 
a
 Dairy and beef cattle 
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Table 3. (Continued) 
Category  Biosecurity components Dairy 
(n=33) 
Beef 
(n=16) 
Mixed
a
 
(n=25) 
Off herd 
movements 
Cadaver storage facility at herd entrance 48 50 40 
Cadaver storage facility inaccessible for vermin 21 19 8 
Cadaver storage facility frequently cleaned and disinfected 24 44 36 
Lorry of cattle salesman cleaned when transporting animals 82 100 60 
Lorry of cattle salesman empty when transporting animals 12 44 4 
Cattle salesman does not enter the stables when loading animals 39 6 16 
No material in common use with other farmers 64 63 72 
Score (mean; SD) (4.2; 2.0) (4.6; 1.8) (3.4; 1.5) 
Onto herd 
movements: 
animals 
Purchase of animals 48 94 72 
Purchase of animals in gestation 38 27 33 
Purchasing animals from farms with a higher or equal sanitary 
status 
56 67 17 
Testing of all purchased animals 88 100 94 
Using a quarantine stable when purchasing animals 25 67 17 
Applying a quarantine period of at least 3 weeks when purchasing 
animals 
6 33 17 
Score (mean; SD) (7.0; 3.2) (5.9; 2.1) (5.3; 3.4) 
Hygiene 
visitors 
Visitors have to check in when entering the herd 79 81 72 
Visitors have direct access to the stables 73 69 88 
Presence of a hygiene lock 39 6 8 
Stable entry through hygiene lock 3 0 0 
Use of farm-specific boots for visitors 33 13 8 
Use of farm-specific clothing for visitors 24 6 4 
Use of a disinfection footbath 3 19 12 
Feed supplier does not enter stables when supplying feed 85 56 52 
Score (mean; SD) (3.1; 2.2) (2.0; 1.5) (1.7; 1.5) 
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CATPCA and TSCA 
The result of a two-dimensional solution of the CATPCA explained 58.8% of the 
variance of the scores provided by the 74 herds for the six variables, which means 58.8% of 
the original information was retained. The PVAF in the first dimension was 32.6% and 26.2% 
in the second dimension. Fig. 2 shows the plot of component loadings, i.e. the position of the 
original variables in the two-dimensional space, and the centroid coordinates of the multiple 
nominal category points (herd types and sizes).  
 
Fig. 2. Biplot of component loadings (the position of the original variables in the two-
dimensional space, represented by vectors) and multiple nominal category points (herd types 
and sizes), resulting from the categorical principal component analysis. The vector of a 
variable points in the direction of the highest category of the variable, in this case indicating a 
higher level of biosecurity or lower farm visit frequencies. The first and second dimension 
distinguish between the production types. Mixed and beef farms tend to have on average the 
lowest and highest biosecurity scores, respectively, with dairy farms somewhere in between. 
None of the dimensions distinguishes between different herd sizes, which are all very close to 
the centre of the plot.  
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All variables (component loadings, represented by vectors) appear in the upper right 
and lower right quadrants. The projections of the vectors on each dimension represent the 
contribution of each variable to that dimension. As their projections on the first dimension 
point in the same direction and have more or less the same length, they have more or less an 
equal contribution to the first dimension. The vector of a variable points in the direction of the 
highest category of the variable, in this case indicating a higher level of biosecurity or lower 
farm visit frequencies. Beef farms tend to have on average the highest biosecurity scores, as 
the corresponding category point lies in the direction of the component loading points. The 
category point of mixed farms is located in the opposite direction of the vectors, which 
suggests these farms have on average the lowest biosecurity scores. Dairy farms are located 
somewhere in between. The first dimension thus distinguishes between the production types. 
Farms having higher scores for the ‘Off herd movements’ category are likely to also have 
high scores for the ‘Hygiene visitors’ category, as both vectors point in the same direction 
(small angle between both vectors). Both categories have a high contribution to the second 
dimension, which is opposite to the contribution to the second dimension of the ‘Other 
animals’ and to a smaller extent the ‘Onto herd movements’ categories. This dimension again 
distinguishes well between dairy and beef farms. Beef farms are likely to have higher scores 
for the ‘Onto herd movements’ categories, but lower scores for ‘Hygiene visitors’ and ‘Off 
herd movements’. None of the dimensions distinguishes between different herd sizes, which 
are all very close to the centre of the plot. 
The object scores obtained from the CATPCA solution, together with the solutions of 
the TSCA, are presented in Fig. 3. Three clusters were formed. 
Cluster 1 (n = 19) – ‘low biosecurity status’: Those herds are all located in the upper 
left and lower left quadrant, in the opposite direction of all variable groups. This cluster had 
the lowest scores in all biosecurity groups compared to the other clusters and mainly consists 
of mixed herds (13 out of 19). 
Cluster 2 (n = 31) – ‘low-medium biosecurity status’: This cluster had the highest 
score for the ‘Other animals’ category compared to the other clusters, but had low scores for 
‘Off herd movements’ (mean score 3.1) and ‘Hygiene visitors’ (mean score 1.6). The 
distribution of herd types within this cluster represents the overall distribution of herd types. 
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Cluster 3 (n = 24) – ‘high-medium biosecurity status’: This category had the highest 
scores for all biosecurity groups, except for ‘Other animals’, compared to the other clusters 
and scored well for the ‘Onto herd movements of animals’. This can be explained by the fact 
that 10 out of the 25 farms not purchasing animals are represented in this cluster, while only 
14 out of the 49 farms purchasing cattle are represented. Except for this variable group (mean 
score 7.4), the mean scores for the other variable groups varied between 4.1 and 5.8. So, 
although this cluster had the highest scores for all variable groups except one, these scores 
were low. 
 
Fig. 3. Object scores of the categorical principal component analysis and two-step cluster 
solution. Cluster 1 (n = 19) is the group with a low biosecurity status, cluster 2 (n = 31) is the 
group with a low-medium biosecurity status and cluster 3 (n = 24) is the group with a high-
medium biosecurity status.  
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Discussion 
 
This paper describes the results of a survey on biosecurity and management practices 
in selected Belgian cattle farms. This is the first Belgian study concerning cattle as other 
studies described the application of biosecurity measures in pig and poultry farms (Ribbens et 
al., 2008; Van Steenwinkel et al., 2011). The present study also gives an overview of the 
frequency of professional visitors entering cattle farms. 
A non-random sample of cattle farms was obtained, as the selected farms had a history 
of BVDV and were assumed BVDV free at the moment of participation. This indicates they 
had eradicated the virus from their herd and should therefore, in collaboration with the herd 
veterinarian, be aware of the measures necessary to eradicate the virus and to prevent a 
possible re-infection. Biosecurity is a crucial pillar in the control of BVDV (Smith and 
Grotelueschen, 2004; Lindberg and Houe, 2005) and therefore we assumed having selected 
for farms with a higher implementation of biosecurity measures in their daily management. 
Notwithstanding this fact, also in these herds a low internal and external biosecurity level was 
observed. 
All participating farms were questioned by means of a face-to-face interview 
conducted by one person, the first author. By doing so, the purpose of the study and the 
questions could be explained well, a high participation rate was obtained and interviewer bias 
was reduced as much as possible. Social desirability response bias, the tendency of some 
respondents to report a higher biosecurity level than what is really applied (Holbrook et al., 
2003), was reduced by checking the answers during a visit of the farm. Another disadvantage 
of face-to-face interviews is that a smaller sample was obtained than we possibly could have 
obtained using mailed questionnaires (Smeeth et al., 2001). Face-to-face interviews usually 
are geographically limited to areas close to the interviewer. Although the studied farms were 
centred, no farms were excluded from the study because of their geographical location in 
Belgium. By sending the second call for participation via the newsletter of the regional 
centres for animal disease control, all Belgian veterinary practices were reached. Very few 
veterinary practices from the southern part of Belgium responded to the call. Although the call 
for participation was sent in Dutch and French, a language barrier could be an explanation. 
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Similar to the study of Van Steenwinkel et al. (2011), the present study aimed at 
creating a linear scoring system to compare cattle farms relative to each other, rather than 
developing a risk-based weighted scoring system defining biosecurity in absolute terms. 
When evaluating the level of biosecurity implementation, three clusters were described based 
on our interpretation of which variables were more present in each cluster and names were 
given to each cluster. As none of the studied cattle farms had an overall high integration of 
biosecurity measures in their management practices, the cluster with the highest variable 
group scores (cluster 3) only was attributed a ‘high-medium biosecurity status’ instead of a 
‘high biosecurity status’. While no clear contrast between herd size was made based on the 
biosecurity level, a distinction between the herd production types was more explicit. The 
group with the lowest biosecurity level (cluster 1) mainly consisted of mixed farms. 
Compared to the other production types mixed farms obtained the lowest scores for each 
biosecurity group. This suggests that the focus should be on this type of farms when 
consulting regarding biosecurity is concerned, notwithstanding the fact that further 
enhancement of preventive measures was still possible for each farm. 
Ribbens et al. (2008) and Van Steenwinkel et al. (2011) both reported an “acceptable” 
biosecurity level in Belgian pig and poultry herds, respectively, while we described a “poor” 
application of biosecurity measures in cattle herds. In general, measures for visitors entering 
herds (e.g. herd-specific clothing and disinfection footbaths) were better applied in pig and 
poultry herds, while further enhancement of preventive measures concerning contact with 
other animals within and between herds was possible for all types of livestock (pigs, poultry 
and cattle). Also other studies observed a higher implementation of biosecurity measures in 
pig herds compared to cattle herds (Nöremark et al., 2010; Sahlström et al., 2014). 
Very little attention was paid to the prevention of direct contact with cattle from other 
herds as high percentages were obtained for pasture fence-line contact and low scores for 
good quarantine application. The recommended isolation period length varies, but for diseases 
with a short incubation period preferably 3 to 4 weeks is advised (Barrington et al., 2002; 
Callan and Garry, 2002; Wells et al., 2002; Villarroel et al., 2007). Even when animals are 
tested upon arrival, they should be quarantined until test results are available, which very 
often was not done. One also should realize that cattle can be carriers of other disease agents 
(e.g. Mortellaro disease, Psoroptes ovis mange, Staphylococcus aureus mastitis) than those 
few tested for. Moreover, despite the fact the regional centres for animal health in Belgium 
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offer a cheap ‘purchase kit’ which tests for endemic diseases such as bovine viral diarrhoea, 
paratuberculosis and neosporosis, not all farmers used this kit for all purchased cattle. 
Contact with other animals besides cattle such as rodents and cats and/or dogs freely 
moving on the farm, may hamper internal and external biosecurity. Rodent control was 
generally well applied by means of poison and traps. Additionally, all farmers reported to 
have cats freely moving on the farm and entering the stables to support rodent control. 
However, cats have already been identified as a risk factor for the presence of Salmonella 
(Evans and Davies, 1996) and Q-fever (Schimmer et al., 2011). Furthermore, the role of dogs 
in the epidemiology of neosporosis is well understood (Almeria and Lopez-Gatius, 2013). 
Although animal movements are generally considered as the major cause of disease 
spread, (professional) visitors and vehicles entering the farm also should be considered when 
establishing a biosecurity strategy for the farm (Alvarez et al., 2011). The risk of disease 
transmission depends among other things on the type of vehicle: for instance, rendering 
company trucks are considered a higher biosecurity risk than feeding company trucks 
(Ribbens et al., 2009). Nevertheless, only half of the herds provided a cadaver storage facility 
at herd entrance and the feed supplier had to enter the stables when delivering feed on one 
third of the farms. Although feed and milk collection trucks are rarely exposed to the animals 
on a farm (Nöremark et al., 2013), these vehicles should be considered as a biosecurity risk as 
they visit several herds on the same day (Ribbens et al., 2009). Our study revealed that cattle 
farms are very often visited by professional visitors, but biosecurity measures concerning 
visitors (biosecurity group ‘Hygiene visitors) were poorly implemented. Similar to the study 
of Nöremark et al. (2013), the veterinarian, AI technician and cattle salesman were most 
frequently entering the herd and having direct contact with the animals. The higher visiting 
frequencies of veterinarians on beef and mixed farms compared to dairy farms in Belgium can 
be explained by the presence of Belgian Blue cattle on these farms. This is a breed of cattle 
characterized by a double-muscled phenotype and by consequence a caesarean section for 
routine management of parturition (Kolkman et al., 2012). When professional visitors 
frequently enter the herd (and have direct contact with animals), adequate biosecurity 
measures such as herd-specific protective clothing and boots and/or well-maintained 
disinfection footbaths should be provided (Villarroel et al., 2007; Nöremark et al., 2013). In 
this study it was noticed that, despite their presence in the majority of the farms, these basic 
biosecurity measures were rarely used. Moreover, these measures were not implicated by all 
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visitors in the same extent: veterinarians used protective clothing and boots more often than 
AI technicians, followed by cattle salesmen. 
A low level of internal biosecurity, described by the biosecurity group ‘Hygiene 
infrastructure’, was observed. Analogous with the biosecurity measures for visitors entering 
the herd, facilities for an adequate internal biosecurity often were present, but they were 
insufficiently or incorrectly used. For instance, at 64% of the farms with a separate calving 
box sick animals were sometimes placed in that box. An explanation for a low level of 
internal biosecurity could be that farmers tend to overlook the implementation of management 
strategies to reduce disease spread within the herd (Brennan and Christley, 2013). As internal 
biosecurity involves that measures should be undertaken by the farmers themselves, they may 
also experience some biosecurity recommendations as time consuming and impractical (Gunn 
et al., 2008). 
Especially in regions with a high cattle density, small distances to neighbouring herds 
and high frequencies of professional visits as frequently encountered in Belgium, farmers 
should be aware of the various ways disease agents can enter and spread within the herd. 
Nöremark et al. (2010) noticed that even farmers with a poor biosecurity level indicated their 
on-farm biosecurity was sufficient. This finding and the results from the present study suggest 
the necessity of informing and guiding farmers in establishing an adequate biosecurity 
strategy. Another study revealed that most farmers were familiar with the broad concept of 
biosecurity, but the practical implementation was lacking (Brennan and Christley, 2013). 
Farmers often argue that the implementation of biosecurity measures is more likely to benefit 
society (e.g. zoonotic risk, international trade and welfare) rather than the individual farmer, 
while the direct costs for this purpose are at farm-level (Kristensen and Jakobsen, 2011). 
Some basic biosecurity measures such as the use of protective clothing, boots and disinfectant 
footbaths can be implemented without additional costs since these measures were already 
present in the majority of the studied farms. Newly acquired cattle can easily be isolated on a 
pasture or a quarantine stable can be installed in a shed, away from the rest of the herd. This 
illustrates that the implementation of biosecurity measures involves a behavioural change 
(Ellis-Iversen et al., 2010). Such a preventive strategy is farm-specific and should be 
developed in collaboration with the herd veterinarian who knows the specific herd structure 
and can inform the farmer on the critical points (Villarroel et al., 2007; Ellis-Iversen et al.; 
2010; Brennan and Christley, 2013). Besides the farmer and the herd veterinarian, all 
(professional) visitors should be willing to contribute to the biosecurity strategy. 
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Conclusions 
 
A sample of selected cattle farms with a history of BVDV and assumed BVDV free at 
the moment of participation was used to map the implementation of biosecurity measures in 
the daily management practices of Belgian cattle farms. Although we may in this way have 
selected for farms with better management practices, a low internal and external biosecurity 
level was observed. Depending on the biosecurity level, three groups of cattle farms were 
differentiated, but none of them demonstrated an overall high integration of biosecurity 
measures in their management practices. Especially in regions with a high cattle density, 
small distances to neighbouring herds and high frequencies of professional visits, measures 
should be taken to maintain herd health. Such a biosecurity strategy should be developed in 
collaboration with the herd veterinarian, but all (professional) visitors should contribute to the 
practical implementation. 
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Summary 
 
In Belgium, the control of bovine viral diarrhoea virus (BVDV) occurs on a voluntary 
basis at the herd level. Studies have demonstrated that the essential measures for successful 
control are poorly implemented and the BVDV prevalence remains high. To better understand 
the drivers for re-infection with BVDV and to evaluate the risk of re-infection, a cross-
sectional and a longitudinal study were conducted.  
In the cross-sectional study young stock were sampled for BVDV antibodies and a 
face-to-face interview with the farmer was conducted on 61 farms with a history of BVDV 
circulation, but which were assumed BVDV free at the moment of participation. Potential risk 
factors for a herd being re-infected were identified by a multivariable logistic regression 
model. In 11 of the 61 herds (18%) at least 20% of the young stock tested BVDV 
seropositive. Farms monitoring the BVDV status were less likely to be BVDV re-infected 
(OR 0.09; 95% CI 0.02; 0.55). There was also a decrease in risk when the neighbouring cattle 
farm was located further away (OR per km 0.06; 95% CI 0.00; 0.96). Re-infection was more 
likely when farmers participated to auctions and/or competitions (OR 140.27; 95% CI 3.00; 
6559.65). 
In the longitudinal study the BVDV status of 26 tested BVDV free and non-
vaccinating farms was monitored for 18 months by means of a spot test every 6 months. 
Positive spot tests were detected in 6 farms, corresponding to an incidence risk of re-infection 
of 15.4% per year. PI animals were detected on four of the re-infected farms. All mothers of 
the PI animals detected on the re-infected farms were BVDV virus-negative, which indicated 
that these dams were transiently infected with BVDV during gestation. The purchase of PI 
cattle was identified as cause of re-infection on one farm. 
These results demonstrated a high risk of BVDV re-infection in Belgian cattle herds. 
Given the violations of essential measures in BVDV control (monitoring and biosecurity) and 
a high BVDV prevalence, the risk of BVDV re-infection is likely to remain high. 
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Introduction 
 
Bovine viral diarrhoea virus (BVDV) is worldwide spread and can cause considerable 
economic losses in cattle (Gunn et al., 2005). The virus is able to infect multiple organ 
systems, including the uterus of animals in gestation (Baker, 1995). A congenital infection 
from the second up to the fourth month of gestation may result in the birth of a persistently 
infected (PI) calf (Peterhans et al., 2010). In a susceptible population BVDV is especially 
maintained through these PI animals, as they continuously shed BVDV in large quantities 
once colostrum-derived BVDV antibody titres have declined (Lindberg and Houe, 2005).  
Given the economic importance of BVDV, several countries have launched control 
programmes. A general model for BVDV control was proposed by Lindberg and Houe (2005) 
and consists of three essential measures: elimination of PI animals to reduce the source of 
infection, implementation of biosecurity to prevent new BVDV infections and monitoring the 
BVDV status to detect re-infection. The implementation of vaccination is optional and can be 
used as an additional biosecurity measure when the risk of re-infection is high, for instance in 
cattle-dense areas with intense animal trading (Lindberg et al., 2006).  
Studies have demonstrated that re-infections occur in regions where BVDV is endemic 
as well as in regions with a control programme. In the Netherlands, antibodies were detected 
each year in 5% to 10% of the herds participating in the voluntary BVDV control programme 
after these herds had been certified as ‘BVDV free’ (Mars and Van Maanen, 2005). In 
Denmark about 1% of the cattle herds that previously had been found free, was re-infected 
during the fourth year of the control and eradication programme (Bitsch et al., 2000). 
In Belgium, an important beef cattle and milk producing country in Europe and a very 
densely populated livestock area, BVDV control occurs on a voluntary basis at the herd level. 
Although BVDV control strategies are well-described, studies have demonstrated that the 
essential measures for successful control are poorly implemented in the daily management of 
Belgian farmers. Many control strategies are based on vaccination alone, without tracking and 
removing PI animals and without further follow-up of the BVDV status (Laureyns et al., 
2013). Furthermore, since few biosecurity measures are undertaken by Belgian cattle farmers, 
they expose their herd to re-infection with BVDV (Sarrazin et al., 2014). As a consequence, 
the BVDV prevalence remains high. About one-third of the young stock and half of the cattle 
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herds are BVDV seropositive in Belgium (Sarrazin et al., 2013). Recently, the outline of the 
first phase of a Belgian mandatory BVDV control programme has been published (Royal 
Decree on the control of BVD, 2014). The programme focuses on the detection of PI animals.  
Given these conditions a considerable risk of re-infection is expected in Belgian cattle 
herds. To better understand the drivers for re-infection with BVDV and to evaluate the risk of 
re-infection, given the current circumstances in Belgian cattle herds, a cross-sectional and a 
longitudinal study were conducted. 
 
Materials and methods 
 
Selection of the farms 
Cross-sectional study 
The target population for this study comprised of cattle farms in Belgium. A first 
inclusion criterion was a history of BVDV circulation in the herd. BVDV circulation in the 
herd was defined as the detection of at least one PI and/or transiently infected (TI) animal. 
The second inclusion criterion was the eradication of BVDV from the herd and the 
assumption of being free from BVDV at the moment of participation. This assumption was 
based on the herd veterinarian’s judgement and previous test results. Farms were selected as 
described by Sarrazin et al. (2014). In brief, herd veterinarians were contacted to propose 
cattle farms satisfying the inclusion criteria. Subsequently, proposed farms fulfilling the 
inclusion criteria were contacted to explain the study objectives and to verify their willingness 
to participate. 
 
Longitudinal study 
The target population for this study comprised of Belgian cattle farms that did not 
apply BVDV vaccination during the last 3 years. At the onset of the study the farms were 
assumed BVDV free based upon the herd veterinarian’s judgement and previous test results in 
combination with a negative spot test during the first visit (see further ‘Sample collection’). 
Farms were selected as described for the cross-sectional study.  
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Sample collection 
For each farm included in the cross-sectional study, 10 animals aged 8-15 months 
were randomly selected and blood sampled for serologic examination (spot test). The spot test 
is an indirect screening for the presence of PI animals in the herd by testing a limited number 
of young stock (3-10 animals) for BVDV-specific antibodies (Houe, 1992; 1994). On farms 
with less than 10 animals in this age range, all animals in this age range (with a minimum of 
five animals) were sampled. On farms with more than one herd, each was sampled. All blood 
samples were collected by the first author between March 2011 and November 2013. 
Farms considered to be included in the longitudinal study were sampled with a first 
spot test to verify their BVDV free status. On farms with no seropositive test results in the 
spot test during this first visit, three additional spot tests were performed every 6 months. All 
blood samples were collected by the first author between March 2011 and November 2013. 
 
Laboratory analysis 
For the detection of BVDV-specific antibodies in the spot test a commercial enzyme-
linked immunosorbent assay (ELISA) was used (SERELISA® BVD p80 Ab Mono Blocking, 
Synbiotics). This ELISA provides a specificity and sensitivity of respectively 97.7% and 
95.7% (BVD Technical Brochure). Analyses were done on serum samples according to the 
instructions provided by the manufacturer. Analyses were performed by the regional centre 
for animal disease control “Dierengezondheidszorg Vlaanderen (DGZ)”.  
 
Data collection 
In the cross-sectional study farmers were subjected to a face-to-face questionnaire 
interview, conducted by the first author. The questionnaire was designed to collect data 
regarding BVDV management and control at the herd level. According to the control strategy 
plan of Lindberg and Houe (2005), the questionnaire consisted of 93 questions on four main 
topics: biosecurity, virus detection, monitoring and vaccination. Most questions were semi-
closed. Except for the language (Flanders = Dutch and Wallonia = French), the questionnaires 
for both parts of the country were identical and checked for consistency by a bilingual 
researcher. The full questionnaire is available upon request to the first author. The 
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questionnaire was pre-tested regarding content, interpretation of questions and responses. It 
was emphasised to the farmers that questionnaires would be processed anonymously.  
When during the longitudinal study recirculation of BVDV was suspected following at 
least one seropositive animal in the spot test, possible causes of infection were explored using 
a farm-specific questionnaire investigation and additional sample collection if necessary. 
 
Data analysis 
Cross-sectional study 
A farm was classified as infected with BVDV when more than 20% of the sampled 
animals tested positive for the presence of BVDV antibodies. The outcome of interest was 
therefore binary, presence or absence of BVDV infection at the herd level. 
First, univariable analysis was performed of each potential risk factor obtained in the 
questionnaire. For categorical variables the proportion of herds positive within each of the 
categories was compared using a chi-square test. The association of continuous variables with 
the outcome of interest was verified by univariable logistic regression. Subsequently, all 
variables with a p-value < 0.25 were selected.   
 The correlation between categorical variables was evaluated using a chi-square test (p 
< 0.05) and Pearson and Spearman correlation coefficients were estimated (r > 0.6) to verify 
correlation between continuous variables. The choice of which correlated variable to include 
in the multivariable model was based on the variable with the smallest p-value in the 
univariable analysis. Subsequently a multivariable model was built in a stepwise backward 
manner resulting in a model in which only significant risk factors (p < 0.05) were retained 
based on a likelihood ratio test. Odds ratios, including 95% CI, are reported for all significant 
variables. Confounding was checked for by monitoring the change in regression parameters 
and was considered to be present if parameters changed by > 0.25. In the final model all two-
way interactions were tested and significant interactions (p < 0.05) were taken up in the 
model. The goodness-of-fit of the final multivariable model was tested using the Hosmer-
Lemeshow test (Hosmer and Lemeshow, 2000) with a significance level set at 5% and by 
examination of the residuals. All statistical analyses were performed using SAS 9.4 (SAS 
Institute Inc., Cary, NC, USA). 
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Longitudinal study 
A farm was classified as infected with BVDV (case) when at least one seropositive 
animal was detected in the spot test. 
 
 
Results 
 
Cross-sectional study 
A total of 74 farms were willing to participate, of which 13 farms had no documented 
history of BVDV circulation in the herd. Therefore, the latter farms were excluded from the 
cross-sectional study. A total of 61 farms were considered for further analysis in the cross-
sectional study.  
 
General characteristics of the selected farms 
Of the selected farms, 25 were dairy farms, 16 beef farms and 20 mixed farms (farms 
containing beef and dairy cattle). The average number of cattle present at the studied farms 
was 140 (SE 9), ranging from 30 to 370. At the moment of the farm visit the farms were 
believed to be BVDV free (i.e. removal of the last PI animal or detection of a TI animal) for 
on average 5 years (SE 0.4), ranging from 1 to 15 years. After conducting the spot test, 11 out 
of 61 farms (18.0%) were indicated as BVDV infected, since more than 20% of the sampled 
young stock was BVDV seropositive following the spot test.  
 
Risk factor analysis 
A total of 15 variables tested had p < 0.25, of which seven variables were not included in the 
multivariable model due to correlation (data not shown). “Purchase of cattle”, a well-
described risk factor for BVDV infection, was correlated with “Participation to 
auctions/competitions” (p = 0.02) and since the latter variable had the smallest p-value in the 
univariable analysis, this variable was included in the multivariable model. In the final 
multivariable model three factors remained significantly associated with BVDV re-infection 
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at the herd level: “Monitoring for BVDV”, “Distance to the nearest cattle farm” and 
“Participation to auctions/competitions” (Table 1). No confounding or significant two-way 
interactions were detected. The model fitted the data sufficiently well, as no significant lack 
of fit was detected with the Hosmer and Lemeshow test (p = 0.39) and residual analysis. 
Farms monitoring the BVDV status of the herd had a significant lower probability of being 
BVDV re-infected, with a more or less 10-fold lower odds compared to farms without BVDV 
monitoring (p = 0.004). There was also a decrease in risk when the neighbouring cattle farm 
was located further away: per km to the nearest cattle farm the odds of infection was 17 times 
lower (p = 0.007). An increase in the probability of BVDV infection was detected when 
farmers participate to auctions and/or competitions (p < 0.001).  
 
Table 1. Multivariable odds ratios (OR) and 95% confidence intervals (CI) for risk factors 
associated with a herd to be BVDV re-infected in the cross-sectional study (n = 61). 
Risk factor Category 
No. of 
herds 
% 
positive 
P OR 
95% CI 
Lower Upper 
Monitoring BVDV status 
No 21 33.3 0.004    
Yes 40 10.0  0.09 0.02 0.55 
Participation to 
auctions/competitions 
No 56 14.3 < 0.001    
Yes 5 60.0  140.27 3.00 6559.65 
Distance to nearest cattle farm 
(average: 0.6 km; 95% CI 0.4; 0.8) 
- - - 0.007 0.06 0.00 0.96 
 
 
Longitudinal study 
A total of 36 non-BVDV-vaccinating farms were identified to be potentially included 
in the longitudinal study. Of these farms, 26 (10 dairy, 5 beef and 11 mixed) had a negative 
spot test during the first visit and were further monitored in the longitudinal study. Of the 
farms included in the longitudinal study, 20 farms had a history of BVDV circulation in the 
herd but were cleared from BVDV at the onset of the study whereas 6 herds had no 
indications of any previous BVDV infection.   
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Infection with BVDV was detected on 6 out of 26 farms (23.1% in 18 months), which 
resulted in an incidence risk of BVDV infection of 15.4% per year. BVDV re-infection was 
detected in 5 out of 20 (25.0%) farms with a history of BVDV circulation in the herd, while 
one farm with no previous history of BVDV circulation (16.7%) was BVDV infected. At least 
one PI animal was detected in four of the infected farms (Table 2). On the two other re-
infected farms (case 2 and 6) no virus-positive animals were detected during a screening of 
the entire herd and no additional seropositive animals were detected in the spot test during the 
final farm visit. 
The cause of re-infection could be conclusively confirmed in one herd (case 3). On 
this farm an animal in gestation was purchased 2 months before the third spot test. The animal 
was tested for BVDV upon arrival and calved before the result of the analysis was available. 
The cow was moved to the lactating group and the calf was housed with other new-born 
calves. Test results revealed that the purchased cow was PI and by consequence also her calf 
was PI.  
When testing the mothers of the detected PI animals (case 1, 4 and 5) for BVDV 
viraemia, all dams were virus-negative, which indicated the PI animals resulted from transient 
BVDV infections of the dams during gestation. 
  
 
Table 2. Overview of the BVDV infected herds in the longitudinal study (n = 6). Following a negative spot test during the first visit three 
additional spot tests were performed, each with an interval of 6 months. Per spot test the total number of tested animals and the number of 
seropositive (+) or non-interpretable (between negative and positive; NI) test results are shown. Additionally, the period during which the farms 
had been BVDV free at the moment of the first spot test, the number of detected PI animals during the longitudinal study, the herd size and the 
monitoring strategy applied by the herd veterinarian are presented. 
Case Spot test Assumed 
BVDV free 
since (years) 
No. of PI 
animals 
detected 
Herd size 
(No. of cattle) 
Monitoring strategy applied by 
the herd veterinarian 
 1 2 3 4 
1 
0/10 + 
 
3/9 + 
1/9 NI 
5/8 + 
 
2/10 + 
2/10 NI 
6 2 190 
Virological testing (pools) of 
calves born during the last year 
2 
0/10 + 
 
4/10 + 
2/10 NI 
 
1/9 NI 
0/10 + 
 
4 0 130 Spot test (every year) 
3 
0/6 + 
 
0/8 + 
 
2/9 + 
2/9 NI 
0/10 + 
 
1.5 2 92 Spot test (every year) 
4 0/8 + 9/10 + No visit 1/10 NI 6 8 130 
Individual virological testing 
of new-born calves 
5 0/10 + 0/9 + No visit 2/8 + 2 1 210 
Virological testing of bulk tank 
milk (every 6 months) 
6 0/8 + 0/10 + 3/11 + 0/10 + No history 0 75 Spot test (every 6 months) 
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Discussion 
 
This paper reports on the risk of BVDV re-infection in Belgian cattle herds that 
previously had been considered free from BVDV. As can expected in a region with a high 
BVDV prevalence, a high cattle density and no systematic BVDV control, a high frequency 
of re-infection was demonstrated both in the cross-sectional and the longitudinal study. 
Similar studies were already performed in a country with (Bitsch et al., 2000) and without 
systematic BVDV control (Mars and Van Maanen, 2005), but in the present study the risk of 
re-infection was considerably higher. Furthermore, biologically plausible risk factors for re-
infection could be identified despite the limited sample size. 
Instead of testing all animals in the herd for BVDV viraemia, the spot test was used to 
verify the BVDV status of the herd. The spot test is less expensive and time-consuming and is 
able to detect a recent or current infection when used in young animals (Houe, 1992; 
Brülisauer et al., 2010; Laureyns et al., 2010). It is obvious that sampling a subset of the herd 
to obtain information on the entire herd is less sensitive compared to testing every individual 
animal. Factors that may impair the sensitivity of the spot test have already been discussed 
(Sarrazin et al., 2013). Nevertheless, the reliability of the spot test increases by repeating it at 
regular intervals (Houe, 1999), as was clearly demonstrated during the longitudinal study. 
In the cross-sectional study a herd was considered BVDV infected when at least 20% 
of the young stock was BVDV seropositive. However, there is no clear recommendation in 
the scientific literature regarding a cut-off value (Cuttance and Cuttance, 2014). A similar cut-
off was used by Gates et al. (2013a; 2013b), based on the results from Brülisauer et al. (2010). 
Moreover, no DIVA (Differentiating Infected from Vaccinated Animals) vaccines for BVDV 
are available and a seropositive test result may thus originate from vaccination (Raue et al., 
2011). Finally, given the specificity of 97.7% of the used antibody test and the number of 
animals tested (n = 559), false positive results are expected. Since the animals were not 
retested in the cross-sectional study, it is impossible to determine which of the seropositive 
animals could have been false positive, but it is possible that spot tests with only one single 
seropositive animal were in fact false positive and these herds (n = 6) were therefore not 
considered as infected. 
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The assumption of the selected farms being BVDV free at the moment of participation 
was based on the herd veterinarian’s judgement and previous test results. Farms in the cross-
sectional study were believed to be BVDV free for on average 5 years, but 34% (21/61) of 
these farms did not monitor the BVDV status after elimination of the PI animals (Table 1). As 
a consequence it is likely that some of the re-infected farms had already been re-infected for a 
longer period than assumed by the herd veterinarians, who were convinced that the farms they 
proposed for the study were still BVDV free. For the longitudinal study only farms with a 
negative spot test following the first farm visit were selected, hereby increasing the 
probability that the selected farms were actually still BVDV free at the onset of the study. 
The importance of monitoring the BVDV status has clearly been demonstrated in this 
study. First, farms continuing to verify the BVDV status were less likely to be re-infected 
following the multivariable model. Secondly, six herds having a negative spot test during the 
first visit eventually became BVDV infected in the longitudinal study. Thirdly, several of the 
assumed free herds turned out to be not free from BVDV. This result indicates that the BVDV 
free status should be confirmed on a regular basis by means of diagnostic methods and cannot 
be based on a clinical evaluation solely. However, in 2 out of 6 farms considered infected 
following seropositive results in the spot test no virus-positive animals were detected during a 
screening of the entire herd (case 2 and 6). A possible explanation could be that a PI animal 
was no longer present at the moment of the screening of the herd (Lindberg and Houe, 2005), 
e.g. a male calf that was sold for fattening within 2 weeks after birth or a PI animal that died 
before it was identified as PI. Additionally, BVDV can be spread when PI animals are aborted 
or stillborn (Lindberg et al., 2004). The detection of animals that have been TI in absence of 
PI animals could be another explanation. Given the low implementation of biosecurity 
measures and frequent contact between farms on the one hand (Sarrazin et al., 2014) and a 
high BVDV prevalence in Belgian cattle herds on the other hand (Sarrazin et al., 2013), 
transient infections following direct virus transmission (e.g. fence-line pasture contact or 
during transport) or indirect transmission (e.g. professional visitors with no farm-specific 
clothing) are likely. To verify whether the virus spread is maintained in the herd the spot test 
can be repeated 3 months later (Laureyns et al., 2010) or can be repeated with a larger sample, 
e.g. by including heifers (Pillars and Grooms, 2002; Houe et al., 2006). 
Besides monitoring the BVDV status by serologic evaluation of young stock, herd 
veterinarians also used pooled samples of non-coagulated blood from a group of calves, ear 
notch sampling or bulk tank milk samples to directly detect virus-positive animals as 
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monitoring strategies (Table 2). However, it was noticed that calves destined for fattening and 
staying on the farm only for a short period of time very often were not tested to reduce the 
costs. Yet, although PI calves under protection of colostral antibodies shed only low amounts 
of BVDV (Palfi et al., 1993), all animals should be tested when testing BVDV viraemia to 
avoid false negative results in the detection of PI animals (Laureyns et al., 2010). 
The purchase of cattle was not retained in the multivariable model of the cross-
sectional study as this variable was strongly correlated with “Participation to 
auctions/competitions”. However, the purchase of cattle was identified as a cause of re-
infection in the longitudinal study (case 3). Furthermore, another re-infected farm (case 5) had 
also purchased BVDV viraemic animals without putting the animals in quarantine while 
awaiting the purchase test results, but housed the animals in a shed where contact with other 
cattle was possible. In both cases the purchased animals were tested for BVDV viraemia, but 
they were not strictly quarantined until the result of the blood test was known. Strict 
quarantine includes no direct animal contact and additional hygiene measures such as 
changing footwear and work clothes before entering and leaving the quarantine area 
(Villarroel et al., 2007). Furthermore, for diseases with a short incubation period such as 
BVDV animals should be quarantined for at least 3 weeks (Barrington et al., 2002; Villarroel 
et al., 2007). As pregnant PI dams invariably transmit the virus to the foetus, resulting in new 
generations of PI calves (Moennig and Liess, 1995), the calf of the purchased PI heifer (case 
3) was also PI, which was rapidly detected following the positive test result of the dam. 
However, attention must also be paid to the risk of the ‘Trojan’ cow or heifer, i.e. a non-PI 
animal that was transiently infected during gestation and that is carrying a PI foetus as a result 
(Laureyns et al., 2010; Lanyon et al., 2014). When testing such a dam at purchase, she will be 
virus-negative, but she will introduce BVDV in the herd by giving birth to a PI animal. As a 
consequence, the calf of a purchased dam should be quarantined until testing for the presence 
of BVDV. Moreover, purchased animals should calve while they are still in quarantine, as 
BVDV is transmitted at the birth of PI calves through foetal fluids and uterine lochia, hereby 
contaminating the environment (Lindberg et al., 2004). In another study investigating re-
infection with BVDV the purchase of a pregnant cow or heifer was found to be the cause in 
28% of the cases (Bitsch et al., 2000).  
Although it is required for cattle to be BVDV free when participating to auctions or 
competitions in Belgium, this parameter was identified as a risk factor for re-infection and 
indicates that control measures such as quarantine and testing should also be used for cattle 
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returning to a farm (Villarroel et al., 2007). Even when every animal is virus-negative at 
auctions, indirect transmission of BVDV is possible through persons (Ståhl et al., 2005) or 
cattle trailers. The latter seem a plausible source of infection, as BVDV can persist in the 
environment (Niskanen and Lindberg, 2003).  
Farms were more likely to be BVDV re-infected when the neighbouring farm was 
located nearby. This risk factor was already described in other studies (Houe, 1999; Ersbøll et 
al., 2010; Gates et al., 2013b) and is of concern, given the short distances between Belgian 
cattle farms: the mean distance was 0.6 km (Table 1) and the minimum distance was only 
0.04 km (data not shown). A possible route of transmission could be fence-line pasture 
contact, which is frequently possible on Belgian cattle farms (Sarrazin et al., 2014) and has 
already been described as a risk factor (Valle et al., 1999). This way of transmission was also 
hypothesized as cause of re-infection in the longitudinal study (case 1, 2 and 4), but could not 
be confirmed. Airborne transmission of BVDV has also been described as a local mechanism 
for BVDV spread, but only for short distances up to 10 m (Niskanen and Lindberg, 2003). 
Assumed self-clearance or the elimination of BVDV from the herd without 
intervention (Lindberg and Houe, 2005) was observed in two herds (case 2 and 6): no virus-
positive animals were detected during the screening of the whole herd, no PI animals were 
born during the year following the positive spot test and/or no additional positive spot test 
results were obtained. Self-clearance especially tends to occur in smaller herds (Lindberg and 
Houe, 2005), but was also noticed irrespective of herd size in regions with a high cattle 
density and high BVDV prevalence (Ståhl et al., 2008). Herd size in case 2 and 6 was 130 and 
75, respectively. In case 3 also no additional PI animals were detected and the final spot test 
was negative. However, ear notch sampling was only used for female calves and the birth of 
male PI animals that remained unnoticed can therefore not be excluded. 
During the longitudinal study, one farmer decided to move a detected PI animal to his 
father’s farm (case 1). Nonetheless, the spot tests remained positive. As the father frequently 
enters the farm without using farm-specific clothing, these two geographically separated units 
should be considered as one entity (Laureyns et al., 2010). Given the frequent contacts 
between these units, indirect BVDV transmission is possible (Ståhl et al., 2005; Niskanen and 
Lindberg, 2003). Other studies suggest that BVDV can continue to spread for a long time 
after the removal of PI animals (Moerman et al., 1993; Moen et al., 2005), but also the birth of 
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additional PI animals in this herd cannot be excluded since only female calves were tested for 
BVDV. 
In four of the herds where re-infection was noticed during follow-up (case 1, 3, 4 and 
5) at least one PI animal was detected. Once PI animals are removed, the herd will gradually 
become seronegative, starting with young calves losing their colostral antibodies (Houe et al., 
2006). BVDV re-introduction in such a susceptible population can result in an outbreak as 
demonstrated in case 4, where no less than eight PI animals were born. In regions with a high 
risk of re-infection, vaccination can limit the spread of infection within a population and 
reduce disease severity in an infected animal (Ridpath, 2013). However, for vaccination to 
succeed, also the three essential measures for systematic BVDV control have to be 
implemented: biosecurity, removal of PI animals and monitoring (Lindberg and Houe, 2005; 
Ridpath, 2013). 
 
 
Conclusions 
 
This paper demonstrated a considerable risk of BVDV re-infection in Belgian cattle 
herds. Although not monitoring the BVDV status was identified as a risk factor for BVDV re-
infection and the fact that the importance of this measure is well-described, it was noticed that 
monitoring often was not or wrongly performed. Furthermore, nevertheless the purchase of 
cattle is known to be a frequent cause of infection, essential biosecurity measures to prevent 
BVDV infection such as quarantine were not implemented. Given these violations of essential 
measures in BVDV control, the short distances between cattle farms and a high BVDV 
prevalence, the risk of BVDV re-infection in Belgian cattle herds is likely to remain high. 
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Introduction 
 
The control of bovine viral diarrhoea virus (BVDV) in Belgium has been on a 
voluntary basis at the herd level for about 20 years. Despite the voluntary control programme, 
this doctoral thesis has demonstrated that the BVDV prevalence in Belgian cattle herds is high 
(Chapter 3). Reasons for this high BVDV prevalence in Belgium will be discussed in the first 
paragraph of this general discussion.  
 Currently more efficient diagnostic BVDV tests are available, which can reduce the 
costs of a BVDV control programme at the national level. Taken into account the high BVDV 
prevalence in Belgium and the economic importance of BVDV, a mandatory BVDV control 
programme was launched the 1
st
 of January 2015. The second paragraph introduces the 
outline of this programme as it is currently designed. 
Elimination of PI animals to reduce the source of infection, implementation of 
biosecurity to prevent new BVDV introductions and monitoring the BVDV status to detect re-
infection are described as necessary measures to obtain and maintain a BVDV free status. 
Assessment how these necessary elements for BVDV control are implemented and whether 
they are essential to maintain a BVDV free status in Belgian cattle herds, given their current 
implementation and the high BVDV prevalence is another aim of this doctoral thesis. 
Therefore, the third paragraph of this general discussion is dedicated to recommendations on 
each specific level of BVDV control, including vaccination. These recommendations will be 
discussed in the light of the mandatory Belgian BVDV control programme. 
 
 
Factors contributing to a high BVDV prevalence in Belgian cattle 
herds 
 
A first step in the decision process to control a disease at the national level is to verify 
to what extent the disease poses a problem (Saatkamp et al., 2006), for instance the impact on 
animal health, its economic consequences and prevalence. The impact of BVDV on animal 
health and the economic consequences of BVDV infections are important drivers for control 
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in regions where the virus is endemic (Lindberg et al., 2006) and have already been described 
(General Introduction). It is thus important to have a good insight into the current BVDV 
prevalence (Brülisauer et al., 2010). Knowledge about this prevalence makes it possible to 
evaluate whether any progress is made during BVDV control (Lindberg et al., 2006; Barrett et 
al., 2011). In Belgium, the true prevalence of BVDV-specific antibodies at the herd and 
animal level (young stock) was estimated to be 47.4% and 32.9%, respectively (Chapter 3). 
This high BVDV prevalence in Belgian cattle herds clearly suggests that the a voluntary 
approach in BVDV control had little effect and that a more coordinated approach in the form 
of a mandatory control programme is needed. Moreover, the results also raise questions about 
the reasons for this high prevalence. Whenever these results are compared with prevalence 
studies in other countries before initiating a control or eradication programme, caution has to 
be applied to the target population and the methodology used (e.g. blood samples versus bulk 
tank milk samples) (Brülisauer et al., 2010). In Switzerland, 22.9% of young stock within the 
same age category (6-12 months) as in the Belgian prevalence study were BVDV seropositive 
(Rüfenacht et al., 2000). Another study where young stock was sampled demonstrated that 
11.6% to 19.7% of the Scottish beef suckler herds had young stock with a median 
seroprevalence of 91.9 to 99.8% (Brülisauer et al., 2010). In general, regardless of the target 
population and the methodology used, BVDV herd seroprevalence in European countries 
before initiating a mandatory national control or eradication programme varied between 1% 
(Finland) and 100% (Switzerland) (Rüfenacht et al., 2000; Greiser-Wilke et al., 2003).  
 
Cattle density and herd size 
In Belgium 2,441,319 domestic cattle were registered in the animal identification and 
registration system (SANITEL) in November 2013 (NIS, 2013), which results in an average 
cattle population density at municipality level of 85 animals/km² (OIE, 2013). Together with 
the Netherlands, Belgium is one of the most densely populated cattle areas in Europe. It has 
been shown in this thesis that the average distance to neighbouring farms is small (Chapter 
5): the mean distance to the nearest cattle farm was only 0.57 km (95% CI 0.39; 0.75). 
Moreover, it was also shown that the odds for a farm to be BVDV seropositive was 16.7 times 
higher when the distance to the nearest cattle farm decreased with 1 km (Chapter 6). 
 For several years both the number of cattle farms and heads of cattle have been 
declining in Belgium. However, the number of cattle farms is decreasing faster than the 
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number of cattle, which indicates that the average herd size is increasing. In November 2013 
the average herd size of Belgian cattle farms was 120 animals (NIS, 2013). 
As the transmission rate of an infectious disease is influenced by the number of 
contacts per unit of time (Lindberg and Houe, 2005), a high cattle density and herd size can 
facilitate BVDV spread. Studies have shown that both herd size (Chapter 3; Ersbøll and 
Stryhn, 2000; Humphry et al., 2012; Graham et al., 2013; Cuttance and Cuttance, 2014) and 
herd density (Houe et al., 1995a; Houe, 1999) are associated with the presence of BVDV.  
When discussing transmission mechanisms for local BVDV spread, pasture contact is 
considered a very important route of infection (Gates et al., 2013b). Although zero-grazing is 
becoming more and more popular for dairy cattle, in Belgium most cattle are grazing and in 
70% of the farms fence-line contact with cattle from other farms is possible on pastures 
(Chapter 4). Pasture contacts are shown to be associated with (Valle et al., 1999) or the cause 
of BVDV infections (Bitsch et al., 2000). 
With an increasing herd size it is less likely that self-clearance of BVDV occurs, i.e. the 
elimination of BVDV from the herd without intervention (Lindberg and Houe, 2005; Ståhl et 
al., 2008). With reproduction ratios (R) of +∞ (95% CI 1.88; +∞) for PI animals and < 1 
(point estimates of 0.24, 0.25 and 0.49 depending on the strain) for TI animals (Chapter 4), it 
is obvious that self-clearance tends to occur when no PI animals are present in the herd, since 
these data indicate that only PI animals are able to maintain BVDV in a herd. As PI animals 
originate from infections of susceptible animals in early pregnancy, the probability of self-
clearance is likely to be negatively associated with the number of susceptible animals in early 
pregnancy and thus indirectly with the herd size (Lindberg and Houe, 2005). The importance 
of transient BVDV infections of cattle in early pregnancy as the source of PI animals was 
demonstrated in the longitudinal study (Chapter 6), where all mothers of the detected PI 
animals were no PI animals themselves. They had by consequence been infected in early 
pregnancy. This issue is further discussed below.  
Yet, herd size, herd density and initial prevalence are not meaningful predictors for the 
prospects for successful reduction in BVDV prevalence. It rather is the way in which control 
activities are organized and implemented that will determine the progress (Lindberg and 
Houe, 2005). 
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Contact with cattle through national and international  trade 
BVDV is still present in all the neighbouring countries of Belgium. In the Netherlands 
no mandatory control programme at the national level is implemented and BVDV is endemic 
(Mars and Van Maanen, 2005). In France BVDV is only controlled in specific regions 
(Holleville, 2013; Maurin, 2013; Potaufeux, 2013), whereas mandatory control and 
eradication programmes at the national level are on-going in Germany (Ståhl and Alenius, 
2012) and Luxembourg (Brownlie and Booth, 2014). Of the approximately 168,000 imported 
cattle in Belgium in 2011, 95% originated from these neighbouring countries and only 164 
animals came from countries where BVDV has been eradicated (FAO, 2014). The majority of 
the imported cattle are calves destined for fattening, approximately 91% during the period 
2005-2009 (Ensoy et al., 2014). Nonetheless, the introduction of BVDV in herds via imported 
virus-positive cattle was possible, as is was not compulsory to test these animals for BVDV 
viraemia. Additionally, a same amount of cattle was exported from Belgium in 2011 (FAO, 
2014). Due to its favourable central location, there is also a considerable amount of through 
traffic of cattle in Belgium. In the current Belgian mandatory control programme all imported 
cattle born after 1 January 2015 has to be tested for BVDV viraemia (see below). 
When considering national cattle trade, animals are usually transported over short 
distances within the same province or to neighbouring provinces (Ensoy et al., 2014). 
According to the same study the Walloon region (southern part of Belgium) appeared to be an 
important source of movement towards the rest of the country, with the provinces West and 
East Flanders as important receivers. A study of Ribbens et al. (2012) demonstrated that 
almost half of the presumed PI animals (Ag-ELISA or RT-PCR positive) were first being 
moved to another herd in Flanders (northern part of Belgium) before being classified dead in 
the animal identification and registration system. This was also observed in the longitudinal 
study of this thesis (Chapter 6). Based on the study of Ribbens et al. (2012) it has been 
estimated that presumed PI animals had been present in about 6.3% of all active cattle herds 
in Flanders between October 2009 and October 2011. These results show that, in Belgium, PI 
animals very often are traded, even when the BVDV status is known, which stresses the need 
of testing purchased cattle and a more strict legislation concerning the trade of PI animals.  
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Unawareness of the presence 
About 70% to 90% of acute BVDV infections occur with only mild fever and 
leukopenia (Ames, 1986; Baker, 1995). Although these subclinical infections cause economic 
losses by affecting animal productivity (Fourichon et al., 2005; Gates et al., 2013a), very often 
they remain unnoticed by the farmer. In the herds where the presence of a PI animal was 
assumed based on a positive spot test ( ≥ 60% seropositive), 83.4% of the farmers stated not 
to have had any BVDV-related problems (Chapter 3). Furthermore, clinical presentations of 
BVDV infections widely vary, making it a challenge for the farmer and veterinarian to detect 
the presence of BVDV based on clinical signs (Laureyns, 2014). 
Therefore, laboratory tests are needed to confirm the presence of BVDV (Sandvik, 
2005). First, the herd status is verified by a spot test or bulk tank milk analysis. When the 
presence of PI animals is assumed, the BVDV status of all individual animals needs to be 
tested. As a consequence, analysis costs may mount up which may withhold farmers from 
performing a screening of the entire herd, even when the presence of a PI animal is suspected 
(Laureyns et al., 2011).  
As BVDV can cause abortion (Grooms, 2004), laboratory investigations into cases of 
abortion may provide an additional way of identifying (newly) infected herds. However, the 
annual report of 2013 of the regional centre for animal disease control in the southern part of 
Belgium (ARSIA) showed that it is assumed that only about 7% of the abortions in cattle are 
reported (ARSIA, 2013). Moreover, the same report showed that about 29% of the herds with 
at least one calving per year did not report an abortion for 3 years. Taken into account that 
Belgian farmers are assumed to report each abortion within the framework of the preservation 
of the free status of brucellosis and that BVDV analyses on aborted foetuses are performed for 
free, it is regrettable that this abortion protocol is not used more frequently. 
 
Systematic versus non-systematic BVDV control 
BVDV control strategies can be described as being either non-systematic or systematic 
(Lindberg et al., 2006). A systematic approach implies that there is a goal oriented reduction 
in the incidence and prevalence of BVDV infections. Three essential elements of systematic 
control approaches can be identified (Lindberg and Houe, 2005; Lindberg et al., 2006): a) 
biosecurity measures to prevent (re)introduction, b) elimination of PI animals from infected 
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herds, and c) monitoring the BVDV status. Non-systematic approaches lack one or more of 
these elements. In cattle-dense areas with intense cattle trading and a high BVDV prevalence 
such as Belgium, vaccination as additional biosecurity measure may be advised to avoid 
infection (Lindberg et al., 2006). For vaccination to succeed, also the three essential measures 
for systematic BVDV control have to be implemented (Lindberg and Houe, 2005; Ridpath, 
2013). Based on this, the general model for BVDV control as proposed by Lindberg and Houe 
(2005) was slightly modified by Laureyns (2014) (Fig. 1). 
 
Fig. 1. The general model for BVDV control as proposed by Lauryens (2014) and adapted 
from Lindberg and Houe (2005) consists of three essential measures: biosecurity measures, 
removal of PI animals and monitoring. In Belgium, a cattle-dense areas with intense cattle 
trading and a high BVDV prevalence, vaccination as additional biosecurity measure may be 
advised to avoid infection. 
 
Systematic control can be implemented either at the herd level or at the 
regional/national level. In Belgium recommendations for systematic control were proposed by 
the regional centres for animal health control to be implemented on a voluntary basis at the 
herd level for about 20 years. This approach has resulted in a low number of cattle farms 
implementing control strategies and a variety of strategies, of which some are not adequate 
(Laureyns et al., 2013; Chapters 5 and 6).  
The results of this doctoral thesis illustrate that a voluntary approach for BVDV 
control at the herd level has not been successful in reducing the BVDV prevalence and the 
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risk of re-infection in Belgium (Chapters 3 and 6). The same has been observed before in 
other countries (O’Rourke, 2002; Lindberg et al., 2006; Ridpath, 2012). Therefore, a 
mandatory national control programme is needed to achieve a thorough decrease in 
prevalence. In Belgium, such a control programme was launched in January 2015 with the 
final aim of eradicating BVDV. 
 
 
The Belgian BVDV control programme as it is actually designed 
The national control programme will be executed in several phases, of which the first 
phase has started in January 2015 (Royal Decree on the control of BVD, 18 June 2014). 
During the first phase the programme focuses on the determination of the BVDV status of 
individual animals by the mandatory testing of new-born calves for BVDV viraemia within 7 
days after birth. Although not compulsory, the preferred way of sampling is via ear notch 
samples, which are obtained when the farmer places the official ear tag. After testing, the 
BVDV status is mentioned on the official individual identification document. A BVDV-
positive animal is considered PI until the contrary is proven in case of retesting. By this 
concise and straightforward approach, about a third of the Belgian cattle population will be 
tested every year, given a Belgian cattle population of approximately 2.6 million animals and 
950,000 new-born calves per year. This legislation also applies to imported cattle born after 1 
January 2015. Secondly, following the test result of the new-born calf, a BVDV status will 
also be assigned to the mother of the calf. Dams of non-PI calves will be considered “non-PI 
by descent” while dams of PI calves will have a “PI-suspected” status, which will have to be 
verified (Table 1). Finally, by testing individual animals, also information about the BVDV 
status at herd level is obtained. 
Depending on the status of the animal specific movement restrictions are imposed. PI 
animals are not allowed to be grazed or transported, except for slaughter. There is no 
obligation to cull PI animals from the start of the programme, but PI animals must be 
quarantined to prevent contact with the rest of the herd. The mandatory testing of cattle with 
an unknown BVDV status at purchase will start in January 2017. In a next phase a BVDV 
free status will be assigned to herds of which all individual cattle tested BVDV negative 
(monitoring and surveillance). Specific directives about how this phase will be implemented 
are not yet determined and will depend on the progress of the first phase of the programme. 
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Table 1. Possible BVDV statuses and their implications following the Belgian mandatory 
BVDV control programme. Source: Dierengezondheidszorg Vlaanderen (DGZ), 2015.  
Status Meaning Consequence 
PI  - BVDV-positive test result 
- Calf of dam with PI status 
- Only free for slaughter 
- No grazing  
- Quarantine 
PI-suspected - Invalid or missing analysis  
- Dam of a BVDV-positive calf or foetus 
- Belated analysis of new-born calf 
Only free for slaughter while 
awaiting coming analysis  
Non-PI following analysis - BVDV-negative test result 
- Valid foreign BVDV certificate 
Free for trade 
Non-PI by descent  Dam of a non-PI calf  Free for trade 
Unknown BVDV status  Born before 2015 and no analysis Free for trade for the moment 
 
The legal basis of the Belgian BVDV control programme especially focuses on the 
detection and movement restrictions of PI animals. Since PI animals do not have to be culled 
immediately after detection, this programme could be considered as incomplete from a 
scientific point of view since these PI animals may continue to spread virus and therefore 
maintain an infection in a herd. However, in order to obtain an achievable control programme 
that was acceptable for all stakeholders in cattle production and economically feasible, some 
measures of a scientifically optimal control programme were not included in the legal basis of 
the Belgian BVDV control programme as it is actually designed. Nonetheless, even when a 
control programme is not optimal from the start, BVDV eradication – the final aim – can be 
achieved, given it is implemented in a systematic manner (Hult and Lindberg, 2005). 
Therefore, in addition to this legal basis, non-compulsory guidelines regarding the removal of 
PI animals and the prevention of re-infection are provided (DGZ, 2015). The herd 
veterinarians will be closely involved in the recommendation and communication of these 
guidelines. 
The programme provides some financial compensations (DGZ, 2015). First, the postal 
charges related to the sending of ear notch samples to the laboratories for analysis are for free. 
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Secondly, when the BVDV status of a mother has to be verified following a BVDV-positive 
test result of a new-born calf, a financial compensation of €34.62 is provided for the visit of 
the herd veterinarian, the sampling of the mother and the analysis of the blood sample. 
Finally, when during this herd visit, the BVDV-positive new-born calf is euthanized, the costs 
related to the euthanasia are covered (€10).   
In the next paragraph each of the four measures for BVDV control, including 
vaccination (Fig. 1), will be further discussed in the light of the Belgian mandatory control 
programme. The order in which these measures will be discussed is based on the way the 
programme is actually designed with first the detection of PI animals and secondly monitoring 
and surveillance. Finally, it is discussed how biosecurity and vaccination can contribute to the 
maintenance of a BVDV free status in Belgian cattle herds.  
 
 
Assessment of the implementation of systematic BVDV control 
and recommendations to maintain a BVDV free status in Belgian 
cattle herds 
 
Elimination of BVDV from infected herds 
 
 When herds are BVDV infected it is essential to eliminate the virus from the herd. PI 
and TI animals are well-described sources of BVDV and therefore possible targets in BVDV 
eradication.  
 
The essentials of PI animals in the epidemiology of BVDV 
 During the transmission study (Chapter 4) a PI animal infected all three remaining 
susceptible animals in a group of seven seropositive calves within 8 days after its introduction 
in the group. During the longitudinal study (Chapter 6) in one herd young stock (n = 10) was 
sampled for BVDV antibodies. All but one calf tested BVDV seropositive. This suggested the 
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presence of a PI animal, which appeared to be the animal that was BVDV seronegative. These 
results clearly demonstrated that PI animals are very successful virus transmitters and the 
main source of new infections (Fulton et al., 2006; Nickell et al., 2011) and illustrate why the 
removal of PI animals is generally considered the key to successful BVDV control (Lindberg 
and Alenius, 1999; Lindberg and Houe, 2005; Presi and Heim, 2010; Ridpath, 2010; Ståhl and 
Alenius, 2012).  
Therefore, detection and quick removal of PI animals is strongly recommended. The 
longer PI animals remain present in a herd, the greater the risk of transmitting the virus. In 
herds with PI animals and where cattle are housed in close contact most animals are 
undergoing acute infection and usually more than 90% of the animals become seropositive 
within 3 to 5 months (Houe, 1999). A delayed within-herd transmission is seen when cattle 
are kept in separate buildings or pens (Houe et al., 1995b; Taylor et al., 1997). The herd 
infrastructure thus influences the within-herd BVDV spread, but unless PI animals are kept in 
strict quarantine and meticulous hygienic procedures are implemented, BVDV will spread 
within the herd (Ezanno et al., 2008). Taken into account the very low level of internal 
biosecurity in Belgian cattle herds (Chapter 5), PI animals should not remain in the herd. 
However, farmers will tend to fatten such animals, especially when the animals appear to be 
perfectly healthy (Laureyns et al., 2010). Nevertheless, farmers should be strongly encouraged 
to cull cattle diagnosed as PI immediately after detection. 
Limiting the movements of detected PI animals (no transport or grazing) as foreseen in 
the programme will likely reduce the between-herd BVDV spread. Nevertheless, indirect 
transmission remains possible, since PI animals are considered to be the origin of these minor 
important transmission routes (General Introduction; Lindberg and Houe, 2005). When the 
probability of direct contact with PI animals decreases, relatively more emphasis should be 
put on preventing infection through indirect contacts (Hult and Lindberg, 2005), which can be 
achieved by the implementation of biosecurity measures (see below).  
In Switzerland and Germany new-born calves are also tested through ear notch 
sampling. When PI animals are detected, removal from the herd of these BVDV positive 
animals is mandatory (Switzerland and Germany), completed with testing of all adult cattle 
(Switzerland) and trading with non-PI animals only (Switzerland and Germany). The mean 
time elapsed between a positive test result and the slaughter of a virus-positive calf is 12.5 
days in Switzerland (Presi et al., 2011), while in Germany confirmed PI animals should be 
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eliminated without delay. In Germany, this confirmation had to be performed within 60 days 
after the first positive test result (Schirrmeier, 2014). The proportion of virus-positive new-
born calves 2 years after the start of mandatory testing decreased from 1.5% to 0.15% and 
from 0.55% to 0.17% in Switzerland and Germany, respectively (Presi et al., 2011; 
Schirrmeier, 2014). The proportion of virus-positive new-born calves 2 years after the start of 
mandatory testing decreased from 1.5% to 0.15% and from 0.55% to 0.17% in Switzerland 
and Germany, respectively (Presi et al., 2011; Schirrmeier, 2014). Although a same 
proportion of virus-positive new-born calves was obtained after 2 years, the decrease was 
more distinct in Switzerland. Possible explanations could be the quick removal of PI animals 
and the testing of all cattle to detect PI animals. Taken this into account, farmers and 
veterinarians should be encouraged to implement the immediate removal of PI animals and to 
perform an additional screening of the herd when a PI animal is detected.  
  
The essentials of TI animals in the epidemiology of BVDV 
TI animals are believed to be of minor importance in the epidemiology of BVDV, 
because of the short duration of the infection on the one hand and the intermittent shedding of 
relatively low amounts of virus on the other hand (Lindberg and Houe, 2005). In our 
experimental studies (Chapter 4) the duration of viraemia in TI animals varied between 1 and 
9 days with a maximum viral titre of 1.6 x 10
4
 TCID50/mL. For comparison, the serum viral 
titre of the PI calf used in the transmission study was approximately 2.4 x 10
4
 TCID50/mL. 
Although one TI animal thus obtained a viral load almost equivalent to that in PI animals, this 
was limited in time (2 days) and the viral titres of the other TI animals in the study were 
below 9.3 x 10
2
  TCID50/mL. Some reports nonetheless suggest that BVDV can be maintained 
in the population only by transient infections (Moerman et al., 1993; Moen et al., 2005; Doll 
and Holsteg, 2013; Moen, 2013).  
The results from our experimental infections (Chapter 4) nevertheless support the 
assumption that TI cattle are of little importance for BVDV spread. When using Belgian field 
strains in 2 separate transmission experiments only one animal was contact infected during 
each experiment, which resulted in R0 of 0.25 (95% CI 0.01; 1.95) and 0.24 (95% CI 0.01; 
2.11) (Chapter 4.1). Moreover, the blood samples of the contact infected animals became RT-
qPCR-positive 10 days after inoculation, while the PI animal already infected two calves 
within 5 days after the introduction of the PI animal. Even when taking into account the 
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incubation period (which was 2 days in the transmission study) of the inoculated calves, the 
PI animal more rapidly transmitted BVDV compared to the TI animals. Furthermore, also 
when a hypervirulent strain was used, BVDV transmission was insufficient to maintain 
BVDV in a susceptible population (R0 of 0.49; 95% CI 0.06; 2.99) (Chapter 4.2). These 
results are in contradiction to the report that suggested that virulent strains can spread 
explosively through TI animals (Ridpath et al., 2006). Other studies even demonstrated no 
spread of BVDV by experimentally infected animals (Niskanen et al., 2000; Niskanen et al., 
2002). Furthermore, assumed self-clearance of BVDV was noticed in herds where 
seroconversion (i.e. transient infections) but no PI animals were detected (Chapter 6).  
Whenever it is claimed that TI animals maintain BVDV in a population, sufficient 
information is needed to prove that transmission was not due to PI animals that have escaped 
identification (Lindberg and Alenius, 1999; Lindberg and Houe, 2005). For instance, 
Moerman et al. (1993) estimated that horizontal BVDV transmission rate by TI cattle had a R0 
of 3.3 (95% CI 2.6; 4.1). However, although separated from the study group, PI animals were 
present in the herd during this study. In this way they may have attributed to virus spread 
through indirect transmission (Niskanen and Lindberg, 2003; Lindberg et al., 2004), resulting 
in an overestimation of R0. Furthermore it is possible that, for instance during the outbreak in 
Germany (Doll and Holsteg, 2013), PI animals died before they were identified as PI. 
Additionally, BVDV can be spread when PI animals are aborted or stillborn (Lindberg et al., 
2004).   
 The major importance of TI animals in BVDV spread is their ability to deliver a PI 
animal when they are infected in early pregnancy (Chapter 6), hereby becoming a Trojan cow 
(Laureyns et al., 2010; Lanyon et al., 2014). Trojan cows were shown to be a very important 
cause of re-infection in Danish cattle farms (Bitsch et al., 2000). New-born PI animals will 
eventually quickly be detected through ear notch sampling, but they will not necessarily 
immediately be removed and BVDV can also be spread at birth (Lindberg et al., 2004). To 
minimize the contribution of TI animals in BVDV spread it is therefore recommended to: 
a) quarantine purchased pregnant cattle until the test result of the new-born calf is known 
(see below), 
b) prevent contact of pregnant cattle with PI animals by removing PI animals from the herd, 
c) pay attention to the calving management (see below).  
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 Test strategy 
 In the Belgian control strategy, ear notch samples of new-born calves are tested with 
Ag-ELISA, which detect, depending on the kit, Erns or NS-3 antigen. Ag-ELISA kits that 
detect Erns antigen are preferred, since this antigen, in contrast with NS-3, remains detectable 
in ear notch samples even in the presence of colostral antibodies (Fux and Wolf, 2012). The 
sensitivity and specificity of the Ag-ELISA are reported to be 97.1% and 99.8%, respectively 
(Presi et al., 2011). The more expensive RT-qPCR could also be used, for which a sensitivity 
and specificity of 100% and 98%, respectively, are described (Presi et al., 2011). In the 
Belgian programme, the certification for the Ag-ELISA by the national reference laboratory 
was attributed to the BVDV Ag/Serum Plus Test (IDEXX) (CODA-CERVA, 2013), for 
which a specificity of more than 99.7% and a sensitivity of nearly 100% are reported (BVDV 
Ag/Serum Plus Test Brochure, IDEXX).   
Calves with a negative test result receive a non-PI status, which is mentioned on their 
official identification document. Hence, it is very unlikely that one will retest such animals 
once they have been declared BVDV free. 
From this point of view false negative test results should be avoided as much as 
possible and the test with the highest sensitivity is preferred, i.e. RT-qPCR. However, RT-
qPCR is 4 to 6 times as expensive as Ag-ELISA and even with RT-qPCR false negative test 
results due to for example an insufficient sample quality or human errors can never be 
excluded. Instead of the label “non-PI following analysis” for calves with a negative test 
result, the label “PI-unsuspected” could have been an appropriate alternative to point out that 
it is possible that some PI animals incorrectly have been assigned a free status. In the 
programme all stakeholders should therefore be aware that undetected PI animals will be 
freely moved between herds and be the origin of new introductions in BVDV free herds. In 
Switzerland, false negative PI animals have accounted for 57% of identified sources of new-
born virus-positive calves between October 2009 and December 2011 (Presi et al., 2011).  
Given a sensitivity of 97.1% with Ag-ELISA, approximately one million new-born 
calves per year in Belgium and a PI animal prevalence amongst young calves of 
approximately 2%, about 580 false negative PI animals are expected during the first year of 
the programme. These false negative PI animals may result in infections of veal herds (male 
calves for fattening), prolonged infections in the herd of origin and infections of herds 
purchasing these cattle (female animals for breeding and lactating purposes). The introduction 
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of a PI animal in a herd where the majority of the animals are susceptible to infection can 
result in an outbreak, as demonstrated in this doctoral thesis (Chapter 6). When only using ear 
notch sampling, the presence of such a false negative PI animal will only be detected in a herd 
about 5 to 6 months after its introduction at the earliest, given that a susceptible animal in 
early pregnancy is infected immediately after the introduction of the PI animal and gives birth 
to PI calf. Therefore, to early detect re-infection the implementation of serological monitoring 
and surveillance could be considered for BVDV free herds, as is argued below.    
When PI animals will have to be culled obligatorily, farmers will want to avoid culling 
TI animals and could therefore opt for a confirmatory test. In the initial phase (October - 
December 2008) of the Swiss eradication programme the whole bovine population (animals 
born before the 1
st
 October 2008) was tested. Of the 12,092 virus-positive animals, 7393 
(61.1%) had a confirmatory test. With 6229 animals confirmed positive, the confirmation rate 
was 84.3% (Presi et al., 2011). In a next phase all new-born calves (calves born between 1
st
 
October 2008 and 30
th
 September 2009) were tested. Of the 5199 virus-positive animals, 3291 
(63.3%) had a confirmatory test and 2,862 (87.0%) were confirmed positive (Presi et al., 
2011). This means that the probability to cull a TI animal varied between 13.0% and 15.7% 
when no confirmatory test is performed. From a farmer’s point of view and given the fact that 
Belgian Blue beef calves are valuable, it thus seems to be worthwhile to perform a 
confirmatory test. However, the same data also indicate that the probability to have a 
prolonged stay of a PI animal in the herd is between 84.3% and 87.0% when doing a 
confirmatory test. Given the young age of the calves, virus excretion of these potential PI 
calves is partially suppressed by colostral antibodies (Palfi et al., 1993). However, BVDV can 
still be spread and it has been shown that a PI animal can infect susceptible animals within 5 
days (Chapter 4.1). Therefore, whenever a confirmatory test is performed, the animal should 
be quarantined and stringent biosecurity measures should be implemented (see below). Since 
in Belgium only Ag-ELISA is used, a higher confirmation rate can be expected when 
performing a confirmation test, compared to Switzerland, where a combination of Ag-ELISA 
and RT-qPCR is used. As described above, the specificity of RT-qPCR is lower compared to 
Ag-ELISA and therefore more false positive results are expected with RT-qPCR. 
The ultimate goal would be to have one single test to distinguish between PI and TI 
animals. Studies suggest that this differentiation is possible with one single RT-qPCR 
(Bhudevi and Weinstock, 2001; Hanon et al., 2014) or Ag-ELISA (Hanon et al., 2014). The 
distinction is then based on the amount of viral RNA or antigen present in the sample. The 
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determination of an optimal cut-off value to detect all PI animals and to reduce the detection 
of TI animals as much as possible would be crucial in the design of such a test. Furthermore, 
the interpretation of a single quantitative result may be complicated by the variation in levels 
of viraemia such as intermittent viraemia in PI cattle (Laureyns et al., 2010). During the 
BVDV-2c outbreak in Germany some TI animals were believed to have obtained a viral and 
genomic load almost equivalent to that in PI animals, which suggests that these animals have 
substantially contributed to BVDV spread. As a consequence, such animals would be 
considered as PI when using one single test and would thus subsequently be eliminated. 
However, as these animals contribute to virus spread, the removal of these ‘supershedding’ TI 
animals could be considered as acceptable.  
 
 
Follow-up of the BVDV status: monitoring and surveillance 
 
Monitoring and surveillance are defined by the Food and Agriculture Organization 
(FAO) as “all activities aimed at detecting changes in the epidemiological parameters of a 
specified disease” and “all regular activities aimed at ascertaining the health status of a given 
population with the aim of early detection and control of animal diseases”, respectively. In 
the light of the control programme, monitoring and surveillance will especially be used for the 
early detection of newly infected herds and the confirmation of the BVDV status in free herds 
(Lindberg et al., 2006). How monitoring and surveillance will be implemented in the Belgian 
control programme is not yet completely determined and will depend on the phase of the 
programme. Considerations concerning the implementation of monitoring and surveillance 
are discussed. 
 
Detection of disease 
During the first phase the detection of disease is conducted by ear notch sampling. 
This virological testing strategy requires a meticulous administration (Laureyns et al., 2010), 
which is realised by linking the BVDV test result of the ear notch sample to the official 
individual identification document of the calf via the animal identification and registration 
system (SANITEL). This testing system has many advantages such as the fact that all new-
born animals are tested, that the test has a relatively high sensitivity and specificity (see 
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above) and that it is relatively easy to perform. Nonetheless, as every testing system, it is not 
impeccable. Some drawbacks of the ear notch sampling are that sometimes false negative test 
results occur (see above). It may also happen that PI foetuses are stillborn or aborted, and thus 
not tested, but still are able to spread BVDV at the moment of stillbirth or abortion (Lindberg 
and Alenius, 1999; Lindberg et al., 2004). Although it is compulsory to report and test each 
abortion, it was shown that this abortion protocol is only rarely used, as described above. 
Furthermore, PI animals  that do not deliver offspring are not detected and a dam-calf relation 
may be incorrectly registered (Laureyns, 2014). As a consequence, certifying a herd to be 
BVDV free only based on negative test results with ear notch sampling should not be done 
too early as some PI animals may slip through the net and remain present in the herd longer 
than anticipated. Determining the minimal years of delivering BVDV-negative test results 
following ear notch sampling before a herd can be certified BVDV free is therefore one of the 
remaining questions to be answered in the years to come.  
 
Towards freedom from disease 
The progress made during the first phase of the programme can be evaluated by 
follow-up of the prevalence of positive ear notch samples both at animal and herd level. In a 
later phase farms could opt to stop the individual ear notch sampling and switch to a 
certification of the BVDV status at herd level. This switch is crucial, since it involves that 
animals will no longer be tested individually and will receive a BVDV status based on the 
status of the herd. A false negative BVDV status at the herd level could therefore result in the 
trade of BVDV-positive animals and re-infection of free herds. The certification of the BVDV 
status at the herd level should therefore be compared from an epidemiological and economical 
point of view with a continued ear notch sampling of new-born calves. Currently, this option 
to switch the surveillance from the animal level to the herd level is planned 2 years after the 
start of the programme (Laureyns, 2014), but in our opinion, the epidemiological and 
economical optimal moment is likely to be herd-specific and depends on the following 
parameters: 
a) When can a herd be considered BVDV free based on ear notch sampling? 
b) What is the risk of re-infection of these BVDV free herds? 
c) How is the BVDV free status of a herd monitored?   
d) What is the economical trade-off between the different testing systems?  
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When can a herd be considered BVDV free ? 
 By testing new-born calves and also assigning a BVDV status to the dam, the 
proportion of animals with an unknown BVDV status will rapidly decrease. A herd could be 
assumed to be BVDV free based on ear notch sampling if there were no BVDV-positive test 
results following ear notch sampling during a number of years (to be determined) and all 
individual animals in the herd have a non-PI status (by analysis at birth or during an 
additional screening or by descent). However, as mentioned above, there is always a risk of 
some PI animals slipping through the net. To avoid the missing of PI animals, this assumed 
free status should preferably be verified by a serological screening (Houe et al., 2006; 
Lindberg et al., 2006).  
 
What is the risk of re-infection of these BVDV free herds? 
 Even when a herd has been certified BVDV free, it can always be re-infected. Given 
the current BVDV prevalence and limited implementation of biosecurity measures in Belgian 
cattle herds, an incidence risk of re-infection of 15.4% per year was estimated (Chapter 6). In 
the programme the probability of direct animal-animal contacts with PI animals is reduced by 
prohibiting the trade and grazing of cattle with a PI status. As a consequence the risk of re-
infection will decrease during the progress of the programme in line with the decrease of the 
number of new-born PI animals. Nonetheless, increased and continuous efforts to prevent re-
infection, especially of cattle in early pregnancy, should be undertaken (see below).  
 
How is the BVDV free status of herds monitored? 
When moving from individual ear-notch sampling of all new-born calves towards herd 
level certification, the BVDV detection method will typically be based on serology in young 
stock (Lindberg et al., 2006). Serological monitoring of young stock to detect the presence of 
PI animals in a herd is also referred to as the spot test and was first described by Houe (1992; 
1994). By testing young stock a recent or on-going infection will be detected, given the young 
age of the animals (Brülisauer et al., 2010). Furthermore, the interference with vaccination 
can more easily be avoided in young stock compared to older animals that are used for 
breeding (see below).  
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A first prerequisite for a reliable spot test is a sample of young stock representative for 
the entire herd. When cattle are housed close together in the same building or in buildings 
nearby, up to 90% of cattle in herds with PI animals are expected to be BVDV seropositive 
(Houe, 1999). The spot test has proven to be accurate in the distinction of herds with and 
without PI animals under such conditions (Houe, 1992). However, due to an increasing herd 
size and the compartmentalization of herds into separate buildings in Belgium, BVDV could 
spread more slowly with a lower proportion of seropositive animals as a result. A second 
prerequisite is a sample large enough to substantiate freedom from BVDV. This sample size 
depends on the herd size and the design prevalence, i.e. the minimum expected prevalence of 
the BVDV seropositive animals if a herd was infected (Cameron and Baldock, 1998). To 
substantiate freedom from disease, a low design prevalence should be presumed.  
To determine the sample size of young stock needed to substantiate freedom from 
BVDV, different scenarios were tested using FreeCalc version 2.0, as described by Cameron 
and Baldock (1998). The modified hypergeometric exact formula was used with type I and II 
error levels set at 5%. The null hypothesis is that BVDV is present in the herd, at or greater 
than the design seroprevalence. The alternative hypothesis is that the herd is free from BVDV, 
or that the seroprevalence is lower than the specified level (Cameron and Baldock, 1998). 
This calculation assumes random sampling of young stock, which are about one third of the 
herd size. The following parameters were required: 
- Test sensitivity and specificity: set to 95.7% and 97.7%, respectively, based on a 
commercial Ab-ELISA test kit; 
- Number of young stock: was set to vary between 20 and 100 (which represents a total 
herd size of 60 and 300, respectively);   
- Expected within-herd seroprevalence in case of re-infection (design prevalence): was 
set to vary between 10% and 70%. 
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Table 2. Sample size of young stock required to substantiate freedom from BVDV depending 
on the herd size and design seroprevalence. The test sensitivity and specificity were set to 
95.7% and 97.7%, respectively (FreeCalc; Cameron and Baldock; 1998). 
Design 
seroprevalence (%) 
Number of young stock (one third of the herd size) 
20 40
a
 50 70 100 
10 20
b 
36 46 51 55 
20 15 23 24 25 26 
30 11 13 13 13 14 
40 9 10 10 10 10 
50 7 8 8 8 8 
60 6 6 6 6 6 
70 5 5 5 5 5 
a
In November 2013 the average herd size of Belgian cattle farms was 120 animals (NIS, 
2013), which corresponds to a number of young stock of 40. 
b
Even when sampling all young stock, the null hypothesis cannot be rejected and freedom 
from BVDV cannot be substantiated (p = 0.07). 
Especially with a low design seroprevalence (10-20%), a large sample of young stock 
is required to substantiate freedom from BVDV with 95% confidence (Table 2). Once animals 
are no longer tested individually for BVDV viraemia, the early detection of re-infection 
should be able to prevent that an untested PI animal is traded, which implies that the spot test 
should detect re-infection of a herd before a PI animal is born. This means that the infection 
of cattle in gestation and possibly carrying a PI foetus should be detected, and not the PI 
animal itself. Since such a re-infection may involve only very few animals, a very low design 
prevalence should be presumed and by consequence a high sample size is needed. Moreover, 
it is not clear whether a re-infection of some cattle in gestation will be detected by the spot 
test in the young stock, given the minor importance of TI animals in BVDV spread (Chapter 
4). Furthermore, the frequency of substantiating freedom from disease by means of a spot test 
to prevent the birth of PI animals may be high. To detect in case of re-infection the presence 
of BVDV using the spot before a PI calf is born, a spot test should be performed every 4 
months. This is based on the fact that PI animals result from infection of the foetus between 
30 and 125 days of gestation (McClurkin et al., 1984; Blanchard et al., 2010) and that 
neutralizing antibodies become detectable about 2 weeks after infection (Chapter 4). When a 
spot test is performed every 6 months, a PI calf could be born before it is detected with the 
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spot test when the infection occurs between 100 and 125 days of gestation and the sampling 
between 100 and 140 days of gestation. 
To minimize the risk of trading PI animals, the spot test could be combined with the 
individual testing of cattle for trade. In this way the design seroprevalence could be raised to 
reduce the sample size without losing information about the BVDV status at herd level and 
risking the trade of PI cattle.  
Once the final aim, eradicating BVDV in Belgium, is obtained and freedom from 
BVDV is substantiated in every farm, the individual testing of animals for trade will become 
redundant and the BVDV free status can be verified by means of a serological surveillance.  
 
What is the economical trade-off between the different testing systems?  
Several factors will determine whether a switch to certification at herd level is 
economically favourable in a specific case. A first factor is the herd size, which determines 
the number of new-born calves to be tested (if ear notch sampling is used) and the number of 
young stock to be included in the spot test. In the case of ear notch sampling, the number of 
animals to be tested is increasing with the herd size whereas in the spot test the additional 
number of young stock to be included is proportionally decreasing with an increasing herd 
size as shown in Table 2. Therefore, the spot test will become increasingly beneficial as the 
herd size increases. Yet, the sample size of the spot test is also strongly influenced by the 
defined design seroprevalence. If this is set at a relatively low prevalence the sample size will 
always be relatively large, also in large herds. Furthermore, the frequency of substantiating 
freedom from disease by means of a spot test will influence the costs. Finally, when it appears 
that serology in itself is insufficient to minimize the risk of trading PI cattle, additional testing 
of animals for trade is necessary, which increases the number of animals to test for BVDV 
viraemia, but could decrease the sample size for the spot test. To be able to answer all these 
questions, it would be advisable to start a pilot study in some herds that have been shown to 
be BVDV free for some years already.  
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Reducing the risk of BVDV (re-)introduction: biosecurity 
 
Although the implementation of biosecurity measures in the daily management of 
cattle farms is considered the most essential pillar in systematic BVDV control (Lindberg and 
Houe, 2005), a very low biosecurity level was noticed in Belgian cattle farms (Chapter 5). In 
a study asking Belgian farmers about their perspectives towards biosecurity, they indicated 
that little to no barriers are present for taking preventive measures (Laanen et al., 2014). This 
suggests that the limited implementation of biosecurity and disease prevention measures is 
most likely due to insufficient motivation. The following reasons might explain this low 
motivation: 
- There is insufficient information on which measures should be taken; 
- There is insufficient information on the costs and benefits;  
- Biosecurity should be considered a collective responsibility rather than an individual 
responsibility. 
 
There is insufficient information on which measures should be taken. 
Biosecurity includes a very broad range of specific measures preventing pathogens 
from entering a herd and reducing the spread of pathogens within a herd (Villarroel et al., 
2007). Additionally, a preventive strategy is farm-specific and some measures may be of high 
value for some farmers, while the same measures might be less useful for others. As a 
consequence, it is difficult for farmers to choose the most appropriate strategy. 
Cattle farmers prefer to obtain information on biosecurity from their herd veterinarian 
(Brennan and Christley, 2013; Laanen et al., 2014). A farm-specific preventive strategy 
should therefore be developed in collaboration with the herd veterinarian who knows the 
specific herd structure and can inform the farmer on the critical points (Villarroel et al., 2007; 
Ellis-Iversen et al., 2010; Brennan and Christley, 2013). 
For pig and poultry herds, an online risk based biosecurity testing tool is made 
available (www.BioCheck.UGent.be; Laanen et al., 2010; Gelaude et al., 2014). By using this 
tool, farmers can verify their biosecurity level and find out at which level biosecurity can be 
improved in their herd. Secondly, farmers can compare their biosecurity level with other 
farms. A similar testing tool for cattle farms is not yet available, but could be very useful to 
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help cattle farmers to improve their biosecurity level. In this way, information is delivered 
from a neutral source and as a result cattle farmers might be more willing to accept this 
information (Heffernan et al., 2008) and might become more motivated to implement these 
measures. 
 
There is insufficient information on the costs and benefits.  
Belgian cattle farmers consider many biosecurity measures too expensive and are 
therefore not willing to implement them (Laanen et al., 2014). Nevertheless, financial 
contributions by other stakeholders in cattle production toward farmers are made to improve 
biosecurity. For instance, the regional centres for animal disease control offer farmers the 
opportunity to test purchased animals for endemic diseases such as neosporosis, 
paratuberculosis and BVD at reduced price. As mentioned above, basic analyses on aborted 
and stillborn foetuses are performed for free. Moreover, basic biosecurity measures such as 
the use of protective clothing, boots and disinfectant footbaths are already present in many 
cattle farms and can by consequence be implemented without additional material costs. 
Although the implementation of biosecurity also involves an investment in time, farmers 
nonetheless believe that biosecurity is more time efficient than treating disease on-farm 
(Brennan and Christley, 2013). 
The costs of an average BVDV outbreak in a dairy herd are estimated to lie between 
€21 ($25) and €135 ($160) per cow per year (Houe, 2003; Lindberg et al., 2006). Cost-benefit 
analyses for systematic BVDV control, which include the implementation of biosecurity, 
showed that it is economically favourable to control BVDV (Valle et al., 2005; Reichel et al., 
2008). However, these studies are usually performed at the national level and further research 
to obtain information on costs and benefits of investing in biosecurity in general (i.e. not 
focusing on BVDV alone) for different cattle production types is currently lacking and could 
be very useful in convincing farmers to implement biosecurity measures. Belgian farmers 
indicated “more information on the economic benefits of measures” as the primary interest for 
taking measures in disease prevention (Laanen et al., 2014). 
Although quantitative results of implementing biosecurity in disease prevention are 
currently lacking, expected consequences of applying biosecurity measures are improved 
production characteristics, better animal welfare, improved immune responses to vaccines and 
enhanced job satisfaction for farmers (Brennan and Christley, 2012). Moreover, it was shown 
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in pig production that a higher biosecurity status is linked with a reduction in antimicrobial 
usage (Laanen et al., 2013). 
 
Biosecurity should be considered a collective responsibility rather than an individual 
responsibility. 
When considering who should be responsible for the implementation of biosecurity, 
stakeholders in cattle production typically point at each other. In case of epidemic threats 
farmers consider biosecurity the government’s responsibility (Heffernan et al., 2008). 
Furthermore farmers indicate that the government should make a greater contribution towards 
biosecurity in Great Britain (Gunn et al., 2008). From a farmer’s point of view, endemic 
diseases are considered to be an individual problem for farmers with a ‘bad’ herd 
management (Heffernan et al., 2008). Hovi et al. (2005) showed that farmers are more prone 
to implement measures for disease control when also other farmers would join. Although 
farmers consider the herd veterinarian the preferred source of information regarding 
biosecurity (Gunn et al., 2008; Heffernan et al., 2008; Brennan and Christley, 2013; Laanen et 
al., 2014), the veterinarians’ advise appears to be a poor motivator to implement biosecurity 
(Laanen et al., 2014). Conversely, veterinarians considered the farmers’ ability or willingness 
to invest in biosecurity measures a major constraint (Gunn et al., 2008).  
These attitudes suggest that as long as biosecurity measures, or any action in general, 
are not mandatory, a low degree of participation can be expected (Laanen et al., 2014). 
However, mandatory biosecurity measures appear to be a poor motivator to implement 
biosecurity (Laanen et al., 2014). This can be illustrated with the discrepancy between the 
presence and the use of a disinfection footbath in Belgian dairy farms (Chapter 5). A 
disinfection footbath was present in 64% of the farms with dairy cattle, but was only used in 
7% of these farms. For dairy farms the use of a disinfection footbath is required in order to 
fulfil the specifications of a milk quality system. This suggests that farmers only acquired a 
disinfection footbath to avoid penalties. These results clearly show that the mandatory 
implementation of biosecurity alone will not be sufficient and will also involve a behavioural 
change.  
When a farmer invests time and money in eradicating BVDV and the neighbouring 
farm does not undertake any action, re-infection is very likely to occur in Belgium: 6 out of 
26 farms (23.1%) were re-infected within 18 months (Chapter 6). As a consequence, it is 
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indeed quite obvious that some farmers are less motivated to continue their efforts. 
Furthermore, all stakeholders should be willing to contribute to an improved biosecurity level. 
During the farm visits that were performed for the studies in this doctoral thesis some 
remarkable excerpts about the perception regarding biosecurity were noticed. For instance, on 
farms with both pigs and cattle, the herd veterinarian responsible for the pigs always had to 
wear farm-specific clothing and boots because “everyone is doing this”, while the herd 
veterinarian for cattle did not need to change clothes because “nobody is doing this”. Another 
example is that the herd veterinarian always had to wear farm-specific clothing and boots, 
while the AI technician was not required to do this because “he is a very busy man and does 
not have the time for it”. Again, it is quite obvious that farmers are less motivated when not 
everyone is implementing these measures. Conversely, as mentioned above, veterinarians 
considered the farmers’ ability or willingness to invest in biosecurity measures a major 
constraint (Gunn et al., 2008). 
With respect to systematic BVDV control voluntary or compulsory regulations should 
provide a general framework to improve the biosecurity levels in cattle farms in order to 
prevent BVDV (re-)infection. These recommendations should be formulated for all 
stakeholders who are contributing to animal health, hereby focusing on the herd veterinarians, 
as they are familiar with the specific herd structure and have the knowledge to implement 
biosecurity measures. It may however be difficult to impose and control the implementation 
of these preventive measures in a mandatory programme (Laureyns, 2014). Nonetheless, 
when focusing on the main routes of re-infection as encountered in this doctoral thesis and 
described in literature, it should be possible to improve the low implementation of biosecurity 
as currently observed in Belgian cattle farms. It is believed that the mandatory BVDV control 
programme can be a first move in the right direction toward collective behaviour regarding 
biosecurity in cattle farms. The following factors are considered to be of primary interest: 
- purchase of cattle,  
- contact on pastures, 
- calving management, 
- professional visitors entering the farm. 
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Purchase of cattle 
During the first 2 years of the Belgian BVDV control programme, adult cattle can still 
be freely moved. Furthermore, as mentioned above, PI animals incorrectly considered as 
BVDV free at birth can also be transported between herds. It has been noticed in this thesis 
that cattle originating from different herds often are transported together: only 16% of the 
trucks of cattle salesmen were empty upon arrival at the farm (Chapter 5). False negative PI 
animals could thus infect susceptible cattle during transport.  
The purchase of cattle has been shown to be a very important route of BVDV 
transmission and therefore, farmers should test and quarantine all purchased animals from the 
start of the programme. Testing of purchased animals should always be combined with 
quarantine for all cattle entering the herd, including animals that are re-introduced following 
exhibitions, competitions or auctions. The correct application of quarantine measures, i.e. no 
direct or indirect contact with other animals during at least 3 weeks, should be the basis, with 
testing as an additional measure. In this way, purchased cattle are also monitored for other 
disease agents than those tested for. Moreover, if newly introduced animals are only infected 
shortly before arrival at the herd (e.g. during transport) they might have a negative test result 
when entering the herd and therefore be false negative. If these TI animals are kept in 
quarantine for 3 weeks they are likely to be virus-negative at the end of the quarantine period 
according to the results of our transmission studies (Chapter 4).  
 
Contact on pastures 
 Fence-line contact on pastures with cattle of neighbouring farms is another important 
source of potential BVDV (re-)infection (Bitsch et al., 2000). A distance of at least 3 m 
between pasture fences is advised, but difficult to realize. A more suitable recommendation is 
to avoid that cattle in gestation graze where contact with cattle of neighbouring farms is 
possible. Additionally, when cattle in gestation are grazed, special attention should be paid at 
calving as described above.  
 
Calving management 
In addition to purchased and grazed cattle in gestation, all cattle should calve in a 
separate pen. This pen should only be used for this purpose and may never house diseased 
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animals (Villarroel et al., 2007). The dam and the calf should be separated from the rest of the 
herd until the BVDV test result of the calf is known. 
 
Professional visitors entering the farm 
As BVDV spread by persons involves indirect transmission, this route of infection was 
considered to be of minor importance (Lindberg and Alenius, 1999). However, this 
transmission route should not be ignored (Ståhl et al., 2005) and attention should be paid to 
indirect BVDV transmission as the programme proceeds (Hult and Lindberg, 2005). It is of 
interest to already implement these preventive measures from the start of the Belgian 
programme for the following reasons. First, biosecurity tools to prevent disease spread by 
visitors such as the use of protective clothing, boots and disinfectant footbaths are already 
present in the majority of the Belgian cattle farms (Chapter 5). Secondly, the implementation 
of such biosecurity measures will involve a behavioural change (Ellis-Iversen et al., 2010), 
which is needed to integrate more preventive measures in the daily management of Belgian 
farmers (Laanen et al., 2014). 
 
 
An additional biosecurity measure: vaccination 
 
Given the current poor implementation of the necessary elements for systematic 
BVDV control and the high risk of (re-)infection in Belgian cattle herds, the use of 
vaccination seems to be of interest. However, it is not unlikely that because of the frequent 
use of vaccination the previously listed essential measures are ignored, as described by 
Laureyns et al. (2013). Vaccination is often used as the single control measure and it is 
generally accepted that this approach does not result in a decrease of BVDV prevalence 
(O’Rourke, 2002). Moreover, due to incorrect use of vaccines cattle may not be fully 
protected (Meadows, 2010). Nonetheless, BVDV vaccination may be useful as an additional 
biosecurity measure in a systematic control scheme (Lindberg et al., 2006). How BVDV 
vaccination can contribute in BVDV control and subsequently how vaccination can be 
implemented for this purpose in the Belgian control programme should therefore be well 
communicated to all stakeholders. A more correct use of vaccines (e.g. when should animals 
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be vaccinated?) may result from additional information on the goals of vaccination (Lindberg 
et al., 2006; Ridpath, 2013): 
- limiting the spread of infection within a population by protection of foetal infections,  
- reducing the extent of clinical disease in infected animals. 
 
Limiting the spread of infection within a population by protection of foetal infections 
 The major importance of TI cattle in BVDV transmission is when these animals are 
infected during early pregnancy, with birth of PI animals as a result. In Belgium, currently 
two commercial BVDV vaccines are available, of which one claims to be able to prevent 
foetal infection when female cattle is immunised 4 weeks before pregnancy (BCFI, 2014). 
However, even when using artificial insemination, where the moment of conception is thus 
known, vaccination should be used with caution. First, in case of repeat breeding the optimal 
moment of immunization is lost. Secondly, the BVDV vaccines commercially available in 
Belgium contain at least five doses per bottle. When opened, the vaccine should be used 
within maximal 10 h. In case farmers cannot use an entire bottle when not having five animals 
that need to be inseminated, they often store the vaccine until another animal needs to be 
vaccinated. As a result, the efficacy of the vaccine cannot be guaranteed anymore. Instead of 
vaccinating animals individually, vaccination of the entire herd (or female breeding cattle) 
every 6 months is proposed as an alternative. However, even when using this strategy the 
primary vaccination should preferably be performed just before the first pregnancy to obtain 
maximal efficacy. Recently, the European Medicines Agency (EMA) has approved the 
marketing authorisation of a new BVDV modified live vaccine (MLV) that claims to be able 
to prevent foetal infection (EMA, 2014). The vaccine contains both a BVDV-1 and a BVDV-
2 strain and its launch is planned for spring 2015 (Boehringer-Ingelheim, 2014). This vaccine 
could eliminate the incomplete foetal protection against BVDV-2 strains in animals 
vaccinated with BVDV-1 due to the differences in antigenic cross reactivity between BVDV-
1 and BVDV-2 (Ridpath, 2013). 
These recommendations for good vaccination show that a meticulous record keeping 
of when and which animals should be vaccinated is necessary (Laureyns, 2014). When 
bearing these guidelines in mind, vaccination could be effective at the herd level through the 
prevention of intra uterine infection, notwithstanding the fact it may not be fully effective in 
every individual animal (Ridpath, 2013). Therefore, vaccination on its own is not a valuable 
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method for BVDV control. It rather is an additional measure of biosecurity (Laureyns et al., 
2013). Again, this stresses the necessity of the essential measures in BVDV control to counter 
possible vaccination failure. 
 
Reducing the extent of clinical disease in infected animals 
During the progress of a control programme the proportion of seronegative and thus 
susceptible animals increases. As described above, BVDV introduction in susceptible herds 
can result in an outbreak and birth of many PI animals (Chapter 6). When it concerns a 
virulent BVDV strain, BVDV introduction in a susceptible population can lead to high 
mortality rates. During the BVDV-2c outbreak in Germany infected cattle herds were 
restricted and cattle received emergency vaccinations with a commercial  BVDV-1 MLV  
(Doll and Holsteg, 2013). However, the effectiveness of these emergency vaccinations was 
variable, since in some cases the disease appears to have subsided, while in others the losses 
continued unchanged. Following an experimental study using a BVDV field strain isolated 
during the outbreak in Germany an emergency vaccination scenario was simulated by 
vaccinating animals at day 5 post-infection with a single dose of a BVDV MLV. This post-
inoculation did not influence the clinical manifestations: all animals died acutely or had to be 
euthanized (Jenckel et al., 2014). 
 When using BVDV vaccination to reduce the extent of clinical manifestations, cattle 
of all ages are likely to be vaccinated. As a result, vaccination interferes with serological tests 
and thus with monitoring and surveillance, since no DIVA vaccines are available. Therefore, 
vaccination was not allowed in the Scandinavian control programmes (Houe et al., 2006).  
 
Vaccination in the Belgian programme 
A vaccination ban is not advised in the early phase of the Belgian programme. 
Therefore strategies to combine vaccination and monitoring should be used to avoid false 
positive spot tests due to the detection of vaccination antibodies. Given the fact that vaccines 
to prevent bovine respiratory disease in young calves without a BVDV component are 
available and that the main goal of vaccination should be the prevention of foetal infections in 
breeding cattle, the use of unvaccinated sentinel young stock for serological monitoring is 
appropriate. These animals could be kept unvaccinated until the age of first pregnancy.  
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Whether or when a vaccination ban could be imposed in Belgium will become clear 
during the programme. When considering the currently high risk and the tremendous effects 
of a BVDV re-introduction in a fully susceptible population, a vaccination ban is not advised 
at the moment. On the other hand, to optimise the use of monitoring and surveillance, it would 
be of interest to monitor all age groups in a herd. As a consequence, serological analysis of 
older animals (bulk tank milk for dairy herds, blood sampling for beef herds) is also needed. 
Therefore, further research to develop BVDV marker (DIVA) vaccines is necessary. 
Furthermore, one should always bear in mind the risks associated with the use of vaccination. 
For instance, a strong association between the use of a specific BVDV vaccine and bovine 
neonatal pancytopenia was demonstrated (Sauter-Louis et al., 2012). Contamination of a 
bovine herpesvirus marker vaccine with BVDV resulted in an outbreak on Dutch dairy farms 
(Barkema et al., 2001). 
A final overview of the recommendations made in this doctoral thesis to obtain a 
systematic approach in the BVDV control programme in Belgium is given below (Fig. 2). 
  
 
Fig. 2. This figure provides an overview of the Belgian BVDV control programme as it is actually designed and the recommendations to obtain a 
systematic approach in BVDV control based on the results of this doctoral thesis. 
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Conclusions  
 
In the light of the mandatory Belgian BVDV control programme and bearing in mind 
the general model for systematic BVDV control, the following conclusions can be formulated: 
Considering biosecurity, all stakeholders contributing to animal production should be 
informed on the need of the implementation of biosecurity measures in the daily management. 
Basic biosecurity measures focusing on the gaps of the control programme as it is currently 
designed should be introduced. Testing and quarantining of all purchased and re-introduced 
cattle, with special attention to the Trojan cow, awareness of the risk of pasture contacts, 
attention to the calving management and farm-specific clothing and boots for professional 
visitors are basic but essential measures that need to be implemented. 
Considering the removal of virus sources, the mandatory testing of all new-born 
calves is a step forward. Nevertheless, cattle diagnosed as PI should be removed immediately 
after detection. Furthermore, other routes of PI introduction, such as purchase of cattle and 
contact on pastures should not be ignored.  
Considering monitoring and surveillance, recommendations regarding this essential 
measure should be formulated as soon as possible, as evaluation of the progress made in 
control or eradication programmes can stimulate stakeholders to continue and to fully 
collaborate. A pilot study in some herds that have been shown to be BVDV free for some 
years already could be performed to examine which strategy is favourable in a later phase of 
the programme.   
  Considering vaccination, all stakeholders should be informed both on the power and 
incapacities of vaccination. With good biosecurity, removal of PI animals and monitoring, 
vaccination as an additional biosecurity measure, can be helpful to reduce BVDV prevalence 
in the early phase of the programme. The further need of vaccination during the programme 
has to be evaluated regularly and may depend on the development of a DIVA vaccine.  
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The first reports on BVDV date back to 1946. An apparently new transmissible 
disease in cattle with varying clinical signs was described and is nowadays worldwide spread. 
Up to date many studies have been published and are still being performed to understand the 
complex pathogenesis and epidemiology of the virus, but the considerable economic impact 
on cattle production is already generally recognized. Convinced by the economic importance 
of BVDV, several European countries launched an eradication or control campaign. This 
doctoral thesis aimed at gaining insight into the current BVDV approach in Belgian cattle 
herds. 
As a general introduction (Chapter 1), an overview of BVDV, being relevant for this 
thesis is given. BVDV consists of a group of many genetic variants and causes a broad range 
of clinical signs, which vary from subclinical infections to severe outbreaks with high 
mortality. From this, the impact of BVDV on cattle production logically follows. The 
epidemiology of BVDV is highlighted. First, the transmission of BVDV, through PI and TI 
animals or indirectly, is described. Furthermore, risk factors for the occurrence of BVDV 
infections are introduced. The diagnosis of BVDV based upon clinical signs is not obvious 
and should therefore be supported by laboratory tests. Finally, the elements for systematic 
BVDV control are introduced: biosecurity, elimination of virus sources, monitoring and 
finally vaccination as an optional measure.  
In Belgium recommendations for systematic control were proposed by the regional 
centres for animal health control to be implemented on a voluntary basis at the herd level. 
Few recent data on the effect of this approach on the BVDV situation were available. 
However, such information can be very useful for the Belgian mandatory BVDV control 
programme that has been launched in January 2015. Therefore, the overall objectives of this 
doctoral thesis were to estimate the BVDV prevalence, to gain insight into the current 
implementation of essential measures in BVDV control and to evaluate the risk of (re-
)infection in Belgian cattle herds (Chapter 2). The results are used to provide 
recommendations for further improvement of the Belgian mandatory control programme. 
In Belgium only limited and outdated data on the prevalence of BVDV were available. 
Therefore, the first objective was to estimate both the virological and the serological BVDV 
prevalence in Belgium using a large representative sample. Additionally, potential risk factors 
for herds to be BVDV seropositive were studied (Chapter 3). For this, young stock aged 
between 6 and 12 months from randomly selected Belgian cattle herds were tested for BVDV-
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specific antibodies and antigen. Furthermore a questionnaire including different herd 
management topics and questions about participation in animal health programmes, including 
BVDV, was sent to Belgian cattle farmers. The true prevalence of BVDV-specific antibodies 
and antigen at the herd level was respectively 47.4% and 4.4%, while at the animal level this 
was respectively 32.9% and 0.3%. In 44.4% of the herds where BVDV-specific antibodies 
were detected at least 60% of the sampled young stock was BVDV seropositive, which 
suggested the presence of PI animals. Interestingly, 83.4% of these farmers stated not to have 
suffered from problems related to BVDV. Moreover, only 8.4% of all farmers who completed 
the questionnaire reported problems possibly related to BVDV the past 3 years. This 
demonstrated that farmers are often unaware of the presence of BVDV in their herd. Risk 
factors for a herd to be BVDV seropositive were identified by means of a multivariable 
logistic regression model. Large herds were significantly more likely to be BVDV 
seropositive (OR = 1.004, p < 0.01). The interaction between “Antigen positive animal 
detected in this study” and “BVDV vaccination in 2009” was significant (p < 0.01). In non-
vaccinating herds, the detection of antigen positive animals was significantly associated with 
BVDV seropositive herds (OR = 13.8, p < 0.01). In herds with no antigen positive animals 
detected, vaccination resulted in a significant risk factor to be BVDV seropositive compared 
to non-vaccinating herds (OR = 3.4, p < 0.01). Herds reporting BVDV-related problems the 
past 3 years were more likely to be BVDV seropositive (OR = 1.9, p < 0.05). This relation 
became non-significant (OR = 1.8, p = 0.08) when only a subset of herds with no vaccination 
of animals < 12 months was taken into account. The main conclusion was that there is an 
active circulation of BVDV in a considerable number of Belgian cattle herds. 
Next, the importance of TI cattle in the epidemiology of BVDV was assessed 
(Chapters 4.1 and 4.2). In general TI animals are considered to be of minor importance, but a 
recent BVDV-2c outbreak in Germany and the Netherlands has challenged this assumption.  
In a first transmission study (Chapter 4.1), two experimental infections were 
performed to determine basic reproduction ratios (R0). In each experiment three calves were 
infected via intranasal inoculation and housed together with seven susceptible animals. Two 
strains isolated in Belgium were used, a virulent BVDV-1b and a virulent BVDV-2a field 
isolate, resulting in an R0 of 0.25 (95% CI 0.01; 1.95) and 0.24 (95% CI 0.01; 2.11), 
respectively. A PI animal was then introduced to the remaining uninfected animals and 
produced an R of +∞ (95% CI 1.88; +∞). The results supported the suggestion that TI 
animals, compared to PI animals, contribute only a limited amount to BVDV spread. 
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Additionally, the severe clinical symptoms observed in the field with these isolates could not 
be reproduced during these experiments suggesting that other factors besides strain virulence 
influence the clinical manifestations evoked by BVDV. 
 In a second transmission study (Chapter 4.2), an experimental infection was 
performed using a hypervirulent BVDV-2c field strain isolated during a severe BVDV 
outbreak in Germany to determine R0 and to describe the clinical signs caused by such an 
infection. Three calves were intranasally infected and housed together with seven susceptible 
animals. The clinical signs of the BVDV infected animals varied from very mild disease 
(fever, loss of appetite) to severe watery and haemorrhagic diarrhoea and death. The clinical 
signs and the level of BVDV excretion depended on the degree of viraemia. R0 was estimated 
to be 0.49 (95% CI 0.06; 2.99) suggesting a limited viral spread using the BVDV-2c strain. It 
was concluded that also this BVDV-2 infection in TI animals resulted in limited transmission 
towards other animals. 
In modern veterinary medicine, disease prevention at the herd level has become 
increasingly important in replacing individual animal medicine. This shift involves the 
implementation of biosecurity. At present, no studies have considered the implementation of 
biosecurity measures in the daily management of Belgian cattle farms. Therefore another aim 
of the thesis was to map the current application of biosecurity measures in Belgian cattle 
farms in the prevention of disease transmission within and between farms (Chapter 5). The 
data were collected as part of a larger cross-sectional study (Chapter 6), conducted to identify 
risk factors for re-infection with BVDV in cattle herds assumed free from BVDV. 
Questionnaire data from 33 dairy farms, 16 beef farms and 25 mixed (dairy and beef cattle) 
farms were analysed using a combination of a linear scoring system, a categorical principal 
component analysis and a two-step cluster analysis to differentiate these farms based on their 
biosecurity level and visit frequencies. Further enhancement of preventive measures 
considering external and internal biosecurity was still possible for each farm, as none of the 
farms obtained an overall high biosecurity level. Three groups of cattle farms were 
differentiated with a biosecurity level varying from low to high-medium, of which the group 
with the lowest biosecurity level mainly consisted of mixed farms. Animal-to-animal contacts 
with cattle from other herds were frequently possible as only 12% of the farmers purchasing 
cattle quarantined purchased animals at least 3 weeks and contacts over fences on pasture 
were possible in 70% of the herds. Basic biosecurity measures such as farm-specific 
protective clothing and boots were present in the majority of the farms, but they were 
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insufficiently or incorrectly used. Cattle farms were very often visited by professional visitors 
of which the herd veterinarian, the AI technician and the cattle salesman most frequently 
entered the farm. The main conclusion was that since few biosecurity measures were 
undertaken by Belgian cattle farmers, they expose their herd to the risk of disease 
transmission within and between farms.  
In a final study (Chapter 6), a cross-sectional and a longitudinal study were conducted 
to better understand the drivers for re-infection with BVDV and to evaluate the risk of re-
infection in Belgian cattle herds, given the current high BVDV prevalence and poor 
implementation of biosecurity measures. In the cross-sectional study young stock were 
sampled for BVDV antibodies and a face-to-face interview with the farmer was conducted on 
61 farms. Potential risk factors for a herd being re-infected were identified by a multivariable 
logistic regression model. In 11 of the 61 herds (18%) at least 20% of the young stock tested 
BVDV seropositive. Farms monitoring the BVDV status were less likely to be BVDV re-
infected (OR 0.09; 95% CI 0.02; 0.55). There was also a decrease in risk when the 
neighbouring cattle farm was located further away (OR per km 0.06; 95% CI 0.00; 0.96). Re-
infection was more likely when farmers participated to auctions and/or competitions (OR 
140.27; 95% CI 3.00; 6559.65). In the longitudinal study the BVDV status of 26 non-BVDV-
vaccinating farms was monitored for 18 months. An incidence risk of re-infection of 15.4% 
per year was estimated. On 4 of 6 re-infected farms at least one PI animal was detected. The 
purchase of cattle was identified as cause of re-infection on one farm. These results 
demonstrated a high risk of BVDV re-infection in Belgian cattle herds. The main conclusion 
was that the risk of BVDV re-infection is likely to remain high, given the high BVDV 
prevalence and the violations of essential measures in BVDV control such as monitoring and 
biosecurity. 
In the general discussion (Chapter 7), first, the factors contributing to the high BVDV 
prevalence in Belgian cattle herds as described in Chapter 3 are discussed. A high cattle 
density together with an increasing herd size, the frequent contact with cattle through national 
and international trade, the fact that farmers often are unaware of the presence of BVDV and 
especially the absence of a systematic approach for BVDV control were considered to be 
important influencing parameters. Therefore, a mandatory national control programme has 
been launched in January 2015 with the final aim of eradicating BVDV. Secondly, the current 
design of this Belgian control programme is introduced. In an early phase the programme 
focuses on the detection of PI animals by the mandatory testing of new-born calves. The 
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preferred way of sampling is via ear notch samples, which are obtained when the farmer 
places the official ear tag. Following the test result of the new-born calf, a BVDV status will 
also be assigned to the mother of the calf. Depending on the status of the animal specific 
movement restrictions are imposed. PI animals are not allowed to be grazed or transported, 
except for slaughter. In addition to this legal basis, non-compulsory guidelines regarding the 
removal of PI animals and the prevention of re-infection are provided by the regional centres 
for animal disease control. In the final paragraph of the general discussion, each of the 
measures for systematic BVDV control (removal of virus sources, biosecurity and 
monitoring) are discussed in the light of the Belgian mandatory control programme. 
Regarding the removal of virus sources, the focus should be on the detection and elimination 
of PI animals, while the major importance of TI animals in BVDV spread is their ability to 
deliver a PI animal when they are infected in early pregnancy. The mandatory testing of all 
new-born calves is a step forward. Nevertheless, cattle diagnosed as PI should be removed 
immediately after detection to avoid infection of susceptible cattle in early pregnancy. 
Regarding the prevention of infection of cattle in early pregnancy, the risk of infection, which 
is high at the moment, will decrease during the progress of the programme in line with the 
decrease of the number of new-born PI animals. Nonetheless, increased and continuous 
efforts to prevent re-infection should be undertaken. Specific recommendations to prevent 
infection of cattle in early pregnancy are quarantining of purchased cattle, avoiding contact on 
pastures, separating a new-born calf and its dam until the test result is known and finally 
providing herd-specific clothing for professional visitors entering the farm. Given the high 
BVDV prevalence and high risk of infection at the start of the programme, vaccination as an 
additional biosecurity measure to prevent foetal infections may be advised. In a next phase a 
BVDV free status will be assigned to herds of which all individual cattle tested BVDV 
negative. Specific directives about how this phase will be implemented are not yet determined 
and will depend on the progress of the first phase of the programme. Regarding the transition 
to this next phase, it would be advisable to start a pilot study in some herds that have been 
shown to be BVDV free for some years already to examine whether a continued ear notch 
sampling is economically favourable compared to the individual testing of animals for trade in 
combination with a serological screening of young stock.  
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 De eerste publicaties over BVDV dateren van 1946. Toen werd een schijnbaar nieuwe 
overdraagbare runderziekte met variabele klinische symptomen beschreven. BVDV is heden 
ten dage wereldwijd verspreid. Tot op vandaag zijn reeds talloze studies gepubliceerd en 
worden nog steeds uitgevoerd om de complexe pathogenese en epidemiologie van het virus 
beter te begrijpen. De aanzienlijke economische impact van BVD is echter algemeen erkend. 
Gezien het economische belang van BVDV zijn in verschillende Europese landen nationale 
bestrijdingsprogramma’s van kracht. Dit doctoraatsonderzoek is gewijd aan het in kaart 
brengen van de huidige BVDV situatie in Belgische rundveebedrijven. 
 In de algemene inleiding (Hoofdstuk 1) worden de aspecten van BVDV die van 
belang zijn voor deze thesis aangekaart. BVDV omvat een groep van vele genetische 
varianten en veroorzaakt een brede waaier aan klinische symptomen, gaande van subklinische 
infecties tot ernstige uitbraken met hoge mortaliteit. Hierdoor wordt het economische belang 
van BVDV duidelijk. De epidemiologie van BVDV wordt grondig besproken. Eerst worden 
de verschillende verspreidingsmechanismen, via PI en TI dieren of indirect, beschreven. 
Verder worden risicofactoren voor infecties met BVDV aangekaart. Het stellen van de 
diagnose BVDV op basis van enkel de klinische symptomen is niet eenvoudig en daarom zijn 
laboratoriumtesten nodig. Tot slot worden de verschillende maatregelen voor een 
systematische BVDV controle ingeleid: bioveiligheid, verwijderen van de virusbronnen, 
monitoring en tot slot vaccinatie als optioneel onderdeel. 
 In België werden aanbevelingen voor een systematische BVDV controle gegeven door 
de regionale dierengezondheidscentra. Deze aanbevelingen konden op vrijwillige basis 
toegepast worden op bedrijfsniveau. Weinig recente gegevens over het effect van deze aanpak 
op de BVDV situatie zijn voorhanden. Nochtans zijn dergelijke gegevens zeer nuttig voor het 
Belgische verplichte nationale BVDV bestrijdingsprogramma dat vanaf januari 2015 van start 
is gegaan. Daarom waren de doelstellingen van dit doctoraatsonderzoek om de BVDV 
prevalentie te schatten, inzicht te krijgen in de huidige toepassing van de essentiële 
onderdelen voor een systematische BVDV controle en om het risico op (her)besmetting met 
BVDV in Belgische rundveebedrijven in te schatten (Hoofdstuk 2). De bekomen resultaten 
worden gebruikt om aanbevelingen te doen voor het Belgische bestrijdingsprogramma. 
 In België zijn slechts beperkte en gedateerde gegevens over de prevalentie 
beschikbaar. Daarom was de eerste doelstelling om zowel de virologische als serologische 
prevalentie van BVDV in België te schatten, hierbij gebruikmakend van een grote 
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representatieve steekproef. Bijkomend werden risicofactoren voor het BVDV seropositief zijn 
van rundveebedrijven bestudeerd (Hoofdstuk 3). Hiervoor werd jongvee tussen 6 en 12 
maanden oud van willekeurig geselecteerde Belgische rundveebedrijven getest voor de 
aanwezigheid van BVDV antistoffen en antigen. Verder werd een enquête over verscheidene 
onderdelen van het bedrijfsmanagement en over deelname aan dierengezondheids-
programma’s, waaronder BVDV, verstuurd naar Belgische rundveehouders. De ware 
prevalentie van respectievelijk BVDV antistoffen en antigen op bedrijfsniveau was 47.4% en 
4.4%. Op dierniveau was dit respectievelijk 32.9% en 0.3%. Bij 44.4% van de bedrijven waar 
BVDV antistoffen werden gedetecteerd, was minstens 60% van het onderzochte jongvee 
seropositief. Dit deed de aanwezigheid van PI dieren vermoeden. Opmerkelijk was dat 83.4% 
van deze rundveehouders verklaarde geen BVDV-gerelateerde problemen te hebben gehad. 
Verder meldde slechts 8.4% van de rundveehouders die de enquête invulden, mogelijk 
BVDV-gerelateerde problemen te hebben gehad gedurende de afgelopen 3 jaar. Dit toonde 
aan dat rundveehouders zich vaak niet bewust zijn van de aanwezigheid van BVDV op hun 
bedrijf. Risicofactoren voor het BVDV seropositief zijn op bedrijfsniveau werden nagegaan 
aan de hand van een multivariabel logistisch regressiemodel. Grotere bedrijven hadden meer 
kans om seropositief te zijn (OR = 1.004, p < 0.01). De interactie tussen de variabelen 
“Antigen positief dier gedetecteerd tijdens deze studie” en “BVDV vaccinatie in 2009” was 
significant (p < 0.01). Op niet-vaccinerende bedrijven was het detecteren van antigen 
positieve dieren significant geassocieerd met het seropositief zijn op bedrijfsniveau (OR = 
13.8, p < 0.01). Op bedrijven zonder detectie van antigen positieve dieren was vaccinatie een 
risicofactor voor het seropositief zijn in vergelijking met niet-vaccinerende bedrijven (OR = 
3.4, p < 0.01). Bedrijven die BVDV-gerelateerde problemen gedurende de laatste 3 jaar 
rapporteerden, hadden meer kans om seropositief te zijn (OR = 1.9, p < 0.05). Dit verband 
was niet significant wanneer enkel de bedrijven die geen dieren jonger dan 12 maanden 
vaccineerden, werden beschouwd (OR = 1.8, p = 0.08).  De voornaamste conclusie was dat er 
een actieve circulatie van BVDV is op een aanzienlijk deel van de Belgische 
rundveebedrijven.   
 Vervolgens werd het belang van TI dieren in de epidemiologie van BVDV nagegaan 
(Hoofdstukken 4.1 en 4.2). TI dieren worden algemeen van weinig belang beschouwd, maar 
een recente BVDV-2c uitbraak in Duitsland en Nederland heeft deze assumptie in vraag 
gesteld. 
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 Tijdens een eerste transmissiestudie (Hoofdstuk 4.1) werden twee experimentele 
infecties uitgevoerd om de basis reproductie ratio (R0) na te gaan. Tijdens elke infectie 
werden drie kalveren intranasaal geïnoculeerd en samen gehuisvest met zeven gevoelige 
dieren. Twee stammen die werden geïsoleerd in België werden hiervoor gebruikt, een 
virulente BVDV-1b en een virulente BVDV-2a veldstam. Dit resulteerde in een R0 van 
respectievelijk 0.25 (95% CI 0.01; 1.95) en 0.24 (95% CI 0.01; 2.11). Een PI dier werd 
vervolgens bij deze kalveren geplaatst en dit resulteerde in een R van +∞ (95% CI 1.88; +∞). 
Deze resultaten onderbouwen de veronderstelling dat TI dieren, in vergelijking met PI dieren, 
slechts in beperkte mate bijdragen tot het verspreiden van BVDV. Bijkomend konden de 
ernstige klinische symptomen die met deze stammen in het veld werden vastgesteld niet 
worden gereproduceerd, wat erop wijst dat andere factoren, naast de virulentie van stammen, 
een invloed hebben op de klinische symptomen die gepaard gaan met BVDV infecties. 
 Tijdens een tweede transmissiestudie (Hoofdstuk 4.2) werd een experimentele infectie 
uitgevoerd met een hypervirulente BVDV-2c veldstam die werd geïsoleerd tijdens een 
ernstige BVDV uitbraak in Duitsland. De doelstellingen waren om R0 te bepalen en de 
klinische symptomen die gepaard gaan met een dergelijke infectie te beschrijven. Drie 
kalveren werden intranasaal geïnfecteerd en samen gehuisvest met zeven gevoelige kalveren. 
De klinische symptomen gepaard gaande met de infectie waren variabel, gaande van mild 
(koorts en verminderde eetlust) tot ernstige waterige en bloederige diarree en sterfte. De 
klinische symptomen en de graad van BVDV uitscheiding waren afhankelijk van de graad van 
viremie. R0 werd geschat op 0.49 (95% CI 0.06; 2.99), wat wijst op een beperkte 
virusverspreiding met de BVDV-2c stam. Het besluit was dat ook met deze BVDV-2c infectie 
TI dieren slechts beperkt het virus verspreiden naar andere dieren. 
 In de huidige diergeneeskunde neemt het belang van ziektepreventie op bedrijfsniveau 
ter vervanging van individuele geneeskunde op dierniveau toe. Bioveiligheid maakt onderdeel 
uit van deze ziektepreventie. Tot op heden zijn er geen studies uitgevoerd die de toepassing 
van bioveiligheidsmaatregelen in de dagelijkse bedrijfsvoering van Belgische 
rundveebedrijven nagaan. Een volgende doelstelling van deze thesis was dan ook om de 
huidige toepassing van bioveiligheidsmaatregelen op Belgische rundveebedrijven ter 
preventie van ziekteverspreiding tussen en op bedrijven in kaart te brengen (Hoofdstuk 5). 
Gegevens werden verzameld als onderdeel van een dwarsdoorsnede onderzoek (Hoofdstuk 6), 
dat werd uitgevoerd om risicofactoren voor de herinfectie met BVDV op verondersteld 
BVDV-vrije rundveebedrijven te identificeren. Gegevens van 33 melkvee-, 16 vleesvee- en 
  Samenvatting 
236 
 
25 gemengde (melkvee en vleesvee) bedrijven werden verzameld en geanalyseerd met behulp 
van een lineair scoresysteem, een categorische hoofdcomponentenanalyse en een 
clusteranalyse om deze bedrijven te kunnen onderscheiden op basis van hun 
bioveiligheidsniveau en bezoekfrequenties. Verbetering van preventieve maatregelen 
aangaande externe en interne bioveiligheid was mogelijk voor elk bedrijf, aangezien geen 
enkel bedrijf een hoog bioveiligheidsniveau behaalde. Drie groepen rundveebedrijven werden 
onderscheiden met een bioveiligheidsniveau gaande van laag tot gemiddeld-hoog, waarvan de 
groep met het laagste niveau vooral uit gemengde bedrijven bestond. Dier-diercontacten met 
runderen van andere bedrijven waren zeer plausibel aangezien slechts 12% van de 
rundveehouders die runderen aankochten de aangekochte dieren minstens 3 weken in 
quarantaine plaatsten en weidecontact mogelijk was in 70% van de bedrijven. Elementaire 
bioveiligheidsmaatregelen zoals bedrijfskledij en laarzen waren aanwezig in de meerderheid 
van de bedrijven, maar ze werden onvoldoende of verkeerd gebruikt. De rundveebedrijven 
werden zeer vaak bezocht door professionele bezoekers, waarvan de bedrijfsdierenarts, de 
inseminator en veehandelaar het vaakst het bedrijf betraden. De belangrijkste conclusie was 
dat slechts weinig bioveiligheidsmaatregelen in acht worden genomen door Belgische 
rundveehouders. Op deze manier stellen ze hun dieren bloot aan het risico op 
ziektetransmissie binnenin en tussen bedrijven. 
 In een laatste onderzoek (Hoofdstuk 6) werden een dwarsdoorsnede en een 
longitudinale studie uitgevoerd om de factoren die herinfectie met BVDV in de hand werken 
en het risico op herinfectie in Belgische rundveebedrijven na te gaan onder de huidige hoge 
BVDV prevalentie en beperkte toepassing van bioveiligheidsmaatregelen. Tijdens het 
dwarsdoorsnede onderzoek werd jongvee bemonsterd voor serologie en werd een enquête 
afgenomen met de veehouder op 61 bedrijven. Mogelijke risicofactoren voor herinfectie met 
BVDV werden onderzocht met behulp van een multivariabel logistisch regressiemodel. In 11 
van 61 bedrijven (18%) testte minstens 20% van het onderzochte jongvee seropositief. 
Bedrijven die de BVDV status monitoren, hadden minder kans op herinfectie (OR 0.09; 95% 
CI 0.02; 0.55). Het risico op herinfectie daalde ook wanneer de afstand tot het dichtstbijzijnde 
rundveebedrijf verhoogde (OR per km 0.06; 95% CI 0.00; 0.96). De kans op herinfectie was 
groter wanneer rundveehouders deelnamen aan prijskampen en/of veilingen (OR 140.27; 95% 
CI 3.00; 6559.65). Tijdens de longitudinale studie werd de BVDV status van 26 niet-
vaccinerende bedrijven opgevolgd gedurende 18 maanden. Een cumulatieve incidentie van 
herinfectie van 15.4% per jaar werd geschat. Op 4 van de 6 opnieuw geïnfecteerde bedrijven  
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werd de geboorte van minstens één PI dier vastgesteld. De aankoop van rundvee werd 
geïdentificeerd als oorzaak van herinfectie op één bedrijf. Deze resultaten toonden een groot 
risico op herinfectie met BVDV op Belgische rundveebedrijven aan. De voornaamste 
conclusie was dat dit risico op herinfectie waarschijnlijk hoog blijft zolang de BVDV 
prevalentie hoog blijft en er fouten worden gemaakt tegen de essentiële onderdelen van de 
BVDV controle, zoals bioveiligheid en monitoring.  
 In de algemene discussie (Hoofdstuk 7) worden eerst de factoren die bijdragen tot een 
hoge BVDV prevalentie op Belgische rundveebedrijven besproken. Een hoge 
rundveedensiteit in combinatie met een toenemende bedrijfsgrootte, frequente contacten met 
rundvee tijdens nationale en internationale handel, het feit dat rundveehouders zich vaak niet 
bewust zijn van de aanwezigheid van BVDV op hun bedrijf en vooral het ontbreken van een 
systematische aanpak van BVDV worden als belangrijke factoren beschouwd. Daarom is in 
januari 2015 een nationaal verplicht bestrijdingsprogramma van kracht gegaan dat als ultieme 
doelstelling het verwijderen van BVDV in België heeft. In een tweede paragraaf wordt dan 
ook het Belgische bestrijdingsprogramma besproken. In een eerste fase focust dit programma 
zich op het detecteren van PI dieren door het verplicht testen van pasgeboren kalveren. Het 
gebruik van oorweefselstalen, die worden bekomen bij het plaatsen van het oormerk, is 
hiervoor de aangewezen methode. Op basis van het testresultaat van het kalf wordt eveneens 
een BVDV status toegekend aan het moederdier. Afhankelijk van het resultaat wordt de 
beweging van dieren beperkt. PI dieren mogen niet op de weide en mogen het bedrijf niet 
verlaten, tenzij voor de slacht. Als aanvulling op deze wettelijk vastgelegde maatregelen 
worden eveneens richtlijnen aangaande het verwijderen van PI dieren en het voorkomen van 
herinfectie verstrekt door de regionale diergezondheidscentra. In de laatste paragraaf van de 
algemene discussie worden de onderdelen voor een systematische aanpak van BVDV 
(verwijderen van virusbronnen, bioveiligheid en monitoring) besproken in het kader van het 
Belgisch verplicht nationaal bestrijdingsprogramma. Aangaande het verwijderen van 
virusbronnen dient de focus gericht te zijn op het opsporen en opruimen van PI dieren, terwijl 
het belang van TI dieren vooral het voortbrengen van PI dieren betreft, wanneer TI dieren 
worden geïnfecteerd in een vroeg stadium van de dracht. Het verplicht testen van alle 
nieuwgeboren kalveren is een grote stap vooruit. Nochtans zouden runderen die als PI worden 
geïdentificeerd onmiddellijk dienen te worden opgeruimd. Wat het voorkomen van herinfectie 
betreft, zal het risico op herinfectie, dat momenteel hoog is, afnemen naar mate het 
programma vordert en dit in lijn met een daling van het aantal nieuwgeboren PI dieren. 
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Nochtans zou een verhoogde en continue toepassing van bioveiligheidsmaatregelen de norm 
moeten zijn. Specifieke aanbevelingen betreffende bioveiligheid om infectie van dieren in een 
vroeg drachtstadium te voorkomen, zijn het in quarantaine plaatsen van aangekochte dieren, 
het verhinderen van contact met runderen van een ander bedrijf op de weide, het apart houden 
van een pasgeboren kalf en het moederdier tot het testresultaat bekend is en het voorzien van 
bedrijfskledij voor professionele bezoekers. Gezien de hoge BVDV prevalentie en het risico 
op herinfectie bij aanvang van het programma, kan vaccinatie als bijkomende 
bioveiligheidsmaatregel, aangewezen zijn om infectie van de foetus te voorkomen. In een 
latere fase wordt een status toegekend aan bedrijven waar alle individuele runderen een 
BVDV status hebben. Specifieke richtlijnen over hoe deze fase zal worden uitgevoerd zijn 
nog niet voorhanden en zijn afhankelijk van de voortgang van de eerste fase van het 
programma. Aangaande de overgang van de eerste fase van de bestrijding naar het toekennen 
van een status aan het bedrijf, kan een pilootstudie in bedrijven die reeds een tijd vrij zijn van 
BVDV aangewezen zijn om een verderzetting van het bemonsteren van oorweefselstalen 
economisch en epidemiologisch af te wegen ten opzichte van het individueel testen van dieren 
bestemd voor handel in combinatie met een serologische screening van jongvee.  
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realiseren van deze thesis is zeker en vast het vermelden waard. 
Verder wens ik de overige leden van de examencommissie, Prof. Dr. George Gunn, 
Dr. Axel Mauroy, Prof. Dr. Hans Nauwynck, Dr. Koen Mintiens en Dr. Stefaan Ribbens, te 
bedanken voor de opmerkingen en suggesties die bijgedragen hebben tot een betere kwaliteit 
van deze thesis. 
De FOD Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu wordt 
bedankt voor de financiële steun die het uitvoeren van onderzoeksprojecten mogelijk maakt. 
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In het bijzonder wens ik Dr. Dominique Vandekerchove te bedanken voor de begeleiding van 
dit onderzoeksproject. 
Bedankt aan de sponsors, IDEXX, MSD en Boehringer-Ingelheim, om een deel van de 
kosten van het drukwerk voor hun rekening te nemen. 
De collega’s, vrienden eigenlijk, van den 48 kunnen natuurlijk niet ontbreken in dit 
dankwoord. Davy, je hebt er zelfs Garfield bij gehaald om me te overtuigen koffie te drinken. 
Maar helaas, het is nog steeds niet van dat. Jouw plaats in den 48 probeer ik nog steeds in ere 
te houden. Loes, toeval of niet, maar het was plezant mijn meter uit het eerste jaar terug te 
zien. Veel sterkte met je rug! Merel, samen achter het muurke begonnen, samen vanachter het 
muurke gepromoveerd. Soms spreek je sneller dan je denkt, maar gek genoeg is dit hetgene 
wat ik aan jou apprecieer en soms voor de nodige punch zorgt. Béné, je deinst er niet voor 
terug om je eigen mening te geven, wat geapprecieerd wordt. Ik ben ervan overtuigd dat jouw 
doctoraat dik in orde zal zijn. Philippe, was er eindelijk iemand om het testosterongehalte mee 
op een aanvaardbaar niveau te houden met bovendien een interesse voor rundvee, dan blijken 
de kippetjes meer je aandacht te genieten en ben je de praktijk ingetrokken. Niettemin veel 
succes gewenst met het huis en de voorbereidingen van de trouw. Marjolijn, ondertussen ruim 
een jaar in België, het is hier blijkbaar zo slecht nog niet. Hopelijk kan ik je binnenkort de 
nodige hulp bieden bij het uitvoeren van EFFORT. Marilena & Ilias, you provide den 48 with 
southern temperament, which should be seen as a compliment! Iris, de nieuwste aanwinst op 
den 48, alvast veel succes gewenst met de kippetjes. Lotte, ik was vol bewondering hoe je je 
doctoraat hebt afgewerkt, maar ben nu nog meer onder de indruk hoe je nog steeds andermans 
belangen voorop stelt. Meid, ik hoop van harte dat tijd wonden kan helen. Wannes, je passage 
was van korte duur, maar is desondanks niet onopgemerkt voorbij gegaan. We moeten zeker 
eens gaan bierproeven.   
De kliniekcollega’s en -vrienden, Davy, Vanessa, Hilde, Kim, Anneleen, Ilse, Bart, 
Jenne, Valérie, Sofie, Philippe en Kristof, altijd bereid om bij te springen indien nodig, 
zorgden voor een aangename samenwerking. Ook Jan, Vanessa en Davy, bedankt voor het 
geduld bij het eerste gestuntel en de back-up bij het uitvoeren van keizersneden. Verder wens 
ik iedereen op de vakgroep te bedanken voor raad en daad waar nodig. 
Marylene, Miet, Nick en Jean-Baptiste hebben hun vermelding in dit dankwoord zeker 
en vast verdiend. Hoewel ik ervan overtuigd ben dat ik meermaals ongelegen kwam 
aankloppen, hebben ze daar nooit iets van laten merken en werd mij steeds de nodige uitleg 
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verschaft die een labo-leek nodig had. Ook de laboranten van het CODA verdienen een 
woordje van dank. Niet alleen waren zij meer dan eens bereid om te helpen in het verwerken 
van de stalen; zij hebben vooral veel geduld gehad met mij tijdens het aanleren van de 
verschillende diagnostische technieken. Wat de ENZOREM collega’s betreft, mag ik 
natuurlijk Inge, Sara en Antoine niet vergeten. Een bureau met ramen ter vervanging van de 
strandfoto’s, was een verademing! 
In Machelen heb ik steeds kunnen rekenen op de medewerking van Laurent en Willem 
bij het uitvoeren van transmissiestudies. Hun bijdrage in het opzetten en het uitvoeren van de 
deze studies was cruciaal. Met plezier heb ik de nieuwe douches uitgetest. Uiteraard mag het 
stalpersoneel, in het bijzonder Eddy, niet vergeten worden. Ik moest maar laten weten 
wanneer ik me langs de Brusselse ring kon wringen en zij stonden klaar om te helpen bij het 
nemen van de stalen.  
Christian en Laurens, altijd bereid me nog eens te laten ‘sukkelen’ in de praktijk. 
Jammer dat de tijd ontbreekt om dit regelmatiger te doen! Heb er alvast veel van opgestoken. 
Nonkel Michel & Marc, bedankt om te willen meewerken aan het onderzoek in het kader van 
mijn onderzoeksproject. 
Alle vrienden en familie persoonlijk bedanken in dit dankwoord zou ons te ver leiden, 
maar toch meer dan oprechte woorden van dank voor mijn ouders. Papa en mama, ik doe mijn 
uiterste best alle kansen die jullie mij geven ten volle te benutten en jullie trots te maken. 
Mama Chantal en papa Etienne, bedankt voor de warmte en openheid die ik mocht ervaren 
vanaf onze eerste kennismaking (al dan niet toevallig). Tot slot mag natuurlijk zij die erin 
slaagt mij maximaal uit mijn comfortzone te trekken niet ontbreken. Ik ben ervan overtuigd 
dat ze goed en wel beseft dat ze ondertussen, geheel terecht, meer dan één pralientje heeft 
verdiend… 
Bedankt allemaal!    
 
 
  
 
 
